<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2023.1194865</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Current understanding of the genomic abnormities in premature ovarian failure: chance for early diagnosis and management</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Yang</surname> <given-names>Xu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Yang</surname> <given-names>Lin</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2256852/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University</institution>, <addr-line>Chengdu, Sichuan</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Pharmacy, West China Hospital, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Ali &#x00C7;etin, University of Health Sciences, T&#x00FC;rkiye</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Numan Cim, Demiro&#x011F;lu Bilim University, T&#x00FC;rkiye; Harun Egemen Tolunay, Liv Hospital, T&#x00FC;rkiye</p></fn>
<corresp id="c001">&#x002A;Correspondence: Lin Yang, <email>hxyyyl@yeah.net</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>02</day>
<month>06</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>10</volume>
<elocation-id>1194865</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>03</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>05</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2023 Yang and Yang.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Yang and Yang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Premature ovarian failure (POF) is an insidious cause of female infertility and a devastating condition for women. POF also has a strong familial and heterogeneous genetic background. Management of POF is complicated by the variable etiology and presentation, which are generally characterized by abnormal hormone levels, gene instability and ovarian dysgenesis. To date, abnormal regulation associated with POF has been found in a small number of genes, including autosomal and sex chromosomal genes in folliculogenesis, granulosa cells, and oocytes. Due to the complex genomic contributions, ascertaining the exact causative mechanisms has been challenging in POF, and many pathogenic genomic characteristics have yet to be elucidated. However, emerging research has provided new insights into genomic variation in POF as well as novel etiological factors, pathogenic mechanisms and therapeutic intervention approaches. Meanwhile, scattered studies of transcriptional regulation revealed that ovarian cell function also depends on specific biomarker gene expression, which can influence protein activities, thus causing POF. In this review, we summarized the latest research and issues related to the genomic basis for POF and focused on insights gained from their biological effects and pathogenic mechanisms in POF. The present integrated studies of genomic variants, gene expression and related protein abnormalities were structured to establish the role of etiological genes associated with POF. In addition, we describe the design of some ongoing clinical trials that may suggest safe, feasible and effective approaches to improve the diagnosis and therapy of POF, such as Filgrastim, goserelin, resveratrol, natural plant antitoxin, Kuntai capsule et al. Understanding the candidate genomic characteristics in POF is beneficial for the early diagnosis of POF and provides appropriate methods for prevention and drug treatment. Additional efforts to clarify the POF genetic background are necessary and are beneficial for researchers and clinicians regarding genetic counseling and clinical practice. Taken together, recent genomic explorations have shown great potential to elucidate POF management in women and are stepping from the bench to the bedside.</p>
</abstract>
<kwd-group>
<kwd>premature ovarian failure (POF)</kwd>
<kwd>infertility</kwd>
<kwd>genomic variants</kwd>
<kwd>treatment</kwd>
<kwd>clinical trials</kwd>
</kwd-group>
<counts>
<fig-count count="3"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="276"/>
<page-count count="19"/>
<word-count count="17873"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Obstetrics and Gynecology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p>Premature ovarian failure (POF), also known as premature menopause, causes absent menstruation and infertility before expected female menopause (<xref ref-type="bibr" rid="B1">1</xref>). It is characterized by the loss of normal ovarian function, the cessation of menstruation or loss of follicles and the cessation of follicle production (<xref ref-type="bibr" rid="B2">2</xref>). Approximately 1% of females are affected by sporadic POF in reproductive years under the age of 40, 1&#x2030; before 30 years old and 0.1% before 20 years old, where familial POF presented the highest incidence frequency of nearly 12.7% (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). Females with POF usually exhibit follicular atresia, hypoestrogenism and ovarian function loss and then present with primary or secondary amenorrhea and infertility (<xref ref-type="bibr" rid="B5">5</xref>). Clinically, diagnostic criteria are usually based on follicle-stimulating hormone (FSH) levels in the menopausal range (over 40 IU/L) and estradiol levels (less than 50 pmol/L) in females aged before 40 (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). However, ovarian biopsy and ultrasound have minimal effects in the early diagnosis and screening of POF. The diagnosed POF female will suffer a serious psychosocial, economic and health burden (<xref ref-type="bibr" rid="B8">8</xref>). Thus, the prediagnosis of the high-risk POF population becomes particularly important for protection and treatment.</p>
<p>The etiology of POF is highly heterogeneous, with a wide spectrum of causes, such as genetics, living habits, the environment and infection, whereas the genetic contribution is generally considered paramount (<xref ref-type="bibr" rid="B9">9</xref>). POF, as one component of genetic disorders, has been widely recognized (<xref ref-type="bibr" rid="B10">10</xref>). An increasing number of plausible causative genes have been proposed, including genomic mutation, dysregulated gene expression and signaling cascade functions, whereas the gene framework for interpreting the etiology of POF has yet to be elucidated (<xref ref-type="bibr" rid="B11">11</xref>). However, the precise identification of causative genes remains a challenge. Causative genes potentially influence various aspects of the ovary, such as gonadal development, oogenesis, folliculogenesis, meiosis, DNA repair, hormone secretion, metabolism, and immune response (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B11">11</xref>). Defects in multiple genes cause ovarian failure in animal models. It is reasonable to begin by searching causative genes from different angles related to POF development. With contemporary genetic strategy development, genome-wide association studies (GWASs) and genome-wide sequencing of exomes (WES) approaches provide us with more opportunities to locate susceptible loci and more candidate genes related to POF (<xref ref-type="bibr" rid="B12">12</xref>&#x2013;<xref ref-type="bibr" rid="B14">14</xref>).</p>
<p>In particularly, for the early diagnosis of a disease, biomarkers are measurable indicators of a particular disease or physiological state of an organism. In terms of this, any epigenetic phenotype can be attributed to DNA, RNA, or protein changes, which in turn are biomarkers for a specific phenotype (<xref ref-type="bibr" rid="B15">15</xref>). The ideal biomarker should be easily detected in blood or primary tissues and meet regulatory approval for the test to be used to make clinically valid decisions (<xref ref-type="bibr" rid="B16">16</xref>). Understanding specific POF genetic mechanisms will provide guidance for the diagnosis and treatment of high-risk females.</p>
<p>In this review, we summarized POF-related genomic variants, transcriptome abnormalities and protein molecular functions according to recent thought-provoking articles and projects. The etiology and molecular basis of POF are highlighted through different prospective cytogenetic constitutions. In addition, some novel concepts challenging the therapeutic options for POF in clinical reproductive trials have also aroused great interest in the management of this issue. We describe the design of several ongoing clinical trials that might propose safe, feasible and effective approaches to improve the diagnosis and treatment of POF.</p>
</sec>
<sec id="S2">
<title>Genomic instability involved in POF</title>
<p>Chromosomal gene abnormalities have long been regarded as a cause of POF, but the percentages vary widely among reported series (<xref ref-type="bibr" rid="B17">17</xref>). Genetic heterogeneity and disease development have been widely investigated and observed to have a close relationship (<xref ref-type="bibr" rid="B18">18</xref>). With the development of sequencing technology, increasing solid evidence suggests that genomic instability underlies the pathogenesis of POF (<xref ref-type="bibr" rid="B13">13</xref>). Therefore, as an obstacle to basic ovarian development, key gene variants are particularly harmful to ovarian cells and promote POF (<xref ref-type="table" rid="T1">Table 1</xref>). Variants located in conserved regions are more likely to influence the inherent gene functions (<xref ref-type="bibr" rid="B19">19</xref>) 31871067. Thus, variation-induced protein and cell signaling perturbations might yield severe functional defects in ovarian cell development, thereby causing a negative effect on POF. In this section, we summarize several pivotal genes (X chromosome genes and autosomal genes) and their latest research advances (<xref ref-type="fig" rid="F1">Figures 1</xref>, <xref ref-type="fig" rid="F2">2</xref>), whose variants warrant strong consideration as pathogenic candidates for POF.</p>
<table-wrap position="float" id="T1">
<label>TABLE 1</label>
<caption><p>Candidate genetic variants responsible for ovarian disorder and POF.</p></caption>
<table cellspacing="5" cellpadding="5" frame="box" rules="all">
<thead>
<tr>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;"></td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">Gene</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">Location</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">Population</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">Variations</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">Protein</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Prominent related effects</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">References</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="9">X chromosome genes</td>
<td valign="top" align="center" rowspan="3">POF1B</td>
<td valign="top" align="center">Exon 10</td>
<td valign="top" align="center">Lebanese</td>
<td valign="top" align="center">c.986G &#x003E; A</td>
<td valign="top" align="center">p.Arg329Gln</td>
<td valign="top" align="left">Impair the ability of POF1B to bind non-muscle F-actin, and affected germ cells fenlie in POF</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B23">23</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Adjacent to exon 10</td>
<td valign="top" align="center">Chinese</td>
<td valign="top" align="center">c.932A &#x003E; C</td>
<td valign="top" align="center">p.K311T</td>
<td valign="top" align="left">Impair the capacity of POF1B to bind non-muscle actin filaments and lead to secondary amenorrhea</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B26">26</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Intron 4</td>
<td valign="top" align="center">Turkey</td>
<td valign="top" align="center">c.439-2A &#x003E; G</td>
<td valign="top" align="center">Unknown</td>
<td valign="top" align="left">Change the evolutionally conserved splicing acceptor site</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B27">27</xref>)</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="6">BMP-15</td>
<td valign="top" align="center">Exon 2</td>
<td valign="top" align="center">Iranian</td>
<td valign="top" align="center">c.538G &#x003E; A</td>
<td valign="top" align="center">p.A180T</td>
<td valign="top" align="left">reduce mature peptide generation and activity and synergy with growth differentiation factor 9 (GDF9)</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B48">48</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Exon</td>
<td valign="top" align="center">Italian</td>
<td valign="top" align="center">c.704A &#x003E; G</td>
<td valign="top" align="center">p.Y235C</td>
<td valign="top" align="left">Suppressed ovary granulosa cell proliferation and was associated with ovarian dysgenesis.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B43">43</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Exon 2</td>
<td valign="top" align="center">Caucasian</td>
<td valign="top" align="center">c.202C &#x003E; T</td>
<td valign="top" align="center">p.R68W</td>
<td valign="top" align="left">Influence in BMP15 biological activity and difficult to rescue</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B42">42</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Exon 2</td>
<td valign="top" align="center">Iranian</td>
<td valign="top" align="center">c.309T &#x003E; G</td>
<td valign="top" align="center">p.N103K</td>
<td valign="top" align="left">Shows haploinsufficiency or negative dominance effects and is similar with previous mutation features</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B47">47</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Exon 1</td>
<td/>
<td valign="top" align="center">c.551T &#x003E; C</td>
<td valign="top" align="center">p.M184T</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="center">Promoter</td>
<td valign="top" align="center">Indian</td>
<td valign="top" align="center">c.-9C &#x003E; G</td>
<td valign="top" align="center">//</td>
<td valign="top" align="left">Associate with POF and shows the ability to strengthen the assisted reproduction technique response to recombinant FSH</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="13">Autosomes genes</td>
<td valign="top" align="center" rowspan="2">SOHLH2</td>
<td valign="top" align="center">Promoter</td>
<td valign="top" align="center">Chinese</td>
<td valign="top" align="center">c.-210G &#x003E; T</td>
<td valign="top" align="center">//</td>
<td valign="top" align="left">Disturb the SOHLH2 gene expression through interfering the upstream transcriptional regulator recognition</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B109">109</xref>, <xref ref-type="bibr" rid="B110">110</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Intron 5</td>
<td valign="top" align="center">Serbian</td>
<td valign="top" align="center">c.530 + 6T &#x003E; G</td>
<td valign="top" align="center">//</td>
<td valign="top" align="left">Impair RNA splicing and decrease the number of translated proteins in POF</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B109">109</xref>)</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="6">FOXL2</td>
<td valign="top" align="center">Exon</td>
<td valign="top" align="center">New Zealand</td>
<td valign="top" align="center">772<sub>1009</sub>T &#x003E; A</td>
<td valign="top" align="center">p.Tyr258Asn</td>
<td valign="top" align="left">Lead to FOXL2 haploinsufficiency</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B122">122</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">//</td>
<td valign="top" align="center">American</td>
<td valign="top" align="center">c.448_448delA</td>
<td valign="top" align="center">p.K150Rfs&#x002A;121</td>
<td valign="top" align="left">contribute to POF in the phenotypic variability of BPES</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B128">128</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Exon</td>
<td valign="top" align="center">Caucasian</td>
<td valign="top" align="center">Missense mutation</td>
<td valign="top" align="center">p.H104R</td>
<td valign="top" align="left">Cause BPES-induced POF</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B130">130</xref>)</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="center">In-frame duplication</td>
<td valign="top" align="center">p.A222_A231dup10</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="center">Exon</td>
<td valign="top" align="center">Mexican</td>
<td valign="top" align="center">c.76G &#x003E; T</td>
<td valign="top" align="center">p.Glu26&#x002A;</td>
<td valign="top" align="left">Contribute to FH domain deleted protein and FOXL2 haploinsufficiency</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B132">132</xref>)</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="center">c.290delG</td>
<td valign="top" align="center">p.Gly97Alafs&#x002A;53</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="center" rowspan="5">SALL4</td>
<td valign="top" align="center">Exon 2</td>
<td valign="top" align="center">Chinese</td>
<td valign="top" align="center">c.541G &#x003E; A</td>
<td valign="top" align="center">p.Val181Met</td>
<td valign="top" align="left">Influence the structure and DNA binding of SALL4</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B137">137</xref>)</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="center">c.2449A &#x003E; G</td>
<td valign="top" align="center">p.Thr817Ala</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="center">Exon 2</td>
<td valign="top" align="center">Chinese</td>
<td valign="top" align="center">c.2279C &#x003E; T</td>
<td valign="top" align="center">p.T760I</td>
<td valign="top" align="left">Associated with SALL4 protein level and enhanced regulatory activity to downstream<break/> POU5F1</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B140">140</xref>)</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="center">c.1790A &#x003E; G</td>
<td valign="top" align="center">p.K597R</td>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="center">c.541G &#x003E; A</td>
<td valign="top" align="center">p.V181M</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left" rowspan="8"></td>
<td valign="top" align="center" rowspan="8">FSHR</td>
<td valign="top" align="center">Exon 7</td>
<td valign="top" align="center">Finland</td>
<td valign="top" align="center">566C &#x003E; T</td>
<td valign="top" align="center">p.Ala189Val</td>
<td valign="top" align="left">contribute to the defection of targeting protein in cell surface and serious phenotype of the ovarian failure</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B143">143</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Exon 6</td>
<td valign="top" align="center">German</td>
<td valign="top" align="center">c.479T &#x003E; C</td>
<td valign="top" align="center">p.I160T</td>
<td valign="top" align="left">impair the FSHR expression</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B144">144</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Exon 10</td>
<td valign="top" align="center">Asian Indian</td>
<td valign="top" align="center">c.1253T &#x003E; G</td>
<td valign="top" align="center">p.Ile418Ser</td>
<td valign="top" align="left">Lead to decreased transmembrane signal transduction and follicle retardation</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B147">147</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Exon 10</td>
<td valign="top" align="center">Turkish</td>
<td valign="top" align="center">c.1222G &#x003E; T</td>
<td valign="top" align="center">p.Asp408Tyr</td>
<td valign="top" align="left">Decrease granulosa cell-surface transduction signal and total second messenger cAMP production</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B149">149</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Exon 10</td>
<td valign="top" align="center">Chinese</td>
<td valign="top" align="center">c.1789C &#x003E; A</td>
<td valign="top" align="center">p.L597I</td>
<td valign="top" align="left">Suppress FSH-induced cAMP production and ERK1/2 phosphorylation</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B152">152</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Exon 10</td>
<td valign="top" align="center">Asians</td>
<td valign="top" align="center">c.2039G &#x003E; A</td>
<td valign="top" align="center">p.S680N</td>
<td valign="top" align="left">Serve as a potential genetic biomarker for POF</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B156">156</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Exon 2</td>
<td valign="top" align="center">Chinese</td>
<td valign="top" align="center">c.175C &#x003E; T</td>
<td valign="top" align="center">p.R59X</td>
<td valign="top" align="left">Arrest folliculogenesis, decrease FSHR expression and abolish the granulosa cells response to FSH stimulation</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B157">157</xref>)</td>
</tr>
<tr>
<td valign="top" align="center">Exon 10</td>
<td valign="top" align="center">Brazil/German</td>
<td valign="top" align="center">c.919A &#x003E; G</td>
<td valign="top" align="center">p.Ala307Thr</td>
<td valign="top" align="left">Associate with ovary stimulation acceleration, therefore leading to ovarian depletion in POF patients</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B144">144</xref>, <xref ref-type="bibr" rid="B160">160</xref>)</td>
</tr>
</tbody>
</table></table-wrap>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>Summary of some X chromosome gene variants and related functions in the POF.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-10-1194865-g001.tif"/>
</fig>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p>The summary of some autosomal gene variants and related functions in the POF.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-10-1194865-g002.tif"/>
</fig>
</sec>
<sec id="S3">
<title>Abnormal X chromosome genes</title>
<sec id="S3.SS1">
<title>The premature ovarian failure 1B (POF1B)</title>
<p>The premature ovarian failure 1B evolutionary novel gene was found only in vertebrates (<xref ref-type="bibr" rid="B19">19</xref>) and has been identified by breakpoint mapping of X-autosome translocations (<xref ref-type="bibr" rid="B20">20</xref>). Generally, this gene alludes to a specific region following the law of Online Mendelian Inheritance in Man (OMIM) (<xref ref-type="bibr" rid="B21">21</xref>). It was previously detected that POF1B (an interrupted gene) in POF patients appeared to be mutated (<xref ref-type="bibr" rid="B20">20</xref>). Whole-genome sequencing of a Lebanese POF familial genetic group revealed point mutations localized in POF1B exon 10 characterized by a nucleotide (G &#x003E; A) at position 1,123 (<xref ref-type="bibr" rid="B22">22</xref>). Among these, the protein sequence alteration occurred at 329 amino acid site p. Arg329Gln (c.986 G &#x003E; A), similar to arginine to glutamine, and the mutant POF1B protein showed a lower ability to bind non-muscle F-actin (<xref ref-type="fig" rid="F1">Figure 1</xref>), thus influencing the POF patients&#x2019; germ-cell division (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). Moreover, the POF1B p.Arg329Gln variant influenced the F-actin amount and contributed to the loss of tight junctions in polarized epithelial cells in POF (<xref ref-type="bibr" rid="B24">24</xref>). More recently, Zhang et al. demonstrated that there was a novel POF1B missense variant in Chinese POF patients, namely, p.K311T (c. 932A &#x003E; C), which was adjacent to p.Arg329Gln and was supposed to have similar functions to non-muscle F-actin (<xref ref-type="bibr" rid="B25">25</xref>). Recently, in a 21-year-old Chinese POF woman with long-term oligomenorrhea and high sex hormone levels, exome sequencing revealed p.K311T (c.932A &#x003E; C) variant in POF1B was closely associated with POF (<xref ref-type="bibr" rid="B25">25</xref>). The p.K311T was milder than p.Arg329Gln and was more likely to lead to secondary amenorrhea (<xref ref-type="bibr" rid="B25">25</xref>). Through comparative analysis with p.Arg329Gln, p. K311T was suspected to damage the capacity of POF1B to bind non-muscle F-actin and lead to secondary amenorrhea (<xref ref-type="bibr" rid="B25">25</xref>). Moreover, another variant (c.439-2A &#x003E; G) in intron 4 of POF1B was observed to be associated with POF, which mainly changes the evolutionally conserved splicing acceptor site (<xref ref-type="bibr" rid="B26">26</xref>).</p>
<p>In some keratinocytes, the POF1B expression level was observed to be inversely associated with keratinocyte number and correlated with defects in cell adhesion (<xref ref-type="bibr" rid="B27">27</xref>). Keratinocyte-related cytokines might promote the primordial to primary follicle transition (<xref ref-type="bibr" rid="B28">28</xref>). As an upstream modulator, CBX2.1 has the ability to stimulate POF1B activation, whereas silencing CBX2.1 significantly downregulated POF1B expression and potentially was associated with POF development (<xref ref-type="bibr" rid="B29">29</xref>). CBX2.1 in human sex development has been reported to inhibit the female pathway and is related to female hypoplasia (<xref ref-type="bibr" rid="B30">30</xref>). The pathogenic variants of POF1B have been continuously studied (<xref ref-type="bibr" rid="B23">23</xref>), and increasing evidence supports the importance of POF1B variants in POF occurrence.</p>
</sec>
<sec id="S3.SS2">
<title>Bone morphogenetic protein 15 (BMP15)</title>
<p>Bone morphogenetic protein 15 is an X-linked coding gene and is related to primary-stage protein generation from oocytes (<xref ref-type="bibr" rid="B31">31</xref>). As a member of the TGF-&#x00DF; superfamily family, BMP-15 also has significant advances in our understanding of early follicle development and oocyte regulation in mammals (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). BMP-15 was demonstrated to be expressed in oocytes and pituitary cells but to a much lesser extent in other organs, such as the kidney and heart (<xref ref-type="bibr" rid="B34">34</xref>). The importance of BMP-15 as a fertility marker in females has attracted great attention because it influences all statuses of oocyte development and embryonic quality, especially the regulation of granulosa generation and ovarian functions (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>). Expression of BMP15 in oocytes stimulates granulosa cell growth and inhibits FSH action by suppressing follicle-stimulating hormone receptor (FSHR) expression, which is related to ovulation rate and fertility (<xref ref-type="bibr" rid="B37">37</xref>). Compared to other TGF&#x00DF; superfamily members, BMP-15 has undergone rapid evolution and subjective positive selection in mammalian clades, and its important and particular functional role eventually leads to its importance in female fertility (<xref ref-type="bibr" rid="B38">38</xref>). Abnormal regulation of BMP-15 might be related to female POF and infertility (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>). Recently, attention has been focused on the potential biological impact of BMP15 genomic variation on the POF population. BMP15 variation may predispose to POF and stimulate ovarian defects in cooperation with other alteration features (<xref ref-type="bibr" rid="B41">41</xref>).</p>
<p>Notably, Di Pasquale et al. (<xref ref-type="bibr" rid="B42">42</xref>) reported that the p. Y235C in the X-linked BMP15 gene in 2 sisters, a heterozygous non-conservative substitution in the pro region, suppressed ovary granulosa cell proliferation and was associated with ovarian dysgenesis. Among these, wild-type BMP15 showed the ability to stimulate <sup>3</sup>H-thymidine in ovary granulosa cells and was restored at a concentration nearly five-fold higher than that of p. Y235C BMP15 group. Granulosa cells were demonstrated to deliver nutrients and metabolites through gap junctions to oocytes and are involved in oocyte secretion of paracrine signals (<xref ref-type="bibr" rid="B43">43</xref>). In addition, BMP15 knockdown female mice have a reduced ovulation rate and therefore show lower fertility (<xref ref-type="bibr" rid="B44">44</xref>). BMP15 variation not only influences granulosa cells but also plays an important biological role in the secretion and activation of TGF-&#x03B2; superfamily members in oocytes (<xref ref-type="bibr" rid="B45">45</xref>). Moreover, there are two missense alterations (p.R68W and p.A180T) and one insertion (p.262insLeu) were observed in a POF cohort study (<xref ref-type="bibr" rid="B33">33</xref>). The p.R68W (c.202C &#x003E; T) showed a larger and significant influence on BMP15 biological functions, and p.R68W carriers develop POF before the age of 20 years old (<xref ref-type="bibr" rid="B41">41</xref>). <italic>In vitro</italic> cotransfection experiments with wild-type cDNA indicated that p.R68W is a deleterious mutation in POF patients, where BMP15 activity is difficult to rescue (<xref ref-type="bibr" rid="B41">41</xref>). Moreover, in Iranian POF familial history patients, the detectable p. A180T (c.538G &#x003E; A) was accompanied by a long history of oligomenorrhea, high FSH and very low anti-Mullerian hormone (AMH) levels, whereas without sonographic abnormal symptoms (<xref ref-type="bibr" rid="B46">46</xref>). The p.A180T nucleotide site alteration in exon 2 of BMP15 (named rs104894767) has been recorded in databases. As previously reported, the p. A180T variation was demonstrated to be associated with non-familial POF patients (<xref ref-type="bibr" rid="B33">33</xref>). By Sanger sequencing analysis, the POF family members who carry the p.A180T variant presented premature physiological menopause, while healthy members without p. A180T variant presented regular menses (<xref ref-type="bibr" rid="B46">46</xref>). Besides, BMP15 with p. A180T variant presented fourfold lower activity than the wild-type, which changes the potential to reduce mature peptide generation and activity and synergy with growth differentiation factor 9 (GDF9) (<xref ref-type="bibr" rid="B47">47</xref>). BMP15 protein binds to its closely related paralog GDF9 to form homodimers or heterodimers that regulate many aspects of development by activating transmembrane serine/threonine kinase receptors (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B49">49</xref>). The interaction between GDF9 and BMP15 mutation is regarded as an important internal factor for ovarian hypofunction in POF patients (<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>).</p>
<p>Some novel BMP15 mutations were detected in a number of POF patients. In the BMP15 pro-domain region, p.N103K and p.M184T were observed to prevent the protein from binding to mature dimers, consequently leading to decreased BMP15 activity (<xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B50">50</xref>). The pro-domain is usually uncoupled during the maturation process and modulates the folding and dimerization of the protein structure (<xref ref-type="bibr" rid="B51">51</xref>). BMP15 with p.N103K and p.M184T variant usually showed haploinsufficiency or negative dominance effects and is similar to previous mutation features (<xref ref-type="bibr" rid="B46">46</xref>), which is potentially associated with POF symptoms (<xref ref-type="bibr" rid="B52">52</xref>&#x2013;<xref ref-type="bibr" rid="B54">54</xref>). Moreover, BMP15 with the c.-9C &#x003E; G promoter polymorphism presented a functional association with the POF phenotype (<xref ref-type="bibr" rid="B49">49</xref>). Although c.-9C &#x003E; G in 398 PCOS female cohort studies was not significantly associated with disease pathogenesis, it was related to some specific clinical features, such as anovulation and infertility (<xref ref-type="bibr" rid="B55">55</xref>). Indeed, c.-9C &#x003E; G is a frequent variant in BMP15 and has been reported to be functionally associated with POF (<xref ref-type="bibr" rid="B56">56</xref>). Due to the high reactivity of the G allele, c.-9C &#x003E; G also showed the ability to strengthen the assisted reproduction technique response to recombinant FSH (<xref ref-type="bibr" rid="B57">57</xref>). Additionally, <italic>in silico</italic> analysis in combination with the BMP15 promoter sequence showed that the -14 to -8 bp region of the BMP15 promoter is the primary regulatory target for the pituitary homebox 1 protein (PITX1) (<xref ref-type="bibr" rid="B49">49</xref>), in which two of the active binding regions were validated <italic>in vitro</italic>, namely, prom-G and prom-C constructs. PITX1 was reported to be associated with gonadotroph cell activation and estrogenic signals (<xref ref-type="bibr" rid="B58">58</xref>), and the estrus cycle-related estrogen signaling pathway was positively involved in POF traditional Chinese medicine treatment (<xref ref-type="bibr" rid="B59">59</xref>). Despite recent findings demonstrating the involvement of BMP15 mutation in POF, further studies elucidating the roles of modulators would lead to a better understanding of the disease pathogenesis.</p>
</sec>
<sec id="S3.SS3">
<title>Fragile X messenger ribonucleoprotein 1 (FMR1)</title>
<p>Fragile X messenger ribonucleoprotein 1 is an X-linked gene encoding RNA binding protein, and its mutation in the 5&#x2032;UTR dynamic triplet CGG repeat is related to fragile X syndrome (<xref ref-type="bibr" rid="B60">60</xref>&#x2013;<xref ref-type="bibr" rid="B62">62</xref>). The CGG trinucleotide repeat is usual but unique in the region of FMR1 exon 1, which conducts mRNA transcription but not translation into protein amino acids (<xref ref-type="bibr" rid="B61">61</xref>). The copies of FMR1 premutation CGG can be expanded to varying degrees and associated with different biological function performance (<xref ref-type="bibr" rid="B63">63</xref>). Mutations of FMR1 are usually categorized by the number of CGG trinucleotide repeats: the classic normal is 6-45 CGG repeats in the 5&#x2032;UTR; FMR1 premutation alleles have 50-200 CGG repeats in the 5&#x2032;UTR; FMR1 full mutation has an expansion of more than 200 CGG repeats in the 5&#x2032;UTR; and the intermediate range (also called the gray zone) has an expansion of 45&#x2013;54 repeats in the FMR1 5&#x2032;UTR (<xref ref-type="bibr" rid="B64">64</xref>, <xref ref-type="bibr" rid="B65">65</xref>). The FMR1 gene is primarily associated with neuro/psychiatric risks, while it appeared to control the function of follicle recruitment and ovarian reserve in recent evidences (<xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B66">66</xref>, <xref ref-type="bibr" rid="B67">67</xref>). Moreover, the premutation CGG repeat-related increased FMR1 mRNA transcription was potentially involved in POF pathogenesis compared to the general population, such as 35 and 54 repeats (<xref ref-type="bibr" rid="B64">64</xref>). Two independent studies indicated that FMR1 premutation carriers have an earlier average menopausal age and are more susceptible to POF than non-carriers (<xref ref-type="bibr" rid="B68">68</xref>, <xref ref-type="bibr" rid="B69">69</xref>). Notably, in familial trait ovarian failure, FMR1 premutation CGG was associated with a large number of ascertained idiopathic POF cases (<xref ref-type="bibr" rid="B61">61</xref>). FMR1 premutation expansions are not merely high-risk factors for POF occurrence but are also relevant to cytokine levels, such as serum FSH, in ovarian aging pathological conditions (<xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B71">71</xref>).</p>
<p>Recently, the FMR1 premutation aroused great attention to female reproductive fertility, and women with monogenic FMR1 premutation have an equivalent risk of POF to the top 1% of genetic susceptibility (<xref ref-type="bibr" rid="B72">72</xref>). Approximately 15&#x2013;20% of females with an FMR1 premutation develop POF (<xref ref-type="bibr" rid="B73">73</xref>). In Europe, the frequency of premutation of FMR1 in POF was higher than that in the general population, and FMR1 sequencing has become part of the recommended monitoring indicators for women with POF (<xref ref-type="bibr" rid="B74">74</xref>). However, the FMR1 premutation frequency is relatively lower in Chinese women. In Guo et al. (<xref ref-type="bibr" rid="B75">75</xref>) indicated that 0.49% (2 to 379) FMR1 premutation was found in limited sporadic Chinese POF samples, while none were observed in 402 controls. Recently, another case-control study reported that only 1.6% (2 to 124) of FMR1 permutations were observed in Chinese POF patients, and a 0.9% (1 to 111) premutation frequency existed in the control group (<xref ref-type="bibr" rid="B76">76</xref>). Studies from a Chinese cohort indicated that the distribution of allele 1 (smaller number of CGG repeats) rather than allele 2 in POI was closely associated with POF occurrence, wherein &#x003C;26 and &#x2265;29 CGG repeats potentially have a higher risk for reproduction and POF (<xref ref-type="bibr" rid="B76">76</xref>, <xref ref-type="bibr" rid="B77">77</xref>). The ectopic expression of FMR1 CGG repeats leading to POF was also validated in a mouse model (<xref ref-type="bibr" rid="B78">78</xref>). However, the underlying mechanism of FMR1 CGG repeat-relevant ovarian function modulation remains unclear, including the pathological condition of the reduced ovarian reserve and abnormal follicular and oocyte growth. One hypothesis is that various FMR1 CGG expansions might contribute to transcriptional level changes and lead to ratios of distinct RNA isoforms (<xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B64">64</xref>, <xref ref-type="bibr" rid="B79">79</xref>). The above changes potentially decrease the fragile X messenger ribonucleoprotein 1 (FMRP) level or intercellular localization, thereby affecting steroidogenic enzymes and hormonal receptors and ultimately affecting the occurrence of POF (<xref ref-type="bibr" rid="B79">79</xref>, <xref ref-type="bibr" rid="B80">80</xref>). The increased CGG repeat in FMR1 has the ability to impede the 40S ribosomal subunit in the process of downstream initiation codon recognition, resulting in translational debility and consequently reducing the FMRP level (<xref ref-type="bibr" rid="B80">80</xref>). Generally, during normal folliculogenesis, FMRP is primarily expressed in granulosa cells, which is crucial for oocyte maturation and growth. POF patients with FMR1 CGG repeats, such as 19 &#x003C; n &#x003C; 90, have impaired ovarian reserve, and abnormal FMR1 transcript levels related to FMRP influence the process of oocyte and follicular maturation (<xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B82">82</xref>). Moreover, in these reproduction-related cells, the intracellular signaling cascade is also involved in FMR1 expression and regulation. Rehnitz et al. (<xref ref-type="bibr" rid="B67">67</xref>) reported that inhibition of AKT increases FMR1 expression and decreases FMRP levels, whereas recombinant FSH (rFSH) and mTOR inhibition lead to the opposite phenomenon, indicating that a feedback loop between FMR1/FMRP and the mTOR/AKT signaling cascade interacts during GC proliferation and oocyte maturation. In terms of this, FMRP phosphorylation and activation are thought to be potentially associated with S6K, a downstream molecule of mTOR (<xref ref-type="bibr" rid="B83">83</xref>). The FMR1 knockdown mouse exhibited larger ovaries in mass and volume compared to age-matched controls, wherein increased protein levels of Tsc2 and mTOR were detected (<xref ref-type="bibr" rid="B84">84</xref>). As previously reported, FMR1 expression influenced cholesterol and steroid hormone generation and impaired ovary responses to hormonal stimulation and growth (<xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B82">82</xref>), while the mTOR pathway was involved in ovarian development and enlarged ovaries histologically with precocious follicular development (<xref ref-type="bibr" rid="B84">84</xref>, <xref ref-type="bibr" rid="B85">85</xref>). On the other hand, an <italic>in vivo</italic> experiment in mice observed that permutation transcripts were closely associated with mitochondrial and ovarian abnormalities (<xref ref-type="bibr" rid="B86">86</xref>). mTOR is closely related to the metabolic process of mitochondria in ovarian cells (<xref ref-type="bibr" rid="B87">87</xref>), and inhibition of mTOR significantly improved follicular development and endocrine functions of the ovaries, thereby extending reproductive aging and premature aging of POF mice (<xref ref-type="bibr" rid="B88">88</xref>). These observations suggested that abnormal FMR1 transcription potentially causes POF, but it remains unclear which process plays a prior role in disease initiation.</p>
</sec>
<sec id="S3.SS4">
<title>DACH2</title>
<p>The Dachshund (DACH) gene family is known as a transcriptional cofactor on the basis of highly conserved protein interaction domains, while the DACH genomic mutation was observed to be closely associated with poor female reproductive tract development, namely, DACH1 and DACH2 (<xref ref-type="bibr" rid="B89">89</xref>). The DACH gene was first described in Drosophila, encoding nuclear proteins involved in different organs, such as eyes, limbs, and genital discs, which are required for the genital development of male and female phenotypes (<xref ref-type="bibr" rid="B90">90</xref>, <xref ref-type="bibr" rid="B91">91</xref>). In mammals, the female and male reproductive tracts develop from the M&#x00FC;llerian duct (MD) and Wolffian duct (WD), respectively, wherein the WD regresses, retains the MD and then differentiates into the oviduct, uterus, and cervix (<xref ref-type="bibr" rid="B92">92</xref>, <xref ref-type="bibr" rid="B93">93</xref>). Both DACH1 and DACH2 were observed in MD, and DACH1/DACH2 double mutation is associated with female reproductive tract development retrogression (<xref ref-type="bibr" rid="B89">89</xref>). In addition, DACH2 is expressed in human ovarian tissue and contributes to some ovarian malignant diseases, and variants in DACH2 may be associated with the POF phenotype (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B94">94</xref>). Specifically, DACH2 has been implicated in human POF syndrome, where the genomic alteration of DACH2 was demonstrated to hinder the correct process of ovarian follicle differentiation (<xref ref-type="bibr" rid="B95">95</xref>).</p>
<p>The DACH2 gene in Xq21 is located 700 KB distal to POF1B (<xref ref-type="bibr" rid="B96">96</xref>&#x2013;<xref ref-type="bibr" rid="B98">98</xref>). The genomic mutation analysis of the DACH2 coding region observed that missense mutations of three single nucleotide polymorphisms (SNPs) (P36 L, G59D, and R412K), non-conservative amino acid substitutions, were frequently present in POF patients compared to the control group (<xref ref-type="bibr" rid="B20">20</xref>). These three mutations were proven to be specific in the DACH2 subfamily rather than DACH1, and they occur in the N-terminal region of the DACH2 protein close to the DD1 domain (amino acids 66&#x2013;162). The DD1 domain at the N-terminus was demonstrated to be involved in DNA binding and EYA protein interaction; thus, DACH1 genomic mutation potentially influenced its signaling biological functions (<xref ref-type="bibr" rid="B99">99</xref>, <xref ref-type="bibr" rid="B100">100</xref>). In an animal model, the EYA gene plays an important role in mammalian gonad development, whose response to estrogen-related receptors will directly influence reproduction (<xref ref-type="bibr" rid="B101">101</xref>). Therefore, the interaction between DACH2 alteration and EYA protein might increase the risk of POF by affecting the biological process of ovarian follicle differentiation (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B102">102</xref>). Moreover, another study indicated that genomic mutation was specific to one POF patient, which occurred in the third intron of DACH2 with a C to T transition downstream of Exon_3 (<xref ref-type="bibr" rid="B103">103</xref>). On the basis of their results, this variant was not within the splice or receptor sequences and was unlikely to influence the DACH2 level, and there is no clear evidence to support its direct function in POF pathology. Strengthening the screening of more candidate disease-causing mutation sites, including exons and introns, is helpful for the early diagnosis and prevention of POF. Generally, the nucleotide translocation might disrupt the transcription of itself or nearby genes by affecting the cis/trans-acting regulatory factors from the transcription units and consequently deleterious changes in the expression and protein level (<xref ref-type="bibr" rid="B89">89</xref>, <xref ref-type="bibr" rid="B104">104</xref>). Nevertheless, there is evidence indicating that DACH2 knockout mice are viable and fertile, which is reminiscent of null mutations of DACH2 that might independently affect the reproductive phenotypes of POF patients (<xref ref-type="bibr" rid="B105">105</xref>).</p>
</sec>
</sec>
<sec id="S4">
<title>Autosomal gene abnormalities</title>
<sec id="S4.SS1">
<title>SOHLH2</title>
<p>The transcriptional regulator SOHLH2 was observed to be preferentially expressed in oocytes of immature ovaries and has been deemed a critical regulator for early germ cell development (<xref ref-type="bibr" rid="B106">106</xref>). The SOHLH2-silenced mouse model showed infertility and atrophied ovaries devoid of follicles (<xref ref-type="bibr" rid="B107">107</xref>). Previously, Qin et al. (<xref ref-type="bibr" rid="B108">108</xref>) indicated that SOHLH2 variants were implicated in primary POF, which exhibited several non-synonymous mutations in POF patients compared to normal controls. For example, p.Glu79Lys (c.235G &#x003E; A) and p.Glu105Gly (c.314A &#x003E; G) have high conservation among mammalian potential to be pathogenic for Chinese POF patients. In addition, the SOHLH2 promoter variant c.-210G &#x003E; T was observed in a Chinese POF patient and is located in a region with transcription factor-binding sites and CpG islands (<xref ref-type="fig" rid="F2">Figure 2</xref>) (<xref ref-type="bibr" rid="B108">108</xref>, <xref ref-type="bibr" rid="B109">109</xref>). This variation may potentially disturb SOHLH2 gene expression by interfering with upstream transcriptional regulator recognition (<xref ref-type="bibr" rid="B109">109</xref>). Notably, the loss of SOHLH2 expression contributes to the rapid loss of oocytes, as well as increased oocyte apoptosis (<xref ref-type="bibr" rid="B110">110</xref>). In this respect, SOHLH2 has been regarded as the downstream target of the BMP4/Smad signaling pathway in the survival and apoptosis of oocytes (<xref ref-type="bibr" rid="B111">111</xref>). Moreover, SOHLH2 could bind to the C-kit promoter, act as a positive transcriptional regulator for C-kit and modulate the C-kit/PI3K/Akt/Foxo3a cascade in oocytes, which is directly associated with oocyte survival and follicle development in POF (<xref ref-type="bibr" rid="B111">111</xref>, <xref ref-type="bibr" rid="B112">112</xref>). Furthermore, there is another variant (c.530 + 6T &#x003E; G) in introns that is supposed to affect RNA splicing, thereby decreasing the number of translated proteins in POF (<xref ref-type="bibr" rid="B108">108</xref>).</p>
</sec>
<sec id="S4.SS2">
<title>FOXL2</title>
<p>Forkhead box L2 (FOXL2) belongs to the winged helix/forkhead transcription factor family, containing a 110 amino acid DNA-binding domain, which is associated with protein mislocation, aggregation, and intranuclear mobility, including ovarian development and postpartum recovery (<xref ref-type="bibr" rid="B113">113</xref>). FOXL2, the earliest recognized ovarian differentiation marker in mammals, was observed in the granulosa cells of the ovary as well as the mesenchyme of the developing eyelids (<xref ref-type="bibr" rid="B114">114</xref>&#x2013;<xref ref-type="bibr" rid="B117">117</xref>). FOXL2 might be a pivotal modulator of ovarian development and eyelid formation. Previous studies also concluded that the FOXL2 variant results in a relatively mild blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) phenotype (<xref ref-type="bibr" rid="B118">118</xref>), which is a rare autosomal dominant genetic developmental disorder in the eyelids and ovary (<xref ref-type="bibr" rid="B114">114</xref>). BPES has emerged to have two subtypes: type I is associated with POF, and type 2 has no systemic associations (<xref ref-type="bibr" rid="B119">119</xref>), wherein the different amino acid site alterations will lead to the different subtypes (<xref ref-type="bibr" rid="B120">120</xref>).</p>
<p>Previously, the FOXL2 variants A221-A230del and p.Tyr258Asn (772<sub>1009</sub>T &#x003E; A) were observed in POF patients from the New Zealand and Slovenia cohorts, respectively (<xref ref-type="bibr" rid="B121">121</xref>). The non-conservative substitution of 772<sub>1009</sub>T &#x003E; A might lead to FOXL2 haploinsufficiency, thus promoting POF development (<xref ref-type="bibr" rid="B121">121</xref>). After that, some studies indicated that FOXL2 variants of p.Gly187Asp and c.627delT favor the implication of FOXL2 variants in POF, and more systematic genetic screening of FOXL2 variants is important in POF premature diagnosis and hormonal replacement therapy (<xref ref-type="bibr" rid="B122">122</xref>, <xref ref-type="bibr" rid="B123">123</xref>). Recently, several FOXL2 variants were reported to be associated with a severe BPES phenotype, such as p.Arg103Cys (c.307C &#x003E; T), p.His104Pro (c.311A &#x003E; C), p.Ser107Asn (c.320G &#x003E; A), and p.Phe112Tyr (c.335T &#x003E; A) (<xref ref-type="bibr" rid="B124">124</xref>). Of note, these variants potentially damage the function of STAR and OSR2 protein by abolishing transcriptional activity (<xref ref-type="bibr" rid="B124">124</xref>), and STAR is important for differentiation of granulosa cells, where the FOXL2 variant will lose suppression for the STAR promoter, thereby accelerating differentiation of granulosa cells and secondary depletion of the primordial follicle pool (<xref ref-type="bibr" rid="B125">125</xref>, <xref ref-type="bibr" rid="B126">126</xref>). In addition, the FOXL2 heterozygous deletion variant p.K150Rfs&#x002A;121 (c.448_448delA) and its coexisting gene BMP15 act synergistically and contribute to POF in the phenotypic variability of BPES, and this variant leads to polyalanine deletion and truncated protein at 269 amino acids (aa) (<xref ref-type="bibr" rid="B127">127</xref>, <xref ref-type="bibr" rid="B128">128</xref>). Herein, the digenic inheritance of the FOXL2 variant and its related effector potentially contribute to BPES-related ovarian function impairment and POF 25988799. Moreover, two variants, p.H104R and p.A222_A231dup10 in Caucasian FOXL2 leads to mislocalization and aggregation, thus impairing transactivation, which could cause BPES-induced POF (<xref ref-type="bibr" rid="B129">129</xref>). In one case, estrogen treatment successfully improved menarche and secondary sexual characteristics, which showed promising therapeutic potential in the reproductive outcomes of BPES-related POF patients (<xref ref-type="bibr" rid="B130">130</xref>). In a Latin American cohort, two FOXL2 variants (c.76G &#x003E; T and c.290delG) were also deemed pathogenic factors for POF patients, wherein the former contributes to FH domain deleted protein and FOXL2 haploinsufficiency, while the latter mechanism is still unclear (<xref ref-type="bibr" rid="B131">131</xref>). Generally, the FOXL2 protein acts as a transcription factor for some important molecules in ovarian maintenance and function, such as binding to TESCO to suppress Sox9 expression in ovaries, ultimately contributing to the development of ovaries (<xref ref-type="bibr" rid="B117">117</xref>). The polyalanine tract deletion/expansion-related variant is likely to abolish FOXL2 protein function and thereby abrogate the above process in ovarian maintenance (<xref ref-type="bibr" rid="B132">132</xref>), where the polyalanine tract deletion variant is more likely related to BPES type I (with POF) (<xref ref-type="bibr" rid="B121">121</xref>, <xref ref-type="bibr" rid="B133">133</xref>). Meanwhile, there are many variants present in unaffected POF family members that have not been confirmed to be pathogenic variants. Identification of FOXL2 variants is critical for suspected BPES and/or POF evaluation as well as prevention in due course.</p>
</sec>
<sec id="S4.SS3">
<title>SALL4</title>
<p>Spalt-like transcription factor 4 (SALL4), a zinc finger transcription factor expressed in murine oocytes, binds to POU5F1 and regulates its expression (<xref ref-type="bibr" rid="B134">134</xref>, <xref ref-type="bibr" rid="B135">135</xref>). Previously, genomic sequencing of 100 Han Chinese POF women showed that the SALL4 variants p.Val181Met (c.541G &#x003E; A) and p.Thr817Ala (c.2449A &#x003E; G) potentially influences the structure and DNA binding of SALL4 and is associated with POF development (<xref ref-type="bibr" rid="B136">136</xref>). The pathogenesis of the SALL4 variants might be achieved by abolishing the recognition of the downstream POU5F1 gene and suppressing its expression (<xref ref-type="bibr" rid="B135">135</xref>, <xref ref-type="bibr" rid="B137">137</xref>), ultimately affecting primordial oogonia development and triggering POF (<xref ref-type="bibr" rid="B138">138</xref>). Recently, another POF study in 50 Han Chinese individuals through whole-exome sequencing (WES) analysis discovered several novel variants in POF patients, including p.T760I (c.2279C &#x003E; T) and p.K597R (c.1790A &#x003E; G), as well as the verified variant p.V181M (c.541G &#x003E; A) (<xref ref-type="bibr" rid="B139">139</xref>). Intriguingly, <italic>in vitro</italic> functional experiments showed that these variants were positively associated with the SALL4 protein level and enhanced regulatory activity to downstream POU5F1. According to this phenomenon, posttranslational regulation of SALL4 protein levels might be the molecular mechanism underlying POI (<xref ref-type="bibr" rid="B139">139</xref>). Taken together, the above observations suggested that SALL4 variants are closely associated with POF development, whereas the different variation types of SALL4 might present different manifestations of SALL4 activity and phenotypic variability.</p>
</sec>
<sec id="S4.SS4">
<title>FSHR</title>
<p>Follicle-stimulating hormone receptor has a pivotal role in recognizing FSH, thereby controlling granulosa cells of the ovary and female reproduction (<xref ref-type="bibr" rid="B140">140</xref>). FSHR variants have been identified in women with hypergonadotropic POF symptoms, especially inactivating mutation subtypes (<xref ref-type="bibr" rid="B141">141</xref>). Doherty et al. (<xref ref-type="bibr" rid="B142">142</xref>) reported that inactivating extracellular FSHR variants existed in the ligand recognition region of the receptor, namely, p.Ala189Val (566C &#x003E; T), whose occurrence contributed to the defect of targeting protein in the cell surface and a more serious phenotype of ovarian failure. Interestingly, another transmembrane variant, p.Ala419Thr, of FSHR reduced symptoms when it compounded with p.Ala189Val, which was potentially due to the higher residual activity retained by the transmembrane variant and neutralizing p.Ala189Val variant inactivating functions (<xref ref-type="bibr" rid="B142">142</xref>). Notably, Ledig et al. (<xref ref-type="bibr" rid="B143">143</xref>) observed that p. I160T (c.479T &#x003E; C) is an inactivation variant in FSHR and is associated with POF, which will impair FSHR expression on the cell surface. They simultaneously indicated that p.I160T variant-induced FSHR inhibition potentially further enhanced the BMP15 variant (p.A180T)-related granular cells decrease in the developing follicle (<xref ref-type="bibr" rid="B143">143</xref>). In addition, the interaction between FSHR SNP rs6166 and CYP19A1 SNP rs4646/rs10046 was demonstrated to be involved in POF development by regulating folliculogenesis (<xref ref-type="bibr" rid="B144">144</xref>). Thus, synergistic effects of digenic variants might promote POF development to a considerable extent.</p>
<p>Moreover, there are still many FSHR variants that have been demonstrated to have independent pathogenic roles in POF. FSHR is important in human reproduction and was proven to be the first single gene to cause POF (<xref ref-type="bibr" rid="B145">145</xref>). In an Asian Indian descent family, an inactivating pathogenic variant p.Ile418Ser (c.1253T &#x003E; G) in FSHR was detected in POF patients (<xref ref-type="bibr" rid="B146">146</xref>). The p.Ile418Ser (c.1253T &#x003E; G) occurred in exon 10 of FSHR and impaired the transmembrane helix of the FSHR protein, which led to decreased transmembrane signal transduction and follicle retardation (<xref ref-type="bibr" rid="B146">146</xref>). Based on characteristics in the FSHR helix transmembrane domain (TMD) and highly conserved across species (<xref ref-type="bibr" rid="B147">147</xref>), inactivated p.Ile418Ser variant in FSHR was supposed to cause POF. In the second TMD of FSHR, another inactivating variant, p.Asp408Tyr (c.1222G &#x003E; T) has been observed in two Turkish POF patients, which was also accompanied by decreased granulosa cell-surface transduction signal and total second messenger cAMP production (<xref ref-type="bibr" rid="B148">148</xref>). The lack of sufficient FSHR expression and function in ovarian granulosa cells are unable to promote follicle maturation and ovulation, despite high levels of FSH stimulation (<xref ref-type="bibr" rid="B149">149</xref>, <xref ref-type="bibr" rid="B150">150</xref>). Recently, a large cohort study in Han Chinese with more than 190 POF patients and normal controls detected some novel variants. The p. M265 V (c.793A &#x003E; G) and p.L597I (c.1789C &#x003E; A) variants exclusively existed in Chinese POF patients, former located in extracellular domain (ECD) and later in TMD, wherein the p.L597I can suppress FSH-induced cAMP production and ERK1/2 phosphorylation, thereby stimulating the POF phenotype (<xref ref-type="bibr" rid="B151">151</xref>). Generally, the FSHR variant in ECD impaired trafficking and cell surface expression, while the variant in TMD was characterized by abolished signal transduction (<xref ref-type="bibr" rid="B152">152</xref>, <xref ref-type="bibr" rid="B153">153</xref>). However, the p.L597I decreased FSHR expression in the membrane (<xref ref-type="bibr" rid="B151">151</xref>), which is similar to another inactivating variant p.A575V (TMD) manifestation in primary amenorrhea patients (<xref ref-type="bibr" rid="B154">154</xref>). In addition, another POF-associated FSHR variant p.S680N (c.2039G &#x003E; A) was specifically proven in Asian people rather than other ethnicities and is supposed to serve as a potential genetic biomarker for POF in Asians (<xref ref-type="bibr" rid="B155">155</xref>). Through comparison between a Chinese POF family and 192 control women, Liu et al. (<xref ref-type="bibr" rid="B156">156</xref>) demonstrated that a novel FSHR variant p.R59X (c.175C &#x003E; T) in exon 2 was causative for POF by arresting folliculogenesis. The p.R59X is positively related to decreased FSHR expression and deemed a loss-of-function variant. Additionally, p.R59X variant will abolish the granulosa cell response to FSH stimulation, mainly due to the truncated FSHR protein-related ECD and TMD function region absence (<xref ref-type="bibr" rid="B156">156</xref>). It is thus clear that inactivation of FSHR variants will impair FSHR functions and follicular development, thereby leading to POF (<xref ref-type="bibr" rid="B157">157</xref>). Further study should focus on pharmacological and assisted reproductive treatments targeting disrupted FSHR.</p>
<p>Patients with specific FSHR variants, such as p.Ala307Thr polymorphism in Brazilian patients, while it was not associated with ovarian endocrine variables or clinical ultrasonographic findings (<xref ref-type="bibr" rid="B158">158</xref>). Moreover, an expanded comparative sample identified that p.Ala307Thr is more frequent in POF patients than in controls (<xref ref-type="bibr" rid="B159">159</xref>). Among these, increased FSH levels in p.Ala307Thr carrier might be associated with ovary stimulation acceleration, therefore leading to ovarian depletion in POF patients (<xref ref-type="bibr" rid="B159">159</xref>). Notably, in another study, the p.Ala307Thr variant has also been identified in 3 German patients with POF (<xref ref-type="bibr" rid="B143">143</xref>). In terms of this, menstrual dysfunction precedes the initiation of amenorrhea, such as oligomenorrhea, transient amenorrhea and short cycles, which might be a special signature for ovarian failure and are regarded as &#x201C;prodromal POF&#x201D; (<xref ref-type="bibr" rid="B160">160</xref>). In terms of this, future investigations are needed to explore the potential roles of other FSHR variants in the development of POF.</p>
</sec>
<sec id="S4.SS5">
<title>Dysregulated gene expression in POF</title>
<p>Apart from genomic alterations, abnormal expression of the transcriptome caused by multiple factors also has a great impact on POF. Ovarian insufficiency is a continuum of impaired ovarian function or ovarian aging, which is always accompanied by signature marker gene expression abnormalities (<xref ref-type="bibr" rid="B161">161</xref>). In POF, there are three consecutive but progressive stages, occult, biochemical, and overt ovarian failure (<xref ref-type="bibr" rid="B162">162</xref>), and gene expression changes with pathogenesis can provide better evidence for clinical diagnosis (<xref ref-type="bibr" rid="B163">163</xref>, <xref ref-type="bibr" rid="B164">164</xref>). The monitoring of gene expression has been widely used in the discovery of disease biomarkers or therapeutic targets (<xref ref-type="bibr" rid="B165">165</xref>). However, to our knowledge, the molecular mechanism of POF has not yet been clarified. Below, we summarize the dysregulated expression of POF-related genes identified by recent studies, including Ki-67, proliferating cell nuclear antigen (PCNA), chemokine (C-X-C motif) ligand 12 gene (CXCL12), insulin-like peptide 3 (INSL3), and PTX3 (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p>The abnormal gene expression and relevant cascades in POF.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-10-1194865-g003.tif"/>
</fig>
</sec>
<sec id="S4.SS6">
<title>Ki-67</title>
<p>Ki-67 is expressed in proliferating cells, and its protein is associated with different nuclear domains, whereas the Ki-67 protein was detected in mouse oocytes rather than mature sperm (<xref ref-type="bibr" rid="B166">166</xref>, <xref ref-type="bibr" rid="B167">167</xref>). Ki-67 is a DNA-binding protein expressed in all active cell cycle stages and can be used as a marker for cell proliferation (<xref ref-type="bibr" rid="B168">168</xref>, <xref ref-type="bibr" rid="B169">169</xref>). Herein, Ki-67 expression has been regarded as the signature for ovarian tissue transplantation activity and was used to evaluate transplantation-associated follicle dynamics, where the higher Ki-67 expression in ovarian granulosa cells indicated an increase in activated growing/primordial follicles (<xref ref-type="bibr" rid="B170">170</xref>). Moreover, an <italic>in vivo</italic> POF model indicated that the ovarian proliferation index can be evaluated by Ki-67, which is expressed in epithelial cells of the endometrium and glands (<xref ref-type="bibr" rid="B171">171</xref>). Additionally, lower expression of Ki-67 was detected in the POF group than in the control group. In contrast, ovarian tissue with higher FSH levels showed morphologically normal follicles and significantly decreased Ki-67 expression (<xref ref-type="bibr" rid="B172">172</xref>, <xref ref-type="bibr" rid="B173">173</xref>), and gonadotropin inhibited mitosis in granulosa cells early in the periovulatory interval (<xref ref-type="bibr" rid="B174">174</xref>). When follicular atresia occurs, the mutual intensive interaction between granulosa cell death and oocytes plays an indispensable role (<xref ref-type="bibr" rid="B175">175</xref>). Moreover, the inhibition of NF-&#x03BA;B signaling reversed the loss of Ki-67 expression in granulosa cells (<xref ref-type="bibr" rid="B176">176</xref>). A previous study indicated that CYP19A1 expression and estradiol secretion in human ovarian granulosa cells were directly modulated by NF-&#x03BA;B signaling (<xref ref-type="bibr" rid="B177">177</xref>), and these two elements and Ki-67 expression have served as indicators in ovarian disease estrogen treatment (<xref ref-type="bibr" rid="B178">178</xref>). The intervention of Ki-67 expression will directly promote ribosome synthesis during cell division, which is necessary for ovarian granulosa cell proliferation (<xref ref-type="bibr" rid="B179">179</xref>). This evidence supports it as a useful feature to better understand ovarian granulosa cells and follicles, as well as abnormalities in human POF.</p>
</sec>
<sec id="S4.SS7">
<title>PCNA</title>
<p>Proliferating cell nuclear antigen (PCNA) is a key factor for DNA replication and cell cycling, which can be used as an indicator of ovarian cell proliferation and define the extent of departure from Strzalka and Ziemienowicz (<xref ref-type="bibr" rid="B180">180</xref>), Thomas et al. (<xref ref-type="bibr" rid="B181">181</xref>), Muskhelishvili et al. (<xref ref-type="bibr" rid="B182">182</xref>). Through immunohistochemical detection, PCNA has been proven to distinguish follicles with different maturation statuses, where PCNA expression is significant in oocytes, granulosa cells and growing follicles and acts as a primary regulator (<xref ref-type="bibr" rid="B183">183</xref>, <xref ref-type="bibr" rid="B184">184</xref>). However, atretic follicles undergoing atresia were negative for PCNA expression (<xref ref-type="bibr" rid="B185">185</xref>). In a secondary POF model, the mRNA expression of PCNA was significantly decreased in ovarian tissue compared with healthy controls (<xref ref-type="bibr" rid="B186">186</xref>). Moreover, coenzyme Q10 (CoQ10) and/or cryptotanshinone treatment promoted primary follicle and granulosa PCNA expression and improved ovarian injury in POF (<xref ref-type="bibr" rid="B186">186</xref>, <xref ref-type="bibr" rid="B187">187</xref>). A previous study indicated that miR-376a influenced primordial follicle assembly and oocyte apoptosis by binding to the mRNA 3&#x2019; untranslated region (3&#x2019;-UTR), thereby inhibiting PCNA expression (<xref ref-type="bibr" rid="B188">188</xref>). The microRNA modulatory effect on gene expression has been proven to be associated with POF in a mouse model (<xref ref-type="bibr" rid="B189">189</xref>). In POF, increased p53 might disturb oocyte quality and damage ovarian functions (<xref ref-type="bibr" rid="B190">190</xref>), mainly through a posttranslational mechanism (<xref ref-type="bibr" rid="B191">191</xref>). In this respect, the cyclin-dependent kinase suppressor protein p21 is a key downstream target for p53, where p53 boosts downstream effector expression by elevating nascent RNA amounts (<xref ref-type="bibr" rid="B192">192</xref>, <xref ref-type="bibr" rid="B193">193</xref>). Meanwhile, p21 is known as a dual inhibitor for both cyclin-dependent kinases and PCNA, and p21 has the ability to displace chromatin-bound PCNA to interfere with S phase (<xref ref-type="bibr" rid="B194">194</xref>, <xref ref-type="bibr" rid="B195">195</xref>). Not surprisingly, the upregulated p53 expression and enhanced p21 transcription simultaneously existed in POF ovarian tissues and were positively associated with disease development (<xref ref-type="bibr" rid="B196">196</xref>). The reduction in PCNA will lose the balance between apoptosis and fail to ensure successful follicle development and protect follicular growth tissue homeostasis (<xref ref-type="bibr" rid="B197">197</xref>). In addition, another regulator of follicular growth is the Wnt signaling pathway, which is important for pregranulosa cell transition during the period of primordial follicle activation (<xref ref-type="bibr" rid="B198">198</xref>). Notably, significant expression of Wnt-2 in all stages of follicles was positively associated with PCNA and induced granulosa cell proliferation (<xref ref-type="bibr" rid="B199">199</xref>). A study in human cumulus cells demonstrated that Wnt-2 recognizes its receptor FZD9 to regulate the formation of &#x03B2;-catenin and E-cadherin (<xref ref-type="bibr" rid="B200">200</xref>). The knockdown of &#x03B2;-catenin in granulosa cells inhibited PCNA expression but did not affect Wnt-2 expression (<xref ref-type="bibr" rid="B199">199</xref>). Herein, the Wnt-2/&#x03B2;-catenin cascade controls diverse ovarian developmental processes and has the potential to modulate PCNA expression in POF (<xref ref-type="bibr" rid="B201">201</xref>).</p>
</sec>
<sec id="S4.SS8">
<title>CXCL12</title>
<p>Chemokine (C-X-C motif) ligand 12 gene, also known as stromal cell-derived factor (SDF-1), interacts with its receptor CXCR4 and plays an essential role in primordial germ cell (PGC) migration, proliferation, and survival (<xref ref-type="bibr" rid="B202">202</xref>). Moreover, there is evidence indicating that the expression of CXCL12/CXCR4 was increased in a POF mouse model and was negatively associated with primordial-to-primary follicle transition (<xref ref-type="bibr" rid="B203">203</xref>). In the Chinese Han population, CXCL12 polymorphism-related CXCL12 expression and high CXCL12 protein levels were supposed to be associated with POF and have the potential to be candidate biomarkers (<xref ref-type="bibr" rid="B204">204</xref>). A high level of CXCL12 expression has been deemed a potentiator for primordial follicle densities and smaller follicle sizes due to chemokine and receptor interactions, and increased CXCL12 expression inhibits follicle activation and ovarian functions (<xref ref-type="bibr" rid="B205">205</xref>). However, the detailed CXCL12 regulation mechanisms in the pathogenesis of POF are still unclear. In terms of inflammation, POF-related atretic follicles and granulosa cells are usually characterized by an inflammatory response involving leukocytes and their secretory inflammatory factors (<xref ref-type="bibr" rid="B206">206</xref>, <xref ref-type="bibr" rid="B207">207</xref>). Among them, the interaction between CXCL12 and its receptor CXCR4 was demonstrated to participate in physiological inflammatory processes, including follicular dysregulation (<xref ref-type="bibr" rid="B208">208</xref>, <xref ref-type="bibr" rid="B209">209</xref>). In line with this, the cyclophosphamide- and busulfan-induced POF mouse model presented a positive correlation between CXCL12/CXCR4 protein expression and the inflammatory response compared to the normal control, namely, increased proinflammatory cytokines (IL-6, IL-8, and TNF-&#x03B1;) and decreased anti-inflammatory cytokines (IL-10) (<xref ref-type="bibr" rid="B203">203</xref>). On the other hand, the chemotaxis role of the CXCL12/CXCR4 axis in mesenchymal stem cell (MSC) transplantation also attracted great interest in POF therapy. Ling et al. (<xref ref-type="bibr" rid="B210">210</xref>) reported that CXCL12 can induce CXCR4-expressing MSC migration and homing in the ovaries of POF mice, and blocking the CXCL12/CXCR4 axis significantly reduced MSC homing to ovaries and reduced their therapeutic efficacy in POF. As in previous studies, the CXCL12/CXCR4 axis might be a prerequisite for MSC homing, where CXCL12 acts as a chemoattractant molecule to guide CXCR4<sup>+</sup> MSC directional migration (<xref ref-type="bibr" rid="B211">211</xref>&#x2013;<xref ref-type="bibr" rid="B213">213</xref>). In this process, the activated PI3K/Akt signaling pathway was implicated in the CXCL12-CXCR4 interaction as a downstream factor and is thought to be involved in POF (<xref ref-type="bibr" rid="B210">210</xref>, <xref ref-type="bibr" rid="B214">214</xref>). The CXCL12/CXCR4 pathway is known as an upstream switch for Akt phosphorylation, which in turn modulates various biological effects, such as cell migration, chemotaxis and adhesion (<xref ref-type="bibr" rid="B215">215</xref>). The binding of CXCL12 to CXCR4 was accompanied by PI3K/Akt signaling activation, while CXCL12/CXCR4 inhibition synchronously inhibited PI3K/Akt signaling, which directly decreased the MSC transplant treatment effect in the POF model (<xref ref-type="bibr" rid="B210">210</xref>). The higher homing rate and survival of MSCs to the ovary in individuals will reduce depletion of germline stem cells and increase the therapeutic efficacy for POF (<xref ref-type="bibr" rid="B216">216</xref>). Moreover, activation of PI3K/Akt signaling has been reported to promote MSC differentiation into endothelial cells (<xref ref-type="bibr" rid="B217">217</xref>, <xref ref-type="bibr" rid="B218">218</xref>) and is positively associated with granulosa cells and follicle proliferation in therapy for POF (<xref ref-type="bibr" rid="B219">219</xref>&#x2013;<xref ref-type="bibr" rid="B222">222</xref>). In contrast, suppressed PI3K/AKT signaling probably contributed to large-scale oocyte loss and more serious POF (<xref ref-type="bibr" rid="B223">223</xref>). Moreover, PI3K/Akt signaling in MSCs post-transplant also showed the ability to increase the Th17/Tc17 and Th17/Treg ratios to improve the inflammatory immune environment, thereby promoting the recovery of ovarian function in POF (<xref ref-type="bibr" rid="B222">222</xref>). Together, the balance of CXCL12 expression is important in POF development, while the pros and cons of mechanisms should be further investigated.</p>
</sec>
<sec id="S4.SS9">
<title>INSL3</title>
<p>Insulin-like peptide 3 (INSL3) is a member of the relaxin family of neohormones, which is thought to be specific for mammalian traits with respect to reproduction (<xref ref-type="bibr" rid="B224">224</xref>). INSL3 is mainly produced by interna cells of the growing antral follicle and is recognized by the specific receptor RXFP2, which modulates the synthesis of the steroid precursor androstenedione (<xref ref-type="bibr" rid="B225">225</xref>). In the follicle, INSL3 expression and activation orchestrate the generation of steroid precursors and rostenedione and promote estradiol release in granulosa cells (<xref ref-type="bibr" rid="B225">225</xref>, <xref ref-type="bibr" rid="B226">226</xref>). Of note, INSL3 expression was absent in preantral, atretic follicles, granulosa cells or oocytes (<xref ref-type="bibr" rid="B227">227</xref>, <xref ref-type="bibr" rid="B228">228</xref>), while RXFP2 was expressed in mammalian oocytes and was associated with oocyte maturation (<xref ref-type="bibr" rid="B229">229</xref>, <xref ref-type="bibr" rid="B230">230</xref>). Moreover, INSL3 can also be secreted into the circulation and detected in serum, with a level of immunofluorescence detection of &#x223C;100 pg/ml in women, by which we can monitor the growth of antral follicles (<xref ref-type="bibr" rid="B231">231</xref>). As described above, INSL3 expression is consequently increased in polycystic ovary syndrome (PCOS) and decreased in females with POF, which might be a valuable biomarker for POF patients. Importantly, the effect of high INSL3 expression on follicle development might be attributed to the stimulation of GDF9 in oocytes, and the inhibition of GDF9 specifically blocks the INSL3 growth-stimulating effect (<xref ref-type="bibr" rid="B232">232</xref>). Moreover, INSL3 from theca cells induces the generation of the enzyme 17&#x03B1;-hydroxylase (CYP17A1) in the same cell, which can modulate the production of the follicular steroid precursor and androstenedione from pregnenolone or progesterone (<xref ref-type="bibr" rid="B225">225</xref>). Additionally, released androstenedione will be absorbed by granulosa cells and act as a precursor for estrogens (estrone, estradiol). In the development of POF, the serum INSL3 level was observed to be continuously decreased and showed a strong negative association with FSH (<xref ref-type="bibr" rid="B233">233</xref>). Thus, INSL3 might be a promising new specific biomarker for POF progression.</p>
</sec>
<sec id="S4.SS10">
<title>PTX3</title>
<p>PTX3 is a glycoprotein with two structural domains: one is in the C-terminal region and homology with C-reactive protein (CRP)/serum amyloid P component (SAP), and the other is a unique N-terminal domain without homology (<xref ref-type="bibr" rid="B234">234</xref>). PTX3 is specifically expressed in the ovarian cycle and has multifunctional properties under different conditions. Of note, PTX3 was demonstrated to be expressed in cumulus cells, a subtype of granulosa cells surrounding oocytes (<xref ref-type="bibr" rid="B235">235</xref>). Cumulus cells are special and have different fates compared to other granulosa cells, such as facilitating oocyte release and fertilization (<xref ref-type="bibr" rid="B236">236</xref>). In a mouse model, PTX3 expression is significantly increased in cumulus cells before ovulation and is associated with cumulus matrix formation, and PTX3 blockade in mice results in infertility (<xref ref-type="bibr" rid="B237">237</xref>). Due to the specific recognition of heavy chains (HC) to the PTX3 N-terminal domain and its covalent linkage to hyaluronan (HA) polymers (<xref ref-type="bibr" rid="B238">238</xref>), PTX3 indirectly influences the HA biological context in cumulus cells, which can be reversed by PTX3 blockade (<xref ref-type="bibr" rid="B239">239</xref>). Herein, PTX3 might modulate the HA cascade via the interaction between the HC (<xref ref-type="bibr" rid="B240">240</xref>). Notably, HA was reported to be an excellent cell scaffold for MSC transplantation in POF, which not only promotes cell secretory function but also prolongs the retention of MSCs to improve therapeutic efficiency (<xref ref-type="bibr" rid="B241">241</xref>, <xref ref-type="bibr" rid="B242">242</xref>). Moreover, HA also protects ovarian function in an immunosuppressive drug-induced POF mouse model, where HA improves granulosa cell damage, estradiol concentration, and the number of follicles (<xref ref-type="bibr" rid="B243">243</xref>). In ovarian granulosa cells, HA activation potentially increased progesterone receptor membrane component 1 (PGRMC1) expression, thereby preventing abnormal granulosa cell apoptosis and follicle loss in POF (<xref ref-type="bibr" rid="B244">244</xref>). Together, these data indicate that altered expression of PTX3 might influence the POF ovarian microenvironment and cell functions, likely ameliorating proliferation, damage, and hormone levels.</p>
</sec>
<sec id="S4.SS11">
<title>POF relevant clinical trials</title>
<p>Although the POF incidence rate only accounts for 1% of women under the age of 40 (<xref ref-type="bibr" rid="B245">245</xref>), monitoring and management show potential to prevent POF from devastating outcomes (<xref ref-type="bibr" rid="B246">246</xref>). POF, a term that appropriately describes the end-stage of premature ovarian insufficiency, is typically diagnosed when amenorrhea combined with high gonadotrophins and hypoestrogenemia, wherein some adolescent patients have follicular depletion or insult to the ovary and present with delayed puberty or amenorrhea (<xref ref-type="bibr" rid="B247">247</xref>, <xref ref-type="bibr" rid="B248">248</xref>). Current therapeutic management of POF includes psychosocial support, hormone replacement therapy, and fertility management (<xref ref-type="bibr" rid="B249">249</xref>). The diverse etiologies of POF, such as genetics, immune disorders, and microenvironmental dysregulation, have also attracted great attention in the treatment of POF (<xref ref-type="bibr" rid="B250">250</xref>). Interestingly, providing more information regarding the etiology, diagnosis, and treatment of POF in adolescents or high-risk populations will provide new insights into preventing disease development, along with the development of more sensitive markers. Below, we will present the latest clinical trials on the diagnosis and treatment of POF.</p>
</sec>
<sec id="S4.SS12">
<title>Diagnosis</title>
<p>The POF is serious clinical disease with high FSH, low hormonal and ovarian failure. Women of reproductive age diagnosed with POF or premature ovarian failure according to ESHRE criteria are usually based on a sinus follicle count (AFC), AMH, and early follicular serum FSH levels (<xref ref-type="bibr" rid="B251">251</xref>). The premature ovarian insufficiency is usually accompanied with anovulatory cycles leading to abnormal uterine bleeding (AUB), it is important to identify the pathogenies for irregular cycles such as FSH, LH, and estradiol measurements (<xref ref-type="bibr" rid="B252">252</xref>). The FSH levels of premature ovarian insufficiency women are typically higher than 25 mIU/ml (<xref ref-type="bibr" rid="B253">253</xref>), but precise cutoff levels have not been determined. Some patients with premature ovarian insufficiency symptoms show low FSH levels compared with above standard, while FSH &#x003E; 40 mIU/ml was deemed as POF (<xref ref-type="bibr" rid="B254">254</xref>, <xref ref-type="bibr" rid="B255">255</xref>). In addition, simultaneous measurement of upregulated basal luteinizing hormone (LH) levels is helpful to determine whether a high FSH level is associated with ovulation (<xref ref-type="bibr" rid="B254">254</xref>). In clinical practice, more stable and detectable indicators are urgently needed. A clinical trial using a combination of FSH stimulation and transvaginal ultrasound examination developed a method for the precisely detection of POF (NCT00006156). Among these interventions, FSH intervention in normal ovaries showed a significant stimulation in serum inhibin B, and ultrasound examination will further define parameters that could improve the earlier diagnosis of POF (<xref ref-type="bibr" rid="B256">256</xref>). Moreover, ovary ultrasound characteristics appear to predict ovarian activity, where ovarian volume/area and follicle count are associated with the age of menopause and primordial follicles in POF patients (<xref ref-type="bibr" rid="B257">257</xref>, <xref ref-type="bibr" rid="B258">258</xref>). Some clinical trials have been established for endogenous etiological substances, such as the etiological elements endocan, sFlt-1, PIGF, and niacin, in POF patients (NCT03924648, NCT03932877 and NCT04641624). The above prospective studies included POF patients and normal controls with some potential molecular analysis, and blood was obtained at the early follicular phase of the menstrual cycle. These molecular functions are not well studied in the POF mechanism and diagnosis, whereas they are significant in follicle development and POF population (<xref ref-type="bibr" rid="B259">259</xref>&#x2013;<xref ref-type="bibr" rid="B261">261</xref>). These works underscore the idea that additional attempts are needed to understand the impact of POF discrete microenvironments and potential diagnostic markers.</p>
</sec>
<sec id="S4.SS13">
<title>Therapeutic strategies</title>
<p>A randomized clinical trial from South Valley University proposed a hypothesis by using filgrastim to recover ovary functions, with 10 participants from 16 to 40 years (NCT02783937). Filgrastim is a granulocyte-colony stimulating factor (G-CSF) and has been approved to stimulate peripheral blood stem cell numbers (<xref ref-type="bibr" rid="B262">262</xref>) and potentially improve ovarian follicle formation (<xref ref-type="bibr" rid="B263">263</xref>). In ovarian failure, there are still some residual very small embryonic-like stem cells (VSELs) that serve as a backup pool for mature stem cells and are mobilized under stress conditions, which might be involved in gonadal rescue after exogenous/endogenous stimuli (<xref ref-type="bibr" rid="B264">264</xref>, <xref ref-type="bibr" rid="B265">265</xref>). Filgrastim treatment in combination with stem cell studies in a mouse model showed promising results in the recovery of oogenesis and reproductive capacity (<xref ref-type="bibr" rid="B266">266</xref>, <xref ref-type="bibr" rid="B267">267</xref>); thus, further clinical studies in humans potentially promote more appropriate treatment for POF. Recently, another clinical trial with 150 participants used the natural plant antitoxin resveratrol to target the NOX/ROS cascade and improve oxidative stress in POF patients (NCT05410093). NOX function in oxidative damage is harmful to ovarian function and structure (<xref ref-type="bibr" rid="B268">268</xref>). Moreover, resveratrol exhibited estrogen-like effects and showed great potential in estrogen deficiency-related osteoporosis, as well as increasing ovarian serum estrogen (<xref ref-type="bibr" rid="B269">269</xref>). Estrogen upregulation will improve the POF clinical presentation. In this respect, some chemotherapy-induced POF was potentially prevented by the gonadotropin-releasing hormone agonist goserelin (<xref ref-type="bibr" rid="B270">270</xref>). The application of goserelin is associated with amelioration of ovarian reserve markers such as AMH, estradiol and FSH, as well as improving ovarian function (<xref ref-type="bibr" rid="B271">271</xref>). Nevertheless, further exploration of goserelin function in chemotherapy-induced POF through ovarian function biomarkers are still ongoing (NCT04536467). On the other hand, many trials have focused on systemic balance regulation in POF treatment. Zhang et al. (<xref ref-type="bibr" rid="B272">272</xref>) demonstrated that Kuntai capsule, a traditional Chinese medicine, has been widely used for the clinical treatment of menopausal syndrome and showed the ability to improve damaged ovarian function. By improving atretic follicles, AMH expression, the antioxidant pathway, and the Bcl-2/Bax-related apoptotic pathway, Kuntai capsule presented therapeutic potential in the symptoms caused by ovarian failure and ovarian endocrine function recovery. In addition, another POF mouse model demonstrated that Kuntai capsules might inhibit PI3K/AKT/mTOR signaling by decreasing the phosphorylation of pathway protein members, as well as recovering AMH, FSH, and estradiol, ultimately improving ovarian function and protecting reproductive capacity in POF (<xref ref-type="bibr" rid="B273">273</xref>). More recently, a random clinical trial with 120 participants was established, which aimed at the efficacy and safety of the Kuntai capsule in POF patients and first used the Kupperman score to evaluate the therapeutic efficacy of the Kuntai capsule (NCT05021094). Another traditional Chinese medicine (HuYang YangKun Formula) was also put forward for POF treatment (NCT02794948), whose systematic regulatory effect significantly improves the ovarian function of POF, such as AMH, FSH, follicle number, TGF-&#x03B2;/TAK1 signaling, and JAK2/STAT3 signaling (<xref ref-type="bibr" rid="B274">274</xref>, <xref ref-type="bibr" rid="B275">275</xref>). The ongoing clinical trial is exploring more effective strategies to address these issues so that we can begin to provide etiology-based management for POF-affected women.</p>
</sec>
</sec>
<sec id="S5" sec-type="conclusion">
<title>Conclusion and prospective</title>
<p>Despite the increase in emerging research, the underlying mechanisms of POF remain poorly understood due to its variable etiology and complex microenvironment. We summarized the recent dynamic changes in POF that are partly important relevant biomarkers in ovarian development by animal and clinical data, which provided essential evidence to confirm the heterogeneity of genomic variants, gene expression and relevant proteins in POF phenotype and etiology. This review evaluated the role of the above important factor status and pathogenic mechanisms in POF, as well as the downstream and downstream consequences. Future genetic studies should involve different ethnic groups and larger sample sizes to promote the understanding of underlying genetic mechanisms in POF. Additionally, effective diagnosis and management necessitate more reliable biomarker targets in the early point POF, wherein the residual ovarian functions may offer an invaluable chance to intervene early. Currently, the therapeutic options for ovarian functional decline, either physiologically or pathologically, are limited. Established clinical trials provide new insights into developing strategies for ovarian resumption and fertility improvement in POF patients. However, the limitations of current genomic studies have restricted the clinical exploration of POF therapy. Therefore, exploring gene-based effective diagnosis and treatment strategies will be beneficial for the physical, mental, and reproductive health of POF patients.</p>
</sec>
<sec id="S6" sec-type="author-contributions">
<title>Author contributions</title>
<p>XY: original draft and visualization preparation. LY: supervision and concepts of the manuscript. Both authors read and agreed to the published version of the manuscript.</p>
</sec>
</body>
<back>
<sec id="S7" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="S8" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bilgin</surname> <given-names>EM</given-names></name> <name><surname>Kovanci</surname> <given-names>E</given-names></name></person-group>. <article-title>Genetics of premature ovarian failure.</article-title> <source><italic>Current Opin Obstet Gynecol.</italic></source> (<year>2015</year>) <volume>27</volume>:<fpage>167</fpage>&#x2013;<lpage>74</lpage>.</citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neumannov&#x00E1;</surname> <given-names>H</given-names></name> <name><surname>M&#x00FC;llerov&#x00E1;</surname> <given-names>M</given-names></name></person-group>. <article-title>Premature ovarian failure.</article-title> <source><italic>Casopis Lekaru Ceskych.</italic></source> (<year>2018</year>) <volume>157</volume>:<fpage>350</fpage>&#x2013;<lpage>3</lpage>.</citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Conway</surname> <given-names>GS</given-names></name></person-group>. <article-title>Clinical manifestations of genetic defects affecting gonadotrophins and their receptors.</article-title> <source><italic>Clin Endocrinol.</italic></source> (<year>1996</year>) <volume>45</volume>:<fpage>657</fpage>&#x2013;<lpage>63</lpage>.</citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Kasteren</surname> <given-names>YM</given-names></name> <name><surname>Hundscheid</surname> <given-names>RD</given-names></name> <name><surname>Smits</surname> <given-names>AP</given-names></name> <name><surname>Cremers</surname> <given-names>FP</given-names></name> <name><surname>van Zonneveld</surname> <given-names>P</given-names></name> <name><surname>Braat</surname> <given-names>DD</given-names></name></person-group>. <article-title>Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease?</article-title> <source><italic>Hum Reprod (Oxford, England).</italic></source> (<year>1999</year>) <volume>14</volume>:<fpage>2455</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/14.10.2455</pub-id> <pub-id pub-id-type="pmid">10527968</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalantaridou</surname> <given-names>SN</given-names></name> <name><surname>Davis</surname> <given-names>SR</given-names></name> <name><surname>Nelson</surname> <given-names>LM</given-names></name></person-group>. <article-title>Premature ovarian failure.</article-title> <source><italic>Endocrinol Metab Clin North Am.</italic></source> (<year>1998</year>) <volume>27</volume>:<fpage>989</fpage>&#x2013;<lpage>1006</lpage>.</citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vujovi&#x0107;</surname> <given-names>S</given-names></name> <name><surname>Ivovi&#x0107;</surname> <given-names>M</given-names></name> <name><surname>Tanci&#x0107;-Gaji&#x0107;</surname> <given-names>M</given-names></name> <name><surname>Marina</surname> <given-names>L</given-names></name> <name><surname>Bara&#x0107;</surname> <given-names>M</given-names></name> <name><surname>Arizanovi&#x0107;</surname> <given-names>Z</given-names></name><etal/></person-group> <article-title>Premature ovarian failure.</article-title> <source><italic>Srpski Arhiv Celokupno Lekarstvo.</italic></source> (<year>2012</year>) <volume>140</volume>:<fpage>806</fpage>&#x2013;<lpage>11</lpage>.</citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Conway</surname> <given-names>GS</given-names></name></person-group>. <article-title>Premature ovarian failure.</article-title> <source><italic>Br Med Bull.</italic></source> (<year>2000</year>) <volume>56</volume>:<fpage>643</fpage>&#x2013;<lpage>9</lpage>.</citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benetti-Pinto</surname> <given-names>CL</given-names></name> <name><surname>de Almeida</surname> <given-names>DM</given-names></name> <name><surname>Makuch</surname> <given-names>MY</given-names></name></person-group>. <article-title>Quality of life in women with premature ovarian failure.</article-title> <source><italic>Gynecol Endocrinol.</italic></source> (<year>2011</year>) <volume>27</volume>:<fpage>645</fpage>&#x2013;<lpage>9</lpage>.</citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname> <given-names>Y</given-names></name> <name><surname>Jiao</surname> <given-names>X</given-names></name> <name><surname>Simpson</surname> <given-names>JL</given-names></name> <name><surname>Chen</surname> <given-names>ZJ</given-names></name></person-group>. <article-title>Genetics of primary ovarian insufficiency: new developments and opportunities.</article-title> <source><italic>Hum Reprod Update.</italic></source> (<year>2015</year>) <volume>21</volume>:<fpage>787</fpage>&#x2013;<lpage>808</lpage>.</citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vegetti</surname> <given-names>W</given-names></name> <name><surname>Marozzi</surname> <given-names>A</given-names></name> <name><surname>Manfredini</surname> <given-names>E</given-names></name> <name><surname>Testa</surname> <given-names>G</given-names></name> <name><surname>Alagna</surname> <given-names>F</given-names></name> <name><surname>Nicolosi</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Premature ovarian failure.</article-title> <source><italic>Mol Cell Endocrinol.</italic></source> (<year>2000</year>) <volume>161</volume>:<fpage>53</fpage>&#x2013;<lpage>7</lpage>.</citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tucker</surname> <given-names>EJ</given-names></name> <name><surname>Grover</surname> <given-names>SR</given-names></name> <name><surname>Bachelot</surname> <given-names>A</given-names></name> <name><surname>Touraine</surname> <given-names>P</given-names></name> <name><surname>Sinclair</surname> <given-names>AH</given-names></name></person-group>. <article-title>Premature ovarian insufficiency: new perspectives on genetic cause and phenotypic spectrum.</article-title> <source><italic>Endocr Rev.</italic></source> (<year>2016</year>) <volume>37</volume>:<fpage>609</fpage>&#x2013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1210/er.2016-1047</pub-id> <pub-id pub-id-type="pmid">27690531</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname> <given-names>Y</given-names></name> <name><surname>Sun</surname> <given-names>M</given-names></name> <name><surname>You</surname> <given-names>L</given-names></name> <name><surname>Wei</surname> <given-names>D</given-names></name> <name><surname>Sun</surname> <given-names>J</given-names></name> <name><surname>Liang</surname> <given-names>X</given-names></name><etal/></person-group> <article-title>ESR1, HK3 and BRSK1 gene variants are associated with both age at natural menopause and premature ovarian failure.</article-title> <source><italic>Orphanet J Rare Dis.</italic></source> (<year>2012</year>) <volume>7</volume>:<issue>5</issue>. <pub-id pub-id-type="doi">10.1186/1750-1172-7-5</pub-id> <pub-id pub-id-type="pmid">22248077</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>H</given-names></name> <name><surname>Ahn</surname> <given-names>J</given-names></name> <name><surname>Park</surname> <given-names>Y</given-names></name> <name><surname>Sim</surname> <given-names>J</given-names></name> <name><surname>Park</surname> <given-names>HS</given-names></name> <name><surname>Ryu</surname> <given-names>CS</given-names></name><etal/></person-group> <article-title>Identification of potential causal variants for premature ovarian failure by whole exome sequencing.</article-title> <source><italic>BMC Med Genomics.</italic></source> (<year>2020</year>) <volume>13</volume>:<issue>159</issue>. <pub-id pub-id-type="doi">10.1186/s12920-020-00813-x</pub-id> <pub-id pub-id-type="pmid">33109206</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mehrjooy</surname> <given-names>S</given-names></name> <name><surname>Nikbakht</surname> <given-names>R</given-names></name> <name><surname>Mohammadi Asl</surname> <given-names>J</given-names></name> <name><surname>Ghadiri</surname> <given-names>A</given-names></name> <name><surname>Ghandil</surname> <given-names>P</given-names></name></person-group>. <article-title>Utilization of whole exome sequencing in non-syndromic premature ovarian failure: ficolin-3 gene mutation in an iranian family.</article-title> <source><italic>Iran Biomed J.</italic></source> (<year>2021</year>) <volume>25</volume>:<fpage>441</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.52547/ibj.25.6.441</pub-id> <pub-id pub-id-type="pmid">34641644</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taryma-Le&#x015B;niak</surname> <given-names>O</given-names></name> <name><surname>Sokolowska</surname> <given-names>KE</given-names></name> <name><surname>Wojdacz</surname> <given-names>TK</given-names></name></person-group>. <article-title>Current status of development of methylation biomarkers for in vitro diagnostic IVD applications.</article-title> <source><italic>Clin. Epigenet.</italic></source> (<year>2020</year>) <volume>12</volume>:<issue>100</issue>.</citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname> <given-names>MR</given-names></name> <name><surname>Walker</surname> <given-names>MJ</given-names></name> <name><surname>Williamson</surname> <given-names>AJ</given-names></name> <name><surname>Gentry-Maharaj</surname> <given-names>A</given-names></name> <name><surname>Ryan</surname> <given-names>A</given-names></name> <name><surname>Kalsi</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Protein Z: a putative novel biomarker for early detection of ovarian cancer.</article-title> <source><italic>Int J Cancer.</italic></source> (<year>2016</year>) <volume>138</volume>:<fpage>2984</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.30020</pub-id> <pub-id pub-id-type="pmid">26815306</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wood-Trageser</surname> <given-names>MA</given-names></name> <name><surname>Gurbuz</surname> <given-names>F</given-names></name> <name><surname>Yatsenko</surname> <given-names>SA</given-names></name> <name><surname>Jeffries</surname> <given-names>EP</given-names></name> <name><surname>Kotan</surname> <given-names>LD</given-names></name> <name><surname>Surti</surname> <given-names>U</given-names></name><etal/></person-group> <article-title>MCM9 mutations are associated with ovarian failure, short stature, and chromosomal instability.</article-title> <source><italic>Am J Hum Genet.</italic></source> (<year>2014</year>) <volume>95</volume>:<fpage>754</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2014.11.002</pub-id> <pub-id pub-id-type="pmid">25480036</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quilter</surname> <given-names>CR</given-names></name> <name><surname>Karcanias</surname> <given-names>AC</given-names></name> <name><surname>Bagga</surname> <given-names>MR</given-names></name> <name><surname>Duncan</surname> <given-names>S</given-names></name> <name><surname>Murray</surname> <given-names>A</given-names></name> <name><surname>Conway</surname> <given-names>GS</given-names></name><etal/></person-group> <article-title>Analysis of X chromosome genomic DNA sequence copy number variation associated with premature ovarian failure (POF).</article-title> <source><italic>Hum Reprod (Oxford, England).</italic></source> (<year>2010</year>) <volume>25</volume>:<fpage>2139</fpage>&#x2013;<lpage>50</lpage>.</citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rizzolio</surname> <given-names>F</given-names></name> <name><surname>Bione</surname> <given-names>S</given-names></name> <name><surname>Villa</surname> <given-names>A</given-names></name> <name><surname>Berti</surname> <given-names>E</given-names></name> <name><surname>Cassetti</surname> <given-names>A</given-names></name> <name><surname>Bulfone</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Spatial and temporal expression of POF1B, a gene expressed in epithelia.</article-title> <source><italic>Gene Expr Patterns.</italic></source> (<year>2007</year>) <volume>7</volume>:<fpage>529</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.modgep.2006.10.005</pub-id> <pub-id pub-id-type="pmid">17123869</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bione</surname> <given-names>S</given-names></name> <name><surname>Rizzolio</surname> <given-names>F</given-names></name> <name><surname>Sala</surname> <given-names>C</given-names></name> <name><surname>Ricotti</surname> <given-names>R</given-names></name> <name><surname>Goegan</surname> <given-names>M</given-names></name> <name><surname>Manzini</surname> <given-names>MC</given-names></name><etal/></person-group> <article-title>Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B.</article-title> <source><italic>Hum Reprod (Oxford, England).</italic></source> (<year>2004</year>) <volume>19</volume>:<fpage>2759</fpage>&#x2013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/deh502</pub-id> <pub-id pub-id-type="pmid">15459172</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amberger</surname> <given-names>JS</given-names></name> <name><surname>Bocchini</surname> <given-names>CA</given-names></name> <name><surname>Schiettecatte</surname> <given-names>F</given-names></name> <name><surname>Scott</surname> <given-names>AF</given-names></name> <name><surname>Hamosh</surname> <given-names>A</given-names></name></person-group>. <article-title>OMIM.org: online mendelian inheritance in man (OMIM&#x00AE;), an online catalog of human genes and genetic disorders.</article-title> <source><italic>Nucleic Acids Res.</italic></source> (<year>2015</year>) <volume>43</volume>:<fpage>D789</fpage>&#x2013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku1205</pub-id> <pub-id pub-id-type="pmid">25428349</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lacombe</surname> <given-names>A</given-names></name> <name><surname>Lee</surname> <given-names>H</given-names></name> <name><surname>Zahed</surname> <given-names>L</given-names></name> <name><surname>Choucair</surname> <given-names>M</given-names></name> <name><surname>Muller</surname> <given-names>JM</given-names></name> <name><surname>Nelson</surname> <given-names>SF</given-names></name><etal/></person-group> <article-title>Disruption of POF1B binding to nonmuscle actin filaments is associated with premature ovarian failure.</article-title> <source><italic>Am J Hum Genet.</italic></source> (<year>2006</year>) <volume>79</volume>:<fpage>113</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1086/505406</pub-id> <pub-id pub-id-type="pmid">16773570</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tucker</surname> <given-names>EJ</given-names></name> <name><surname>Bell</surname> <given-names>KM</given-names></name> <name><surname>Robevska</surname> <given-names>G</given-names></name> <name><surname>van den Bergen</surname> <given-names>J</given-names></name> <name><surname>Ayers</surname> <given-names>KL</given-names></name> <name><surname>Listyasari</surname> <given-names>N</given-names></name><etal/></person-group> <article-title>Meiotic genes in premature ovarian insufficiency: variants in HROB and REC8 as likely genetic causes.</article-title> <source><italic>Eur J Hum Genet.</italic></source> (<year>2022</year>) <volume>30</volume>:<fpage>219</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1038/s41431-021-00977-9</pub-id> <pub-id pub-id-type="pmid">34707299</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Padovano</surname> <given-names>V</given-names></name> <name><surname>Lucibello</surname> <given-names>I</given-names></name> <name><surname>Alari</surname> <given-names>V</given-names></name> <name><surname>Mina</surname> <given-names>P. Della</given-names></name> <name><surname>Crespi</surname> <given-names>A</given-names></name> <name><surname>Ferrari</surname> <given-names>I</given-names></name><etal/></person-group> <article-title>The POF1B candidate gene for premature ovarian failure regulates epithelial polarity.</article-title> <source><italic>J Cell Sci.</italic></source> (<year>2011</year>) <volume>124</volume>:<fpage>3356</fpage>&#x2013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.088237</pub-id> <pub-id pub-id-type="pmid">21940798</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname> <given-names>ZZ</given-names></name> <name><surname>Wang</surname> <given-names>CY</given-names></name> <name><surname>Jin</surname> <given-names>JY</given-names></name> <name><surname>Sheng</surname> <given-names>Y</given-names></name> <name><surname>Zhao</surname> <given-names>MF</given-names></name> <name><surname>Fan</surname> <given-names>LL</given-names></name><etal/></person-group> <article-title>A novel POF1B variant in a Chinese patient is associated with premature ovarian failure.</article-title> <source><italic>Clin Genet.</italic></source> (<year>2021</year>) <volume>100</volume>:<fpage>773</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1111/cge.14048</pub-id> <pub-id pub-id-type="pmid">34423420</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oral</surname> <given-names>E</given-names></name> <name><surname>Toksoy</surname> <given-names>G</given-names></name> <name><surname>Sofiyeva</surname> <given-names>N</given-names></name> <name><surname>Celik</surname> <given-names>HG</given-names></name> <name><surname>Karaman</surname> <given-names>B</given-names></name> <name><surname>Basaran</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>Clinical and genetic investigation of premature ovarian insufficiency cases from Turkey.</article-title> <source><italic>J Gynecol Obstetr Hum Reprod.</italic></source> (<year>2019</year>) <volume>48</volume>:<fpage>817</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.jogoh.2019.04.007</pub-id> <pub-id pub-id-type="pmid">31026518</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crespi</surname> <given-names>A</given-names></name> <name><surname>Bertoni</surname> <given-names>A</given-names></name> <name><surname>Ferrari</surname> <given-names>I</given-names></name> <name><surname>Padovano</surname> <given-names>V</given-names></name> <name><surname>Mina</surname> <given-names>P. Della</given-names></name> <name><surname>Berti</surname> <given-names>E</given-names></name><etal/></person-group> <article-title>POF1B localizes to desmosomes and regulates cell adhesion in human intestinal and keratinocyte cell lines.</article-title> <source><italic>J Invest Dermatol.</italic></source> (<year>2015</year>) <volume>135</volume>:<fpage>192</fpage>&#x2013;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1038/jid.2014.327</pub-id> <pub-id pub-id-type="pmid">25084053</pub-id></citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skinner</surname> <given-names>MK</given-names></name></person-group>. <article-title>Regulation of primordial follicle assembly and development.</article-title> <source><italic>Hum Reprod Update.</italic></source> (<year>2005</year>) <volume>11</volume>:<fpage>461</fpage>&#x2013;<lpage>71</lpage>.</citation></ref>
<ref id="B29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bouazzi</surname> <given-names>L</given-names></name> <name><surname>Sproll</surname> <given-names>P</given-names></name> <name><surname>Eid</surname> <given-names>W</given-names></name> <name><surname>Biason-Lauber</surname> <given-names>A</given-names></name></person-group>. <article-title>The transcriptional regulator CBX2 and ovarian function: a whole genome and whole transcriptome approach.</article-title> <source><italic>Sci Rep.</italic></source> (<year>2019</year>) <volume>9</volume>:<issue>17033</issue>. <pub-id pub-id-type="doi">10.1038/s41598-019-53370-4</pub-id> <pub-id pub-id-type="pmid">31745224</pub-id></citation></ref>
<ref id="B30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eid</surname> <given-names>W</given-names></name> <name><surname>Opitz</surname> <given-names>L</given-names></name> <name><surname>Biason-Lauber</surname> <given-names>A</given-names></name></person-group>. <article-title>Genome-wide identification of CBX2 targets: insights in the human sex development network.</article-title> <source><italic>Molec Endocrinol (Baltimore, Md.).</italic></source> (<year>2015</year>) <volume>29</volume>:<fpage>247</fpage>&#x2013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1210/me.2014-1339</pub-id> <pub-id pub-id-type="pmid">25569159</pub-id></citation></ref>
<ref id="B31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dube</surname> <given-names>JL</given-names></name> <name><surname>Wang</surname> <given-names>P</given-names></name> <name><surname>Elvin</surname> <given-names>J</given-names></name> <name><surname>Lyons</surname> <given-names>KM</given-names></name> <name><surname>Celeste</surname> <given-names>AJ</given-names></name> <name><surname>Matzuk</surname> <given-names>MM</given-names></name></person-group>. <article-title>The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes.</article-title> <source><italic>Mol Endocrinol (Baltimore, Md.).</italic></source> (<year>1998</year>) <volume>12</volume>:<fpage>1809</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1210/mend.12.12.0206</pub-id> <pub-id pub-id-type="pmid">9849956</pub-id></citation></ref>
<ref id="B32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanfins</surname> <given-names>A</given-names></name> <name><surname>Rodrigues</surname> <given-names>P</given-names></name> <name><surname>Albertini</surname> <given-names>DF</given-names></name></person-group>. <article-title>G9 and BMP-15 direct the follicle symphony.</article-title> <source><italic>J Assist Reproduct Genet.</italic></source> (<year>2018</year>) <volume>35</volume>:<fpage>1741</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1007/s10815-018-1268-4</pub-id> <pub-id pub-id-type="pmid">30039232</pub-id></citation></ref>
<ref id="B33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Di Pasquale</surname> <given-names>E</given-names></name> <name><surname>Rossetti</surname> <given-names>R</given-names></name> <name><surname>Marozzi</surname> <given-names>A</given-names></name> <name><surname>Bodega</surname> <given-names>B</given-names></name> <name><surname>Borgato</surname> <given-names>S</given-names></name> <name><surname>Cavallo</surname> <given-names>L</given-names></name><etal/></person-group> <article-title>Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure.</article-title> <source><italic>J Clin Endocrinol Metab.</italic></source> (<year>2006</year>) <volume>91</volume>:<fpage>1976</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2005-2650</pub-id> <pub-id pub-id-type="pmid">16464940</pub-id></citation></ref>
<ref id="B34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clelland</surname> <given-names>E</given-names></name> <name><surname>Kohli</surname> <given-names>G</given-names></name> <name><surname>Campbell</surname> <given-names>RK</given-names></name> <name><surname>Sharma</surname> <given-names>S</given-names></name> <name><surname>Shimasaki</surname> <given-names>S</given-names></name> <name><surname>Peng</surname> <given-names>C</given-names></name></person-group>. <article-title>Bone morphogenetic protein-15 in the zebrafish ovary: complementary deoxyribonucleic acid cloning, genomic organization, tissue distribution, and role in oocyte maturation.</article-title> <source><italic>Endocrinology.</italic></source> (<year>2006</year>) <volume>147</volume>:<fpage>201</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1210/en.2005-1017</pub-id> <pub-id pub-id-type="pmid">16210364</pub-id></citation></ref>
<ref id="B35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>HM</given-names></name> <name><surname>Qiao</surname> <given-names>J</given-names></name> <name><surname>Leung</surname> <given-names>PC</given-names></name></person-group>. <article-title>Oocyte-somatic cell interactions in the human ovary-novel role of bone morphogenetic proteins and growth differentiation factors.</article-title> <source><italic>Hum Reprod Update.</italic></source> (<year>2016</year>) <volume>23</volume>:<fpage>1</fpage>&#x2013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1093/humupd/dmw039</pub-id> <pub-id pub-id-type="pmid">27797914</pub-id></citation></ref>
<ref id="B36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Persani</surname> <given-names>L</given-names></name> <name><surname>Rossetti</surname> <given-names>R</given-names></name> <name><surname>Di Pasquale</surname> <given-names>E</given-names></name> <name><surname>Cacciatore</surname> <given-names>C</given-names></name> <name><surname>Fabre</surname> <given-names>S</given-names></name></person-group>. <article-title>The fundamental role of bone morphogenetic protein 15 in ovarian function and its involvement in female fertility disorders.</article-title> <source><italic>Hum Reprod Update.</italic></source> (<year>2014</year>) <volume>20</volume>:<fpage>869</fpage>&#x2013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1093/humupd/dmu036</pub-id> <pub-id pub-id-type="pmid">24980253</pub-id></citation></ref>
<ref id="B37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Otsuka</surname> <given-names>F</given-names></name> <name><surname>Yao</surname> <given-names>Z</given-names></name> <name><surname>Lee</surname> <given-names>T</given-names></name> <name><surname>Yamamoto</surname> <given-names>S</given-names></name> <name><surname>Erickson</surname> <given-names>GF</given-names></name> <name><surname>Shimasaki</surname> <given-names>S</given-names></name></person-group>. <article-title>Bone morphogenetic protein-15. Identification of target cells and biological functions.</article-title> <source><italic>J Biol Chem.</italic></source> (<year>2000</year>) <volume>275</volume>:<fpage>39523</fpage>&#x2013;<lpage>8</lpage>.</citation></ref>
<ref id="B38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname> <given-names>HI</given-names></name> <name><surname>Liu</surname> <given-names>G</given-names></name> <name><surname>Jiang</surname> <given-names>X</given-names></name> <name><surname>Edallew</surname> <given-names>SG</given-names></name> <name><surname>Wassie</surname> <given-names>T</given-names></name> <name><surname>Tesema</surname> <given-names>B</given-names></name><etal/></person-group> <article-title>Maximum-likelihood approaches reveal signatures of positive selection in BMP15 and GDF9 genes modulating ovarian function in mammalian female fertility.</article-title> <source><italic>Ecol Evol.</italic></source> (<year>2017</year>) <volume>7</volume>:<fpage>8895</fpage>&#x2013;<lpage>902</lpage>. <pub-id pub-id-type="doi">10.1002/ece3.3336</pub-id> <pub-id pub-id-type="pmid">29177034</pub-id></citation></ref>
<ref id="B39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gilchrist</surname> <given-names>RB</given-names></name> <name><surname>Lane</surname> <given-names>M</given-names></name> <name><surname>Thompson</surname> <given-names>JG</given-names></name></person-group>. <article-title>Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality.</article-title> <source><italic>Hum Reprod Update.</italic></source> (<year>2008</year>) <volume>14</volume>:<fpage>159</fpage>&#x2013;<lpage>77</lpage>.</citation></ref>
<ref id="B40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tiotiu</surname> <given-names>D</given-names></name> <name><surname>Alvaro Mercadal</surname> <given-names>B</given-names></name> <name><surname>Imbert</surname> <given-names>R</given-names></name> <name><surname>Verbist</surname> <given-names>J</given-names></name> <name><surname>Demeestere</surname> <given-names>I</given-names></name> <name><surname>Leener</surname> <given-names>A. De</given-names></name><etal/></person-group> <article-title>Variants of the BMP15 gene in a cohort of patients with premature ovarian failure.</article-title> <source><italic>Hum Reprod (Oxford, England).</italic></source> (<year>2010</year>) <volume>25</volume>:<fpage>1581</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/deq073</pub-id> <pub-id pub-id-type="pmid">20364024</pub-id></citation></ref>
<ref id="B41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rossetti</surname> <given-names>R</given-names></name> <name><surname>Di Pasquale</surname> <given-names>E</given-names></name> <name><surname>Marozzi</surname> <given-names>A</given-names></name> <name><surname>Bione</surname> <given-names>S</given-names></name> <name><surname>Toniolo</surname> <given-names>D</given-names></name> <name><surname>Grammatico</surname> <given-names>P</given-names></name><etal/></person-group> <article-title>BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive protein.</article-title> <source><italic>Hum Mutat.</italic></source> (<year>2009</year>) <volume>30</volume>:<fpage>804</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1002/humu.20961</pub-id> <pub-id pub-id-type="pmid">19263482</pub-id></citation></ref>
<ref id="B42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Di Pasquale</surname> <given-names>E</given-names></name> <name><surname>Beck-Peccoz</surname> <given-names>P</given-names></name> <name><surname>Persani</surname> <given-names>L</given-names></name></person-group>. <article-title>Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene.</article-title> <source><italic>Am J Hum Genet.</italic></source> (<year>2004</year>) <volume>75</volume>:<fpage>106</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1086/422103</pub-id> <pub-id pub-id-type="pmid">15136966</pub-id></citation></ref>
<ref id="B43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname> <given-names>MH</given-names></name> <name><surname>Miyano</surname> <given-names>T</given-names></name></person-group>. <article-title>Interaction between growing oocytes and granulosa cells in vitro.</article-title> <source><italic>Reproduct Med Biol.</italic></source> (<year>2020</year>) <volume>19</volume>:<fpage>13</fpage>&#x2013;<lpage>23</lpage>.</citation></ref>
<ref id="B44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname> <given-names>C</given-names></name> <name><surname>Wang</surname> <given-names>P</given-names></name> <name><surname>DeMayo</surname> <given-names>J</given-names></name> <name><surname>DeMayo</surname> <given-names>FJ</given-names></name> <name><surname>Elvin</surname> <given-names>JA</given-names></name> <name><surname>Carino</surname> <given-names>C</given-names></name><etal/></person-group> <article-title>Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function.</article-title> <source><italic>Mol Endocrinol (Baltimore, Md.).</italic></source> (<year>2001</year>) <volume>15</volume>:<fpage>854</fpage>&#x2013;<lpage>66</lpage>.</citation></ref>
<ref id="B45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>JJ</given-names></name> <name><surname>Sugimura</surname> <given-names>S</given-names></name> <name><surname>Mueller</surname> <given-names>TD</given-names></name> <name><surname>White</surname> <given-names>MA</given-names></name> <name><surname>Martin</surname> <given-names>GA</given-names></name> <name><surname>Ritter</surname> <given-names>LJ</given-names></name><etal/></person-group> <article-title>Modifications of human growth differentiation factor 9 to improve the generation of embryos from low competence oocytes.</article-title> <source><italic>Mol Endocrinol (Baltimore, Md.).</italic></source> (<year>2015</year>) <volume>29</volume>:<fpage>40</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1210/me.2014-1173</pub-id> <pub-id pub-id-type="pmid">25394262</pub-id></citation></ref>
<ref id="B46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Afkhami</surname> <given-names>F</given-names></name> <name><surname>Shahbazi</surname> <given-names>S</given-names></name> <name><surname>Farzadi</surname> <given-names>L</given-names></name> <name><surname>Danaei</surname> <given-names>S</given-names></name></person-group>. <article-title>Novel bone morphogenetic protein 15 (BMP15) gene variants implicated in premature ovarian insufficiency.</article-title> <source><italic>Reproduct Biol Endocrinol.</italic></source> (<year>2022</year>) <volume>20</volume>:<issue>42</issue>.</citation></ref>
<ref id="B47"><label>47.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pati&#x00F1;o</surname> <given-names>LC</given-names></name> <name><surname>Walton</surname> <given-names>KL</given-names></name> <name><surname>Mueller</surname> <given-names>TD</given-names></name> <name><surname>Johnson</surname> <given-names>KE</given-names></name> <name><surname>Stocker</surname> <given-names>W</given-names></name> <name><surname>Richani</surname> <given-names>D</given-names></name><etal/></person-group> <article-title>BMP15 mutations associated with primary ovarian insufficiency reduce expression, activity, or synergy with GDF9.</article-title> <source><italic>J Clin Endocrinol Metab.</italic></source> (<year>2017</year>) <volume>102</volume>:<fpage>1009</fpage>&#x2013;<lpage>19</lpage>.</citation></ref>
<ref id="B48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>R</given-names></name> <name><surname>Alwani</surname> <given-names>M</given-names></name> <name><surname>Kosta</surname> <given-names>S</given-names></name> <name><surname>Kaur</surname> <given-names>R</given-names></name> <name><surname>Agarwal</surname> <given-names>S</given-names></name></person-group>. <article-title>BMP15 and GDF9 gene mutations in premature ovarian failure.</article-title> <source><italic>J Reprod Infertil.</italic></source> (<year>2017</year>) <volume>18</volume>:<fpage>185</fpage>&#x2013;<lpage>9</lpage>.</citation></ref>
<ref id="B49"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fonseca</surname> <given-names>DJ</given-names></name> <name><surname>Ortega-Recalde</surname> <given-names>O</given-names></name> <name><surname>Esteban-Perez</surname> <given-names>C</given-names></name> <name><surname>Moreno-Ortiz</surname> <given-names>H</given-names></name> <name><surname>Pati&#x00F1;o</surname> <given-names>LC</given-names></name> <name><surname>Berm&#x00FA;dez</surname> <given-names>OM</given-names></name><etal/></person-group> <article-title>BMP15 c.-9C&#x003E;G promoter sequence variant may contribute to the cause of non-syndromic premature ovarian failure.</article-title> <source><italic>Reproduct Biomed Online.</italic></source> (<year>2014</year>) <volume>29</volume>:<fpage>627</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.rbmo.2014.07.018</pub-id> <pub-id pub-id-type="pmid">25246117</pub-id></citation></ref>
<ref id="B50"><label>50.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inagaki</surname> <given-names>K</given-names></name> <name><surname>Shimasaki</surname> <given-names>S</given-names></name></person-group>. <article-title>Impaired production of BMP-15 and GDF-9 mature proteins derived from proproteins WITH mutations in the proregion.</article-title> <source><italic>Mol Cell Endocrinol.</italic></source> (<year>2010</year>) <volume>328</volume>:<fpage>1</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2010.05.017</pub-id> <pub-id pub-id-type="pmid">20547206</pub-id></citation></ref>
<ref id="B51"><label>51.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Belli</surname> <given-names>M</given-names></name> <name><surname>Shimasaki</surname> <given-names>S</given-names></name></person-group>. <article-title>Molecular aspects and clinical relevance of GDF9 and BMP15 in ovarian function.</article-title> <source><italic>Vitam Horm.</italic></source> (<year>2018</year>) <volume>107</volume>:<fpage>317</fpage>&#x2013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/bs.vh.2017.12.003</pub-id> <pub-id pub-id-type="pmid">29544636</pub-id></citation></ref>
<ref id="B52"><label>52.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rossetti</surname> <given-names>R</given-names></name> <name><surname>Ferrari</surname> <given-names>I</given-names></name> <name><surname>Bestetti</surname> <given-names>I</given-names></name> <name><surname>Moleri</surname> <given-names>S</given-names></name> <name><surname>Brancati</surname> <given-names>F</given-names></name> <name><surname>Petrone</surname> <given-names>L</given-names></name><etal/></person-group> <article-title>Fundamental role of BMP15 in human ovarian folliculogenesis revealed by null and missense mutations associated with primary ovarian insufficiency.</article-title> <source><italic>Hum Mutat.</italic></source> (<year>2020</year>) <volume>41</volume>:<fpage>983</fpage>&#x2013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1002/humu.23988</pub-id> <pub-id pub-id-type="pmid">31957178</pub-id></citation></ref>
<ref id="B53"><label>53.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname> <given-names>PG</given-names></name> <name><surname>Glister</surname> <given-names>C</given-names></name></person-group>. <article-title>TGF-beta superfamily members and ovarian follicle development.</article-title> <source><italic>Reproduction (Cambridge, England).</italic></source> (<year>2006</year>) <volume>132</volume>:<fpage>191</fpage>&#x2013;<lpage>206</lpage>.</citation></ref>
<ref id="B54"><label>54.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname> <given-names>A</given-names></name> <name><surname>Fouquet</surname> <given-names>B</given-names></name> <name><surname>Pugeat</surname> <given-names>M</given-names></name> <name><surname>Misrahi</surname> <given-names>M</given-names></name></person-group>. <article-title>BMP15 &#x201C;knockout-like&#x201D; effect in familial premature ovarian insufficiency with persistent ovarian reserve.</article-title> <source><italic>Clin Genet.</italic></source> (<year>2017</year>) <volume>92</volume>:<fpage>208</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1111/cge.12970</pub-id> <pub-id pub-id-type="pmid">28094433</pub-id></citation></ref>
<ref id="B55"><label>55.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>G&#x00F3;nzalez</surname> <given-names>A</given-names></name> <name><surname>Ram&#x00ED;rez-Lorca</surname> <given-names>R</given-names></name> <name><surname>Calatayud</surname> <given-names>C</given-names></name> <name><surname>Mendoza</surname> <given-names>N</given-names></name> <name><surname>Ruiz</surname> <given-names>A</given-names></name> <name><surname>S&#x00E1;ez</surname> <given-names>ME</given-names></name><etal/></person-group> <article-title>Association of genetic markers within the BMP15 gene with anovulation and infertility in women with polycystic ovary syndrome.</article-title> <source><italic>Fertil Steril.</italic></source> (<year>2008</year>) <volume>90</volume>:<fpage>447</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2007.06.083</pub-id> <pub-id pub-id-type="pmid">17905236</pub-id></citation></ref>
<ref id="B56"><label>56.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dixit</surname> <given-names>H</given-names></name> <name><surname>Rao</surname> <given-names>LK</given-names></name> <name><surname>Padmalatha</surname> <given-names>VV</given-names></name> <name><surname>Kanakavalli</surname> <given-names>M</given-names></name> <name><surname>Deenadayal</surname> <given-names>M</given-names></name> <name><surname>Gupta</surname> <given-names>N</given-names></name><etal/></person-group> <article-title>Missense mutations in the BMP15 gene are associated with ovarian failure.</article-title> <source><italic>Hum Genet.</italic></source> (<year>2006</year>) <volume>119</volume>:<fpage>408</fpage>&#x2013;<lpage>15</lpage>.</citation></ref>
<ref id="B57"><label>57.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hanevik</surname> <given-names>HI</given-names></name> <name><surname>Hilmarsen</surname> <given-names>HT</given-names></name> <name><surname>Skjelbred</surname> <given-names>CF</given-names></name> <name><surname>Tanbo</surname> <given-names>T</given-names></name> <name><surname>Kahn</surname> <given-names>JA</given-names></name></person-group>. <article-title>A single nucleotide polymorphism in BMP15 is associated with high response to ovarian stimulation.</article-title> <source><italic>Reprod Biomed Online.</italic></source> (<year>2011</year>) <volume>23</volume>:<fpage>97</fpage>&#x2013;<lpage>104</lpage>.</citation></ref>
<ref id="B58"><label>58.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gajewska</surname> <given-names>A</given-names></name> <name><surname>Herman</surname> <given-names>AP</given-names></name> <name><surname>Woli&#x0144;ska-Witort</surname> <given-names>E</given-names></name> <name><surname>Kochman</surname> <given-names>K</given-names></name> <name><surname>Zwierzchowski</surname> <given-names>L</given-names></name></person-group>. <article-title>In vivo oestrogenic modulation of Egr1 and Pitx1 gene expression in female rat pituitary gland.</article-title> <source><italic>J Mol Endocrinol.</italic></source> (<year>2014</year>) <volume>53</volume>:<fpage>355</fpage>&#x2013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1530/JME-14-0092</pub-id> <pub-id pub-id-type="pmid">25258388</pub-id></citation></ref>
<ref id="B59"><label>59.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>H</given-names></name> <name><surname>Yang</surname> <given-names>H</given-names></name> <name><surname>Qin</surname> <given-names>Z</given-names></name> <name><surname>Chen</surname> <given-names>Y</given-names></name> <name><surname>Yu</surname> <given-names>H</given-names></name> <name><surname>Li</surname> <given-names>W</given-names></name><etal/></person-group> <article-title>Exploration of the danggui buxue decoction mechanism regulating the balance of ESR and AR in the TP53-AKT signaling pathway in the prevention and treatment of POF.</article-title> <source><italic>Evid Based Complement Altern Med.</italic></source> (<year>2021</year>) <volume>2021</volume>:<issue>4862164</issue>. <pub-id pub-id-type="doi">10.1155/2021/4862164</pub-id> <pub-id pub-id-type="pmid">35003302</pub-id></citation></ref>
<ref id="B60"><label>60.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname> <given-names>YH</given-names></name> <name><surname>Kuhl</surname> <given-names>DP</given-names></name> <name><surname>Pizzuti</surname> <given-names>A</given-names></name> <name><surname>Pieretti</surname> <given-names>M</given-names></name> <name><surname>Sutcliffe</surname> <given-names>JS</given-names></name> <name><surname>Richards</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox.</article-title> <source><italic>Cell.</italic></source> (<year>1991</year>) <volume>67</volume>:<fpage>1047</fpage>&#x2013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(91)90283-5</pub-id> <pub-id pub-id-type="pmid">1760838</pub-id></citation></ref>
<ref id="B61"><label>61.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname> <given-names>A</given-names></name></person-group>. <article-title>Premature ovarian failure and the FMR1 gene.</article-title> <source><italic>Semin. Reprod Med.</italic></source> (<year>2000</year>) <volume>18</volume>:<fpage>59</fpage>&#x2013;<lpage>66</lpage>.</citation></ref>
<ref id="B62"><label>62.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hinds</surname> <given-names>HL</given-names></name> <name><surname>Ashley</surname> <given-names>CT</given-names></name> <name><surname>Sutcliffe</surname> <given-names>JS</given-names></name> <name><surname>Nelson</surname> <given-names>DL</given-names></name> <name><surname>Warren</surname> <given-names>ST</given-names></name> <name><surname>Housman</surname> <given-names>DE</given-names></name><etal/></person-group> <article-title>Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome.</article-title> <source><italic>Nat Genet.</italic></source> (<year>1993</year>) <volume>3</volume>:<fpage>36</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1038/ng0193-36</pub-id> <pub-id pub-id-type="pmid">8490651</pub-id></citation></ref>
<ref id="B63"><label>63.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pastore</surname> <given-names>LM</given-names></name> <name><surname>Johnson</surname> <given-names>J</given-names></name></person-group>. <article-title>The FMR1 gene, infertility, and reproductive decision-making: a review.</article-title> <source><italic>Front Genet.</italic></source> (<year>2014</year>) <volume>5</volume>:<issue>195</issue>. <pub-id pub-id-type="doi">10.3389/fgene.2014.00195</pub-id> <pub-id pub-id-type="pmid">25071825</pub-id></citation></ref>
<ref id="B64"><label>64.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bretherick</surname> <given-names>KL</given-names></name> <name><surname>Fluker</surname> <given-names>MR</given-names></name> <name><surname>Robinson</surname> <given-names>WP</given-names></name></person-group>. <article-title>FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure.</article-title> <source><italic>Hum Genet.</italic></source> (<year>2005</year>) <volume>117</volume>:<fpage>376</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-005-1326-8</pub-id> <pub-id pub-id-type="pmid">16078053</pub-id></citation></ref>
<ref id="B65"><label>65.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schufreider</surname> <given-names>A</given-names></name> <name><surname>McQueen</surname> <given-names>DB</given-names></name> <name><surname>Lee</surname> <given-names>SM</given-names></name> <name><surname>Allon</surname> <given-names>R</given-names></name> <name><surname>Uhler</surname> <given-names>ML</given-names></name> <name><surname>Davie</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene.</article-title> <source><italic>Hum Reprod (Oxford, England).</italic></source> (<year>2015</year>) <volume>30</volume>:<fpage>2686</fpage>&#x2013;<lpage>92</lpage>.</citation></ref>
<ref id="B66"><label>66.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gleicher</surname> <given-names>N</given-names></name> <name><surname>Barad</surname> <given-names>DH</given-names></name></person-group>. <article-title>The FMR1 gene as regulator of ovarian recruitment and ovarian reserve.</article-title> <source><italic>Obstet Gynecol Surv.</italic></source> (<year>2010</year>) <volume>65</volume>:<fpage>523</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1097/OGX.0b013e3181f8bdda</pub-id> <pub-id pub-id-type="pmid">20955631</pub-id></citation></ref>
<ref id="B67"><label>67.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rehnitz</surname> <given-names>J</given-names></name> <name><surname>Alcoba</surname> <given-names>DD</given-names></name> <name><surname>Brum</surname> <given-names>IS</given-names></name> <name><surname>Hinderhofer</surname> <given-names>K</given-names></name> <name><surname>Youness</surname> <given-names>B</given-names></name> <name><surname>Strowitzki</surname> <given-names>T</given-names></name><etal/></person-group> <article-title>FMR1 and AKT/mTOR signalling pathways: potential functional interactions controlling folliculogenesis in human granulosa cells.</article-title> <source><italic>Reprod Biomed Online.</italic></source> (<year>2017</year>) <volume>35</volume>:<fpage>485</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.rbmo.2017.07.016</pub-id> <pub-id pub-id-type="pmid">28826600</pub-id></citation></ref>
<ref id="B68"><label>68.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hundscheid</surname> <given-names>RD</given-names></name> <name><surname>Sistermans</surname> <given-names>EA</given-names></name> <name><surname>Thomas</surname> <given-names>CM</given-names></name> <name><surname>Braat</surname> <given-names>DD</given-names></name> <name><surname>Straatman</surname> <given-names>H</given-names></name> <name><surname>Kiemeney</surname> <given-names>LA</given-names></name><etal/></person-group> <article-title>Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations.</article-title> <source><italic>Am J Hum Genet.</italic></source> (<year>2000</year>) <volume>66</volume>:<fpage>413</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1086/302774</pub-id> <pub-id pub-id-type="pmid">10677300</pub-id></citation></ref>
<ref id="B69"><label>69.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname> <given-names>A</given-names></name> <name><surname>Ennis</surname> <given-names>S</given-names></name> <name><surname>MacSwiney</surname> <given-names>F</given-names></name> <name><surname>Webb</surname> <given-names>J</given-names></name> <name><surname>Morton</surname> <given-names>NE</given-names></name></person-group>. <article-title>Reproductive and menstrual history of females with fragile X expansions.</article-title> <source><italic>Eur J Hum Genet.</italic></source> (<year>2000</year>) <volume>8</volume>:<fpage>247</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ejhg.5200451</pub-id> <pub-id pub-id-type="pmid">10854106</pub-id></citation></ref>
<ref id="B70"><label>70.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eslami</surname> <given-names>A</given-names></name> <name><surname>Farahmand</surname> <given-names>K</given-names></name> <name><surname>Totonchi</surname> <given-names>M</given-names></name> <name><surname>Madani</surname> <given-names>T</given-names></name> <name><surname>Asadpour</surname> <given-names>U</given-names></name> <name><surname>Zari Moradi</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>FMR1 premutation: not only important in premature ovarian failure but also in diminished ovarian reserve.</article-title> <source><italic>Hum Fertil (Cambridge, England).</italic></source> (<year>2017</year>) <volume>20</volume>:<fpage>120</fpage>&#x2013;<lpage>5</lpage>.</citation></ref>
<ref id="B71"><label>71.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname> <given-names>S</given-names></name> <name><surname>Maitra</surname> <given-names>A</given-names></name> <name><surname>Kadam</surname> <given-names>S</given-names></name> <name><surname>Patel</surname> <given-names>Z</given-names></name> <name><surname>Gokral</surname> <given-names>J</given-names></name> <name><surname>Meherji</surname> <given-names>P</given-names></name></person-group>. <article-title>CCG repeat sizing in the FMR1 gene in Indian women with premature ovarian failure.</article-title> <source><italic>Reprod Biomed Online.</italic></source> (<year>2009</year>) <volume>19</volume>:<fpage>281</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/s1472-6483(10)60086-7</pub-id> <pub-id pub-id-type="pmid">19712568</pub-id></citation></ref>
<ref id="B72"><label>72.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruth</surname> <given-names>KS</given-names></name> <name><surname>Day</surname> <given-names>FR</given-names></name> <name><surname>Hussain</surname> <given-names>J</given-names></name> <name><surname>Mart&#x00ED;nez-Marchal</surname> <given-names>A</given-names></name> <name><surname>Aiken</surname> <given-names>CE</given-names></name> <name><surname>Azad</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Genetic insights into biological mechanisms governing human ovarian ageing.</article-title> <source><italic>Nature.</italic></source> (<year>2021</year>) <volume>596</volume>:<fpage>393</fpage>&#x2013;<lpage>7</lpage>.</citation></ref>
<ref id="B73"><label>73.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wittenberger</surname> <given-names>MD</given-names></name> <name><surname>Hagerman</surname> <given-names>RJ</given-names></name> <name><surname>Sherman</surname> <given-names>SL</given-names></name> <name><surname>McConkie-Rosell</surname> <given-names>A</given-names></name> <name><surname>Welt</surname> <given-names>CK</given-names></name> <name><surname>Rebar</surname> <given-names>RW</given-names></name><etal/></person-group> <article-title>The FMR1 premutation and reproduction.</article-title> <source><italic>Fertil Steril.</italic></source> (<year>2007</year>) <volume>87</volume>:<fpage>456</fpage>&#x2013;<lpage>65</lpage>.</citation></ref>
<ref id="B74"><label>74.</label><citation citation-type="journal"><collab>European Society of Human Genetics, European Society of Human Reproduction and Embryology.</collab> <article-title>The need for interaction between assisted reproduction technology and genetics: recommendations of the European Societies of Human Genetics and Human Reproduction and Embryology.</article-title> <source><italic>Hum Reprod (Oxford, England).</italic></source> (<year>2006</year>) <volume>21</volume>:<fpage>1971</fpage>&#x2013;<lpage>3</lpage>.</citation></ref>
<ref id="B75"><label>75.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>T</given-names></name> <name><surname>Qin</surname> <given-names>Y</given-names></name> <name><surname>Jiao</surname> <given-names>X</given-names></name> <name><surname>Li</surname> <given-names>G</given-names></name> <name><surname>Simpson</surname> <given-names>JL</given-names></name> <name><surname>Chen</surname> <given-names>ZJ</given-names></name></person-group>. <article-title>FMR1 premutation is an uncommon explanation for premature ovarian failure in Han Chinese.</article-title> <source><italic>PLoS one</italic></source> (<year>2014</year>) <volume>9</volume>:<issue>e103316</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0103316</pub-id> <pub-id pub-id-type="pmid">25050920</pub-id></citation></ref>
<ref id="B76"><label>76.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname> <given-names>R</given-names></name> <name><surname>Yu</surname> <given-names>Q</given-names></name></person-group>. <article-title>The significance of FMR1 CGG repeats in Chinese women with premature ovarian insufficiency and diminished ovarian reserve.</article-title> <source><italic>Reprod Biol Endocrinol.</italic></source> (<year>2020</year>) <volume>18</volume>:<issue>82</issue>.</citation></ref>
<ref id="B77"><label>77.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>CL</given-names></name> <name><surname>Li</surname> <given-names>R</given-names></name> <name><surname>Chen</surname> <given-names>XN</given-names></name> <name><surname>Xu</surname> <given-names>YY</given-names></name> <name><surname>Yan</surname> <given-names>LY</given-names></name> <name><surname>Yan</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>The &#x2018;normal&#x2019; range of FMR1 triple CGG repeats may be associated with primary ovarian insufficiency in China.</article-title> <source><italic>Reprod Biomed Online.</italic></source> (<year>2017</year>) <volume>34</volume>:<fpage>175</fpage>&#x2013;<lpage>80</lpage>.</citation></ref>
<ref id="B78"><label>78.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shelly</surname> <given-names>KE</given-names></name> <name><surname>Candelaria</surname> <given-names>NR</given-names></name> <name><surname>Li</surname> <given-names>Z</given-names></name> <name><surname>Allen</surname> <given-names>EG</given-names></name> <name><surname>Jin</surname> <given-names>P</given-names></name> <name><surname>Nelson</surname> <given-names>DL</given-names></name></person-group>. <article-title>Ectopic expression of CGG-repeats alters ovarian response to gonadotropins and leads to infertility in a murine FMR1 premutation model.</article-title> <source><italic>Hum Mol Genet.</italic></source> (<year>2021</year>) <volume>30</volume>:<fpage>923</fpage>&#x2013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddab083</pub-id> <pub-id pub-id-type="pmid">33856019</pub-id></citation></ref>
<ref id="B79"><label>79.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Q</given-names></name> <name><surname>Barad</surname> <given-names>DH</given-names></name> <name><surname>Darmon</surname> <given-names>SK</given-names></name> <name><surname>Kushnir</surname> <given-names>VA</given-names></name> <name><surname>Wu</surname> <given-names>YG</given-names></name> <name><surname>Lazzaroni-Tealdi</surname> <given-names>E</given-names></name><etal/></person-group> <article-title>Reduced RNA expression of the FMR1 gene in women with low (CGGn&#x003C;26) repeats.</article-title> <source><italic>PLoS One.</italic></source> (<year>2018</year>) <volume>13</volume>:<issue>e0209309</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0209309</pub-id> <pub-id pub-id-type="pmid">30576349</pub-id></citation></ref>
<ref id="B80"><label>80.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kenneson</surname> <given-names>A</given-names></name> <name><surname>Zhang</surname> <given-names>F</given-names></name> <name><surname>Hagedorn</surname> <given-names>CH</given-names></name> <name><surname>Warren</surname> <given-names>ST</given-names></name></person-group>. <article-title>Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers.</article-title> <source><italic>Hum Mol Genet.</italic></source> (<year>2001</year>) <volume>10</volume>:<fpage>1449</fpage>&#x2013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/10.14.1449</pub-id> <pub-id pub-id-type="pmid">11448936</pub-id></citation></ref>
<ref id="B81"><label>81.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schuettler</surname> <given-names>J</given-names></name> <name><surname>Peng</surname> <given-names>Z</given-names></name> <name><surname>Zimmer</surname> <given-names>J</given-names></name> <name><surname>Sinn</surname> <given-names>P</given-names></name> <name><surname>von Hagens</surname> <given-names>C</given-names></name> <name><surname>Strowitzki</surname> <given-names>T</given-names></name><etal/></person-group> <article-title>Variable expression of the Fragile X Mental Retardation 1 (FMR1) gene in patients with premature ovarian failure syndrome is not dependent on number of (CGG)n triplets in exon 1.</article-title> <source><italic>Hum Reprod (Oxford, England).</italic></source> (<year>2011</year>) <volume>26</volume>:<fpage>1241</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/der018</pub-id> <pub-id pub-id-type="pmid">21335413</pub-id></citation></ref>
<ref id="B82"><label>82.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gleicher</surname> <given-names>N</given-names></name> <name><surname>Weghofer</surname> <given-names>A</given-names></name> <name><surname>Barad</surname> <given-names>DH</given-names></name></person-group>. <article-title>A pilot study of premature ovarian senescence: i. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-M&#x00FC;llerian hormone.</article-title> <source><italic>Fertil Steril.</italic></source> (<year>2009</year>) <volume>91</volume>:<fpage>1700</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2008.01.098</pub-id> <pub-id pub-id-type="pmid">18384775</pub-id></citation></ref>
<ref id="B83"><label>83.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Narayanan</surname> <given-names>U</given-names></name> <name><surname>Nalavadi</surname> <given-names>V</given-names></name> <name><surname>Nakamoto</surname> <given-names>M</given-names></name> <name><surname>Thomas</surname> <given-names>G</given-names></name> <name><surname>Ceman</surname> <given-names>S</given-names></name> <name><surname>Bassell</surname> <given-names>GJ</given-names></name><etal/></person-group> <article-title>S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade.</article-title> <source><italic>J Biol Chem.</italic></source> (<year>2008</year>) <volume>283</volume>:<fpage>18478</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.C800055200</pub-id> <pub-id pub-id-type="pmid">18474609</pub-id></citation></ref>
<ref id="B84"><label>84.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ascano</surname> <given-names>M</given-names> <suffix>Jr.</suffix></name> <name><surname>Mukherjee</surname> <given-names>N</given-names></name> <name><surname>Bandaru</surname> <given-names>P</given-names></name> <name><surname>Miller</surname> <given-names>JB</given-names></name> <name><surname>Nusbaum</surname> <given-names>JD</given-names></name> <name><surname>Corcoran</surname> <given-names>DL</given-names></name><etal/></person-group> <article-title>FMRP targets distinct mRNA sequence elements to regulate protein expression.</article-title> <source><italic>Nature.</italic></source> (<year>2012</year>) <volume>492</volume>:<fpage>382</fpage>&#x2013;<lpage>6</lpage>.</citation></ref>
<ref id="B85"><label>85.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mok-Lin</surname> <given-names>E</given-names></name> <name><surname>Ascano</surname> <given-names>M</given-names> <suffix>Jr.</suffix></name> <name><surname>Serganov</surname> <given-names>A</given-names></name> <name><surname>Rosenwaks</surname> <given-names>Z</given-names></name> <name><surname>Tuschl</surname> <given-names>T</given-names></name> <name><surname>Williams</surname> <given-names>Z</given-names></name></person-group>. <article-title>Premature recruitment of oocyte pool and increased mTOR activity in Fmr1 knockout mice and reversal of phenotype with rapamycin.</article-title> <source><italic>Sci. Rep.</italic></source> (<year>2018</year>) <volume>8</volume>:<issue>588</issue>. <pub-id pub-id-type="doi">10.1038/s41598-017-18598-y</pub-id> <pub-id pub-id-type="pmid">29330421</pub-id></citation></ref>
<ref id="B86"><label>86.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Conca Dioguardi</surname> <given-names>C</given-names></name> <name><surname>Uslu</surname> <given-names>B</given-names></name> <name><surname>Haynes</surname> <given-names>M</given-names></name> <name><surname>Kurus</surname> <given-names>M</given-names></name> <name><surname>Gul</surname> <given-names>M</given-names></name> <name><surname>Miao</surname> <given-names>DQ</given-names></name><etal/></person-group> <article-title>Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency.</article-title> <source><italic>Mol Hum Reprod.</italic></source> (<year>2016</year>) <volume>22</volume>:<fpage>384</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1093/molehr/gaw023</pub-id> <pub-id pub-id-type="pmid">26965313</pub-id></citation></ref>
<ref id="B87"><label>87.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shiratsuki</surname> <given-names>S</given-names></name> <name><surname>Hara</surname> <given-names>T</given-names></name> <name><surname>Munakata</surname> <given-names>Y</given-names></name> <name><surname>Shirasuna</surname> <given-names>K</given-names></name> <name><surname>Kuwayama</surname> <given-names>T</given-names></name> <name><surname>Iwata</surname> <given-names>H</given-names></name></person-group>. <article-title>Low oxygen level increases proliferation and metabolic changes in bovine granulosa cells.</article-title> <source><italic>Mol Cell Endocrinol.</italic></source> (<year>2016</year>) <volume>437</volume>:<fpage>75</fpage>&#x2013;<lpage>85</lpage>.</citation></ref>
<ref id="B88"><label>88.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heng</surname> <given-names>D</given-names></name> <name><surname>Sheng</surname> <given-names>X</given-names></name> <name><surname>Tian</surname> <given-names>C</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Liu</surname> <given-names>L</given-names></name> <name><surname>Gou</surname> <given-names>M</given-names></name><etal/></person-group> <article-title>Mtor inhibition by INK128 extends functions of the ovary reconstituted from germline stem cells in aging and premature aging mice.</article-title> <source><italic>Aging Cell.</italic></source> (<year>2021</year>) <volume>20</volume>:<issue>e13304</issue>. <pub-id pub-id-type="doi">10.1111/acel.13304</pub-id> <pub-id pub-id-type="pmid">33448083</pub-id></citation></ref>
<ref id="B89"><label>89.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname> <given-names>RJ</given-names></name> <name><surname>Harding</surname> <given-names>M</given-names></name> <name><surname>Moayedi</surname> <given-names>Y</given-names></name> <name><surname>Mardon</surname> <given-names>G</given-names></name></person-group>. <article-title>Mouse Dach1 and Dach2 are redundantly required for M&#x00FC;llerian duct development.</article-title> <source><italic>Genesis (New York, N.Y.).</italic></source> (<year>2008</year>) <volume>46</volume>:<fpage>205</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1002/dvg.20385</pub-id> <pub-id pub-id-type="pmid">18395837</pub-id></citation></ref>
<ref id="B90"><label>90.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keisman</surname> <given-names>EL</given-names></name> <name><surname>Baker</surname> <given-names>BS</given-names></name></person-group>. <article-title>The Drosophila sex determination hierarchy modulates wingless and decapentaplegic signaling to deploy dachshund sex-specifically in the genital imaginal disc.</article-title> <source><italic>Development (Cambridge, England).</italic></source> (<year>2001</year>) <volume>128</volume>:<fpage>1643</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1242/dev.128.9.1643</pub-id> <pub-id pub-id-type="pmid">11290302</pub-id></citation></ref>
<ref id="B91"><label>91.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mardon</surname> <given-names>G</given-names></name> <name><surname>Solomon</surname> <given-names>NM</given-names></name> <name><surname>Rubin</surname> <given-names>GM</given-names></name></person-group>. <article-title>dachshund encodes a nuclear protein required for normal eye and leg development in Drosophila.</article-title> <source><italic>Development (Cambridge, England).</italic></source> (<year>1994</year>) <volume>120</volume>:<fpage>3473</fpage>&#x2013;<lpage>86</lpage>.</citation></ref>
<ref id="B92"><label>92.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Behr</surname> <given-names>SC</given-names></name> <name><surname>Courtier</surname> <given-names>JL</given-names></name> <name><surname>Qayyum</surname> <given-names>A</given-names></name></person-group>. <article-title>Imaging of m&#x00FC;llerian duct anomalies.</article-title> <source><italic>Radiographics.</italic></source> (<year>2012</year>) <volume>32</volume>:<fpage>E233</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="pmid">11740449</pub-id></citation></ref>
<ref id="B93"><label>93.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Venkata</surname> <given-names>VD</given-names></name> <name><surname>Jamaluddin</surname> <given-names>MFB</given-names></name> <name><surname>Goad</surname> <given-names>J</given-names></name> <name><surname>Drury</surname> <given-names>HR</given-names></name> <name><surname>Tadros</surname> <given-names>MA</given-names></name> <name><surname>Lim</surname> <given-names>R</given-names></name><etal/></person-group> <article-title>Development and characterization of human fetal female reproductive tract organoids to understand M&#x00FC;llerian duct anomalies.</article-title> <source><italic>Proc Natl Acad Sci U S A.</italic></source> (<year>2022</year>) <volume>119</volume>:<issue>e2118054119</issue>. <pub-id pub-id-type="doi">10.1073/pnas.2118054119</pub-id> <pub-id pub-id-type="pmid">35858415</pub-id></citation></ref>
<ref id="B94"><label>94.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suzumori</surname> <given-names>N</given-names></name> <name><surname>Pangas</surname> <given-names>SA</given-names></name> <name><surname>Rajkovic</surname> <given-names>A</given-names></name></person-group>. <article-title>Candidate genes for premature ovarian failure.</article-title> <source><italic>Curr Med Chem.</italic></source> (<year>2007</year>) <volume>14</volume>:<fpage>353</fpage>&#x2013;<lpage>7</lpage>.</citation></ref>
<ref id="B95"><label>95.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nodin</surname> <given-names>B</given-names></name> <name><surname>Fridberg</surname> <given-names>M</given-names></name> <name><surname>Uhl&#x00E9;n</surname> <given-names>M</given-names></name> <name><surname>Jirstr&#x00F6;m</surname> <given-names>K</given-names></name></person-group>. <article-title>Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer.</article-title> <source><italic>J Ovarian Res.</italic></source> (<year>2012</year>) <volume>5</volume>:<issue>6</issue>. <pub-id pub-id-type="doi">10.1186/1757-2215-5-6</pub-id> <pub-id pub-id-type="pmid">22284433</pub-id></citation></ref>
<ref id="B96"><label>96.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sala</surname> <given-names>C</given-names></name> <name><surname>Arrigo</surname> <given-names>G</given-names></name> <name><surname>Torri</surname> <given-names>G</given-names></name> <name><surname>Martinazzi</surname> <given-names>F</given-names></name> <name><surname>Riva</surname> <given-names>P</given-names></name> <name><surname>Larizza</surname> <given-names>L</given-names></name><etal/></person-group> <article-title>Eleven X chromosome breakpoints associated with premature ovarian failure (POF) map to a 15-Mb YAC contig spanning Xq21.</article-title> <source><italic>Genomics.</italic></source> (<year>1997</year>) <volume>40</volume>:<fpage>123</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1006/geno.1996.4542</pub-id> <pub-id pub-id-type="pmid">9070928</pub-id></citation></ref>
<ref id="B97"><label>97.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prueitt</surname> <given-names>RL</given-names></name> <name><surname>Ross</surname> <given-names>JL</given-names></name> <name><surname>Zinn</surname> <given-names>AR</given-names></name></person-group>. <article-title>Physical mapping of nine Xq translocation breakpoints and identification of XPNPEP2 as a premature ovarian failure candidate gene.</article-title> <source><italic>Cytogenet Cell. Genet.</italic></source> (<year>2000</year>) <volume>89</volume>:<fpage>44</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1159/000015560</pub-id> <pub-id pub-id-type="pmid">10894934</pub-id></citation></ref>
<ref id="B98"><label>98.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mumm</surname> <given-names>S</given-names></name> <name><surname>Herrera</surname> <given-names>L</given-names></name> <name><surname>Waeltz</surname> <given-names>PW</given-names></name> <name><surname>Scardovi</surname> <given-names>A</given-names></name> <name><surname>Nagaraja</surname> <given-names>R</given-names></name> <name><surname>Esposito</surname> <given-names>T</given-names></name><etal/></person-group> <article-title>X/autosomal translocations in the Xq critical region associated with premature ovarian failure fall within and outside genes.</article-title> <source><italic>Genomics.</italic></source> (<year>2001</year>) <volume>76</volume>:<fpage>30</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1006/geno.2001.6611</pub-id> <pub-id pub-id-type="pmid">11560122</pub-id></citation></ref>
<ref id="B99"><label>99.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>SS</given-names></name> <name><surname>Zhang</surname> <given-names>RG</given-names></name> <name><surname>Braunstein</surname> <given-names>SE</given-names></name> <name><surname>Joachimiak</surname> <given-names>A</given-names></name> <name><surname>Cvekl</surname> <given-names>A</given-names></name> <name><surname>Hegde</surname> <given-names>RS</given-names></name></person-group>. <article-title>Structure of the retinal determination protein Dachshund reveals a DNA binding motif.</article-title> <source><italic>Structure (London, England).</italic></source> (<year>2002</year>) <volume>10</volume>:<fpage>787</fpage>&#x2013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/s0969-2126(02)00769-4</pub-id> <pub-id pub-id-type="pmid">12057194</pub-id></citation></ref>
<ref id="B100"><label>100.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname> <given-names>RJ</given-names></name> <name><surname>Shen</surname> <given-names>W</given-names></name> <name><surname>Sandler</surname> <given-names>YI</given-names></name> <name><surname>Heanue</surname> <given-names>TA</given-names></name> <name><surname>Mardon</surname> <given-names>G</given-names></name></person-group>. <article-title>Characterization of mouse Dach2, a homologue of Drosophila dachshund.</article-title> <source><italic>Mech Dev.</italic></source> (<year>2001</year>) <volume>102</volume>:<fpage>169</fpage>&#x2013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1016/s0925-4773(01)00307-0</pub-id> <pub-id pub-id-type="pmid">11287190</pub-id></citation></ref>
<ref id="B101"><label>101.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Misra</surname> <given-names>S</given-names></name> <name><surname>Pandey</surname> <given-names>AK</given-names></name> <name><surname>Gupta</surname> <given-names>S</given-names></name> <name><surname>Kumar</surname> <given-names>A</given-names></name> <name><surname>Khanna</surname> <given-names>P</given-names></name> <name><surname>Shankar</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Estrogen related receptor is required for the testicular development and for the normal sperm axoneme/mitochondrial derivatives in Drosophila males.</article-title> <source><italic>Sci Rep.</italic></source> (<year>2017</year>) <volume>7</volume>:<issue>40372</issue>. <pub-id pub-id-type="doi">10.1038/srep40372</pub-id> <pub-id pub-id-type="pmid">28094344</pub-id></citation></ref>
<ref id="B102"><label>102.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>H</given-names></name> <name><surname>Jiao</surname> <given-names>Y</given-names></name> <name><surname>Yi</surname> <given-names>M</given-names></name> <name><surname>Zhao</surname> <given-names>W</given-names></name> <name><surname>Wu</surname> <given-names>K</given-names></name></person-group>. <article-title>EYA2 correlates with clinico-pathological features of breast cancer, promotes tumor proliferation, and predicts poor survival.</article-title> <source><italic>Front Oncol.</italic></source> (<year>2019</year>) <volume>9</volume>:<issue>26</issue>. <pub-id pub-id-type="doi">10.3389/fonc.2019.00026</pub-id> <pub-id pub-id-type="pmid">30761270</pub-id></citation></ref>
<ref id="B103"><label>103.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prueitt</surname> <given-names>RL</given-names></name> <name><surname>Chen</surname> <given-names>H</given-names></name> <name><surname>Barnes</surname> <given-names>RI</given-names></name> <name><surname>Zinn</surname> <given-names>AR</given-names></name></person-group>. <article-title>Most X;autosome translocations associated with premature ovarian failure do not interrupt X-linked genes.</article-title> <source><italic>Cytogenet Genome Res.</italic></source> (<year>2002</year>) <volume>97</volume>:<fpage>32</fpage>&#x2013;<lpage>8</lpage>.</citation></ref>
<ref id="B104"><label>104.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Busslinger</surname> <given-names>GA</given-names></name> <name><surname>Stocsits</surname> <given-names>RR</given-names></name> <name><surname>van der Lelij</surname> <given-names>P</given-names></name> <name><surname>Axelsson</surname> <given-names>E</given-names></name> <name><surname>Tedeschi</surname> <given-names>A</given-names></name> <name><surname>Galjart</surname> <given-names>N</given-names></name><etal/></person-group> <article-title>Cohesin is positioned in mammalian genomes by transcription, CTCF and Wapl.</article-title> <source><italic>Nature.</italic></source> (<year>2017</year>) <volume>544</volume>:<fpage>503</fpage>&#x2013;<lpage>7</lpage>.</citation></ref>
<ref id="B105"><label>105.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname> <given-names>RJ</given-names></name> <name><surname>Pesah</surname> <given-names>YI</given-names></name> <name><surname>Harding</surname> <given-names>M</given-names></name> <name><surname>Paylor</surname> <given-names>R</given-names></name> <name><surname>Mardon</surname> <given-names>G</given-names></name></person-group>. <article-title>Mouse Dach2 mutants do not exhibit gross defects in eye development or brain function.</article-title> <source><italic>Genesis (New York, N.Y.).</italic></source> (<year>2006</year>) <volume>44</volume>:<fpage>84</fpage>&#x2013;<lpage>92</lpage>.</citation></ref>
<ref id="B106"><label>106.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ballow</surname> <given-names>DJ</given-names></name> <name><surname>Xin</surname> <given-names>Y</given-names></name> <name><surname>Choi</surname> <given-names>Y</given-names></name> <name><surname>Pangas</surname> <given-names>SA</given-names></name> <name><surname>Rajkovic</surname> <given-names>A</given-names></name></person-group>. <article-title>Sohlh2 is a germ cell-specific bHLH transcription factor.</article-title> <source><italic>Gene Expr Patterns.</italic></source> (<year>2006</year>) <volume>6</volume>:<fpage>1014</fpage>&#x2013;<lpage>8</lpage>.</citation></ref>
<ref id="B107"><label>107.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Toyoda</surname> <given-names>S</given-names></name> <name><surname>Miyazaki</surname> <given-names>T</given-names></name> <name><surname>Miyazaki</surname> <given-names>S</given-names></name> <name><surname>Yoshimura</surname> <given-names>T</given-names></name> <name><surname>Yamamoto</surname> <given-names>M</given-names></name> <name><surname>Tashiro</surname> <given-names>F</given-names></name><etal/></person-group> <article-title>Sohlh2 affects differentiation of KIT positive oocytes and spermatogonia.</article-title> <source><italic>Dev Biol.</italic></source> (<year>2009</year>) <volume>325</volume>:<fpage>238</fpage>&#x2013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2008.10.019</pub-id> <pub-id pub-id-type="pmid">19014927</pub-id></citation></ref>
<ref id="B108"><label>108.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname> <given-names>Y</given-names></name> <name><surname>Jiao</surname> <given-names>X</given-names></name> <name><surname>Dalgleish</surname> <given-names>R</given-names></name> <name><surname>Vujovic</surname> <given-names>S</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Simpson</surname> <given-names>JL</given-names></name><etal/></person-group> <article-title>Novel variants in the SOHLH2 gene are implicated in human premature ovarian failure.</article-title> <source><italic>Fertil Steril.</italic></source> (<year>2014</year>) <volume>101</volume>:<fpage>1104</fpage>&#x2013;<lpage>9.e6</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2014.01.001</pub-id> <pub-id pub-id-type="pmid">24524832</pub-id></citation></ref>
<ref id="B109"><label>109.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname> <given-names>B</given-names></name> <name><surname>Chao</surname> <given-names>H</given-names></name> <name><surname>Chen</surname> <given-names>B</given-names></name> <name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Li</surname> <given-names>L</given-names></name> <name><surname>Sun</surname> <given-names>X</given-names></name><etal/></person-group> <article-title>DNA methylation of germ-cell-specific basic helix-loop-helix (HLH) transcription factors, Sohlh2 and Figl&#x03B1; during gametogenesis.</article-title> <source><italic>Mol Hum Reprod.</italic></source> (<year>2011</year>) <volume>17</volume>:<fpage>550</fpage>&#x2013;<lpage>61</lpage>.</citation></ref>
<ref id="B110"><label>110.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>Y</given-names></name> <name><surname>Yuan</surname> <given-names>D</given-names></name> <name><surname>Rajkovic</surname> <given-names>A</given-names></name></person-group>. <article-title>Germ cell-specific transcriptional regulator sohlh2 is essential for early mouse folliculogenesis and oocyte-specific gene expression.</article-title> <source><italic>Biol Reprod.</italic></source> (<year>2008</year>) <volume>79</volume>:<fpage>1176</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1095/biolreprod.108.071217</pub-id> <pub-id pub-id-type="pmid">18753606</pub-id></citation></ref>
<ref id="B111"><label>111.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>H</given-names></name> <name><surname>Gao</surname> <given-names>Q</given-names></name> <name><surname>Ji</surname> <given-names>S</given-names></name> <name><surname>Bing</surname> <given-names>L</given-names></name> <name><surname>Hao</surname> <given-names>J</given-names></name></person-group>. <article-title>Sohlh2 inhibits the apoptosis of mouse primordial follicle oocytes via C-kit/PI3K/Akt/Foxo3a signalling pathway.</article-title> <source><italic>Reprod Biomed Online.</italic></source> (<year>2015</year>) <volume>30</volume>:<fpage>514</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.rbmo.2015.01.015</pub-id> <pub-id pub-id-type="pmid">25773528</pub-id></citation></ref>
<ref id="B112"><label>112.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>X</given-names></name> <name><surname>Mu</surname> <given-names>Y</given-names></name> <name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Hao</surname> <given-names>J</given-names></name></person-group>. <article-title>Effects of BMP4/SMAD signaling pathway on mouse primordial follicle growth and survival via up-regulation of Sohlh2 and c-kit.</article-title> <source><italic>Mol Reprod Dev.</italic></source> (<year>2013</year>) <volume>80</volume>:<fpage>70</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/mrd.22138</pub-id> <pub-id pub-id-type="pmid">23212987</pub-id></citation></ref>
<ref id="B113"><label>113.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verdin</surname> <given-names>H</given-names></name> <name><surname>De Baere</surname> <given-names>E</given-names></name></person-group>. <article-title>FOXL2 impairment in human disease.</article-title> <source><italic>Horm Res Paediatr.</italic></source> (<year>2012</year>) <volume>77</volume>:<fpage>2</fpage>&#x2013;<lpage>11</lpage>.</citation></ref>
<ref id="B114"><label>114.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prueitt</surname> <given-names>RL</given-names></name> <name><surname>Zinn</surname> <given-names>AR</given-names></name></person-group>. <article-title>A fork in the road to fertility.</article-title> <source><italic>Nat Genet.</italic></source> (<year>2001</year>) <volume>27</volume>:<fpage>132</fpage>&#x2013;<lpage>4</lpage>.</citation></ref>
<ref id="B115"><label>115.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castets</surname> <given-names>S</given-names></name> <name><surname>Roucher-Boulez</surname> <given-names>F</given-names></name> <name><surname>Saveanu</surname> <given-names>A</given-names></name> <name><surname>Mallet-Motak</surname> <given-names>D</given-names></name> <name><surname>Chabre</surname> <given-names>O</given-names></name> <name><surname>Amati-Bonneau</surname> <given-names>P</given-names></name><etal/></person-group> <article-title>Hypopituitarism in patients with blepharophimosis and FOXL2 mutations.</article-title> <source><italic>Horm Res Paediatr.</italic></source> (<year>2020</year>) <volume>93</volume>:<fpage>30</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1159/000507249</pub-id> <pub-id pub-id-type="pmid">32454486</pub-id></citation></ref>
<ref id="B116"><label>116.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crisponi</surname> <given-names>L</given-names></name> <name><surname>Deiana</surname> <given-names>M</given-names></name> <name><surname>Loi</surname> <given-names>A</given-names></name> <name><surname>Chiappe</surname> <given-names>F</given-names></name> <name><surname>Uda</surname> <given-names>M</given-names></name> <name><surname>Amati</surname> <given-names>P</given-names></name><etal/></person-group> <article-title>The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome.</article-title> <source><italic>Nat Genet.</italic></source> (<year>2001</year>) <volume>27</volume>:<fpage>159</fpage>&#x2013;<lpage>66</lpage>.</citation></ref>
<ref id="B117"><label>117.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uhlenhaut</surname> <given-names>NH</given-names></name> <name><surname>Jakob</surname> <given-names>S</given-names></name> <name><surname>Anlag</surname> <given-names>K</given-names></name> <name><surname>Eisenberger</surname> <given-names>T</given-names></name> <name><surname>Sekido</surname> <given-names>R</given-names></name> <name><surname>Kress</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation.</article-title> <source><italic>Cell.</italic></source> (<year>2009</year>) <volume>139</volume>:<fpage>1130</fpage>&#x2013;<lpage>42</lpage>.</citation></ref>
<ref id="B118"><label>118.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname> <given-names>J</given-names></name> <name><surname>Zhou</surname> <given-names>Y</given-names></name> <name><surname>Huang</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Yao</surname> <given-names>Y</given-names></name> <name><surname>Song</surname> <given-names>X</given-names></name><etal/></person-group> <article-title>The combination of polyalanine expansion mutation and a novel missense substitution in transcription factor FOXL2 leads to different ovarian phenotypes in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) patients.</article-title> <source><italic>Hum Reprod (Oxford, England).</italic></source> (<year>2012</year>) <volume>27</volume>:<fpage>3347</fpage>&#x2013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/des306</pub-id> <pub-id pub-id-type="pmid">22926839</pub-id></citation></ref>
<ref id="B119"><label>119.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname> <given-names>AK</given-names></name> <name><surname>Gupta</surname> <given-names>DC</given-names></name> <name><surname>Khan</surname> <given-names>SA</given-names></name> <name><surname>Razi</surname> <given-names>SM</given-names></name></person-group>. <article-title>Blepharophimosis ptosis epicanthus inversus syndrome (BPES) type 1 in an Indian Family.</article-title> <source><italic>J ASEAN Fed Endocr Soc.</italic></source> (<year>2017</year>) <volume>32</volume>:<fpage>68</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.15605/jafes.032.01.13</pub-id> <pub-id pub-id-type="pmid">33442089</pub-id></citation></ref>
<ref id="B120"><label>120.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Baere</surname> <given-names>E</given-names></name> <name><surname>Beysen</surname> <given-names>D</given-names></name> <name><surname>Oley</surname> <given-names>C</given-names></name> <name><surname>Lorenz</surname> <given-names>B</given-names></name> <name><surname>Cocquet</surname> <given-names>J</given-names></name> <name><surname>De Sutter</surname> <given-names>P</given-names></name><etal/></person-group> <article-title>FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation.</article-title> <source><italic>Am J Hum Genet.</italic></source> (<year>2003</year>) <volume>72</volume>:<fpage>478</fpage>&#x2013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1086/346118</pub-id> <pub-id pub-id-type="pmid">12529855</pub-id></citation></ref>
<ref id="B121"><label>121.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname> <given-names>SE</given-names></name> <name><surname>Chand</surname> <given-names>AL</given-names></name> <name><surname>Winship</surname> <given-names>IM</given-names></name> <name><surname>Gersak</surname> <given-names>K</given-names></name> <name><surname>Aittom&#x00E4;ki</surname> <given-names>K</given-names></name> <name><surname>Shelling</surname> <given-names>AN</given-names></name></person-group>. <article-title>Identification of novel mutations in FOXL2 associated with premature ovarian failure.</article-title> <source><italic>Mol Hum Reprod.</italic></source> (<year>2002</year>) <volume>8</volume>:<fpage>729</fpage>&#x2013;<lpage>33</lpage>.</citation></ref>
<ref id="B122"><label>122.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laissue</surname> <given-names>P</given-names></name> <name><surname>Lakhal</surname> <given-names>B</given-names></name> <name><surname>Benayoun</surname> <given-names>BA</given-names></name> <name><surname>Dipietromaria</surname> <given-names>A</given-names></name> <name><surname>Braham</surname> <given-names>R</given-names></name> <name><surname>Elghezal</surname> <given-names>H</given-names></name><etal/></person-group> <article-title>Functional evidence implicating FOXL2 in non-syndromic premature ovarian failure and in the regulation of the transcription factor OSR2.</article-title> <source><italic>J Med Genet.</italic></source> (<year>2009</year>) <volume>46</volume>:<fpage>455</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2008.065086</pub-id> <pub-id pub-id-type="pmid">19429596</pub-id></citation></ref>
<ref id="B123"><label>123.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corr&#x00EA;a</surname> <given-names>FJ</given-names></name> <name><surname>Tavares</surname> <given-names>AB</given-names></name> <name><surname>Pereira</surname> <given-names>RW</given-names></name> <name><surname>Abr&#x00E3;o</surname> <given-names>MS</given-names></name></person-group>. <article-title>A new FOXL2 gene mutation in a woman with premature ovarian failure and sporadic blepharophimosis-ptosis-epicanthus inversus syndrome.</article-title> <source><italic>Fertil Steril.</italic></source> (<year>2010</year>) <volume>93</volume>:<fpage>1006.e3</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2009.08.034</pub-id> <pub-id pub-id-type="pmid">19969293</pub-id></citation></ref>
<ref id="B124"><label>124.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>F</given-names></name> <name><surname>Chen</surname> <given-names>H</given-names></name> <name><surname>Wang</surname> <given-names>Y</given-names></name> <name><surname>Yang</surname> <given-names>J</given-names></name> <name><surname>Zhou</surname> <given-names>Y</given-names></name> <name><surname>Song</surname> <given-names>X</given-names></name><etal/></person-group> <article-title>Functional studies of novel FOXL2 variants in chinese families with blepharophimosis-ptosis-epicanthus inversus syndrome.</article-title> <source><italic>Front Genet.</italic></source> (<year>2021</year>) <volume>12</volume>:<issue>616112</issue>. <pub-id pub-id-type="doi">10.3389/fgene.2021.616112</pub-id> <pub-id pub-id-type="pmid">33796131</pub-id></citation></ref>
<ref id="B125"><label>125.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>M&#x00E9;j&#x00E9;case</surname> <given-names>C</given-names></name> <name><surname>Nigam</surname> <given-names>C</given-names></name> <name><surname>Moosajee</surname> <given-names>M</given-names></name> <name><surname>Bladen</surname> <given-names>JC</given-names></name></person-group>. <article-title>The genetic and clinical features of FOXL2-related blepharophimosis, ptosis and epicanthus inversus syndrome.</article-title> <source><italic>Genes.</italic></source> (<year>2021</year>) <volume>12</volume>:<issue>364</issue>. <pub-id pub-id-type="doi">10.3390/genes12030364</pub-id> <pub-id pub-id-type="pmid">33806295</pub-id></citation></ref>
<ref id="B126"><label>126.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fran&#x00E7;a</surname> <given-names>MM</given-names></name> <name><surname>Mendonca</surname> <given-names>BB</given-names></name></person-group>. <article-title>Genetics of ovarian insufficiency and defects of folliculogenesis.</article-title> <source><italic>Best Pract Res Clin Endocrinol Metab.</italic></source> (<year>2022</year>) <volume>36</volume>:<issue>101594</issue>.</citation></ref>
<ref id="B127"><label>127.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Settas</surname> <given-names>N</given-names></name> <name><surname>Anapliotou</surname> <given-names>M</given-names></name> <name><surname>Kanavakis</surname> <given-names>E</given-names></name> <name><surname>Fryssira</surname> <given-names>H</given-names></name> <name><surname>Sofocleous</surname> <given-names>C</given-names></name> <name><surname>Dacou-Voutetakis</surname> <given-names>C</given-names></name><etal/></person-group> <article-title>A novel FOXL2 gene mutation and BMP15 variants in a woman with primary ovarian insufficiency and blepharophimosis-ptosis-epicanthus inversus syndrome.</article-title> <source><italic>Menopause (New York, N.Y.).</italic></source> (<year>2015</year>) <volume>22</volume>:<fpage>1264</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1097/GME.0000000000000473</pub-id> <pub-id pub-id-type="pmid">25988799</pub-id></citation></ref>
<ref id="B128"><label>128.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Georges</surname> <given-names>A</given-names></name> <name><surname>Auguste</surname> <given-names>A</given-names></name> <name><surname>Bessi&#x00E8;re</surname> <given-names>L</given-names></name> <name><surname>Vanet</surname> <given-names>A</given-names></name> <name><surname>Todeschini</surname> <given-names>AL</given-names></name> <name><surname>Veitia</surname> <given-names>RA</given-names></name></person-group>. <article-title>FOXL2: a central transcription factor of the ovary.</article-title> <source><italic>J Mol Endocrinol.</italic></source> (<year>2014</year>) <volume>52</volume>:<fpage>R17</fpage>&#x2013;<lpage>33</lpage>.</citation></ref>
<ref id="B129"><label>129.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nuovo</surname> <given-names>S</given-names></name> <name><surname>Passeri</surname> <given-names>M</given-names></name> <name><surname>Di Benedetto</surname> <given-names>E</given-names></name> <name><surname>Calanchini</surname> <given-names>M</given-names></name> <name><surname>Meldolesi</surname> <given-names>I</given-names></name> <name><surname>Giacomo</surname> <given-names>M.C. Di</given-names></name><etal/></person-group> <article-title>Characterization of endocrine features and genotype-phenotypes correlations in blepharophimosis-ptosis-epicanthus inversus syndrome type 1.</article-title> <source><italic>J Endocrinol Invest.</italic></source> (<year>2016</year>) <volume>39</volume>:<fpage>227</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1007/s40618-015-0334-3</pub-id> <pub-id pub-id-type="pmid">26100530</pub-id></citation></ref>
<ref id="B130"><label>130.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x00E1;lez-Ni&#x00F1;o</surname> <given-names>C</given-names></name> <name><surname>Yeste</surname> <given-names>D</given-names></name> <name><surname>Carrascosa</surname> <given-names>A</given-names></name></person-group>. <article-title>Tamoxifen treatment in a patient with blepharophimosis-ptosis-epicanthus inversus syndrome and peripheral precocious puberty.</article-title> <source><italic>J Pediatr Endocrinol Metab.</italic></source> (<year>2007</year>) <volume>20</volume>:<fpage>445</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1515/jpem.2007.20.3.445</pub-id> <pub-id pub-id-type="pmid">17451085</pub-id></citation></ref>
<ref id="B131"><label>131.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chac&#x00F3;n-Camacho</surname> <given-names>OF</given-names></name> <name><surname>Salgado-Medina</surname> <given-names>A</given-names></name> <name><surname>Alcaraz-Lares</surname> <given-names>N</given-names></name> <name><surname>&#x00F3;pez-Moreno</surname> <given-names>DL</given-names></name> <name><surname>Barrag&#x00E1;n-Ar&#x00E9;valo</surname> <given-names>T</given-names></name> <name><surname>Nava-Casta&#x00F1;eda</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Clinical characterization and identification of five novel FOXL2 pathogenic variants in a cohort of 12 Mexican subjects with the syndrome of blepharophimosis-ptosis-epicanthus inversus.</article-title> <source><italic>Gene.</italic></source> (<year>2019</year>) <volume>706</volume>:<fpage>62</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2019.04.073</pub-id> <pub-id pub-id-type="pmid">31048069</pub-id></citation></ref>
<ref id="B132"><label>132.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tucker</surname> <given-names>EJ</given-names></name></person-group>. <article-title>The genetics and biology of FOXL2.</article-title> <source><italic>Sex Dev.</italic></source> (<year>2021</year>) <volume>16</volume>:<fpage>184</fpage>&#x2013;<lpage>93</lpage>.</citation></ref>
<ref id="B133"><label>133.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>M&#x00E9;duri</surname> <given-names>G</given-names></name> <name><surname>Bachelot</surname> <given-names>A</given-names></name> <name><surname>Duflos</surname> <given-names>C</given-names></name> <name><surname>Bst&#x00E4;ndig</surname> <given-names>B</given-names></name> <name><surname>Poirot</surname> <given-names>C</given-names></name> <name><surname>Genestie</surname> <given-names>C</given-names></name><etal/></person-group> <article-title>FOXL2 mutations lead to different ovarian phenotypes in BPES patients: case report.</article-title> <source><italic>Hum Reprod (Oxford, England).</italic></source> (<year>2010</year>) <volume>25</volume>:<fpage>235</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/dep355</pub-id> <pub-id pub-id-type="pmid">19819892</pub-id></citation></ref>
<ref id="B134"><label>134.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>K</given-names></name> <name><surname>Chen</surname> <given-names>X</given-names></name> <name><surname>Yang</surname> <given-names>H</given-names></name> <name><surname>Xu</surname> <given-names>Y</given-names></name> <name><surname>He</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>C</given-names></name><etal/></person-group> <article-title>Maternal Sall4 is indispensable for epigenetic maturation of mouse oocytes.</article-title> <source><italic>J Biol Chem.</italic></source> (<year>2017</year>) <volume>292</volume>:<fpage>1798</fpage>&#x2013;<lpage>807</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M116.767061</pub-id> <pub-id pub-id-type="pmid">28031467</pub-id></citation></ref>
<ref id="B135"><label>135.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>J</given-names></name> <name><surname>Tam</surname> <given-names>WL</given-names></name> <name><surname>Tong</surname> <given-names>GQ</given-names></name> <name><surname>Wu</surname> <given-names>Q</given-names></name> <name><surname>Chan</surname> <given-names>HY</given-names></name> <name><surname>Soh</surname> <given-names>BS</given-names></name><etal/></person-group> <article-title>Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1.</article-title> <source><italic>Nat Cell Biol.</italic></source> (<year>2006</year>) <volume>8</volume>:<fpage>1114</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1481</pub-id> <pub-id pub-id-type="pmid">16980957</pub-id></citation></ref>
<ref id="B136"><label>136.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>B</given-names></name> <name><surname>Li</surname> <given-names>L</given-names></name> <name><surname>Ni</surname> <given-names>F</given-names></name> <name><surname>Song</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>J</given-names></name> <name><surname>Mu</surname> <given-names>Y</given-names></name><etal/></person-group> <article-title>Mutational analysis of SAL-Like 4 (SALL4) in Han Chinese women with premature ovarian failure.</article-title> <source><italic>Mol Hum Reprod.</italic></source> (<year>2009</year>) <volume>15</volume>:<fpage>557</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1093/molehr/gap046</pub-id> <pub-id pub-id-type="pmid">19581335</pub-id></citation></ref>
<ref id="B137"><label>137.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>Y</given-names></name> <name><surname>Qin</surname> <given-names>Y</given-names></name> <name><surname>Berger</surname> <given-names>MF</given-names></name> <name><surname>Ballow</surname> <given-names>DJ</given-names></name> <name><surname>Bulyk</surname> <given-names>ML</given-names></name> <name><surname>Rajkovic</surname> <given-names>A</given-names></name></person-group>. <article-title>Microarray analyses of newborn mouse ovaries lacking Nobox.</article-title> <source><italic>Biol Reprod.</italic></source> (<year>2007</year>) <volume>77</volume>:<fpage>312</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1095/biolreprod.107.060459</pub-id> <pub-id pub-id-type="pmid">17494914</pub-id></citation></ref>
<ref id="B138"><label>138.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>B</given-names></name> <name><surname>Song</surname> <given-names>J</given-names></name> <name><surname>Suo</surname> <given-names>P</given-names></name> <name><surname>Ni</surname> <given-names>F</given-names></name> <name><surname>Chen</surname> <given-names>B</given-names></name><etal/></person-group> <article-title>New candidate gene POU5F1 associated with premature ovarian failure in Chinese patients.</article-title> <source><italic>Reprod Biomed Online.</italic></source> (<year>2011</year>) <volume>22</volume>:<fpage>312</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.rbmo.2010.11.008</pub-id> <pub-id pub-id-type="pmid">21273125</pub-id></citation></ref>
<ref id="B139"><label>139.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Q</given-names></name> <name><surname>Li</surname> <given-names>D</given-names></name> <name><surname>Cai</surname> <given-names>B</given-names></name> <name><surname>Chen</surname> <given-names>Q</given-names></name> <name><surname>Li</surname> <given-names>C</given-names></name> <name><surname>Wu</surname> <given-names>Y</given-names></name><etal/></person-group> <article-title>Whole-exome sequencing reveals SALL4 variants in premature ovarian insufficiency: an update on genotype-phenotype correlations.</article-title> <source><italic>Hum Genet.</italic></source> (<year>2019</year>) <volume>138</volume>:<fpage>83</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-018-1962-4</pub-id> <pub-id pub-id-type="pmid">30603774</pub-id></citation></ref>
<ref id="B140"><label>140.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhartiya</surname> <given-names>D</given-names></name> <name><surname>Patel</surname> <given-names>H</given-names></name></person-group>. <article-title>An overview of FSH-FSHR biology and explaining the existing conundrums.</article-title> <source><italic>J Ovarian Res.</italic></source> (<year>2021</year>) <volume>14</volume>:<issue>144</issue>. <pub-id pub-id-type="doi">10.1186/s13048-021-00880-3</pub-id> <pub-id pub-id-type="pmid">34717708</pub-id></citation></ref>
<ref id="B141"><label>141.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tapanainen</surname> <given-names>JS</given-names></name> <name><surname>Aittom&#x00E4;ki</surname> <given-names>K</given-names></name> <name><surname>Min</surname> <given-names>J</given-names></name> <name><surname>Vaskivuo</surname> <given-names>T</given-names></name> <name><surname>Huhtaniemi</surname> <given-names>IT</given-names></name></person-group>. <article-title>Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility.</article-title> <source><italic>Nat Genet.</italic></source> (<year>1997</year>) <volume>15</volume>:<fpage>205</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/ng0297-205</pub-id> <pub-id pub-id-type="pmid">9020851</pub-id></citation></ref>
<ref id="B142"><label>142.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doherty</surname> <given-names>E</given-names></name> <name><surname>Pakarinen</surname> <given-names>P</given-names></name> <name><surname>Tiitinen</surname> <given-names>A</given-names></name> <name><surname>Kiilavuori</surname> <given-names>A</given-names></name> <name><surname>Huhtaniemi</surname> <given-names>I</given-names></name> <name><surname>Forrest</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>A Novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure.</article-title> <source><italic>J Clin Endocrinol Metab.</italic></source> (<year>2002</year>) <volume>87</volume>:<fpage>1151</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1210/jcem.87.3.8319</pub-id> <pub-id pub-id-type="pmid">11889179</pub-id></citation></ref>
<ref id="B143"><label>143.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ledig</surname> <given-names>S</given-names></name> <name><surname>R&#x00F6;pke</surname> <given-names>A</given-names></name> <name><surname>Haeusler</surname> <given-names>G</given-names></name> <name><surname>Hinney</surname> <given-names>B</given-names></name> <name><surname>Wieacker</surname> <given-names>P</given-names></name></person-group>. <article-title>BMP15 mutations in XX gonadal dysgenesis and premature ovarian failure.</article-title> <source><italic>Am J Obstetr Gynecol.</italic></source> (<year>2008</year>) <volume>198</volume>:<fpage>84.e1</fpage>&#x2013;<lpage>5</lpage>.</citation></ref>
<ref id="B144"><label>144.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>S</given-names></name> <name><surname>Pyun</surname> <given-names>JA</given-names></name> <name><surname>Cha</surname> <given-names>DH</given-names></name> <name><surname>Ko</surname> <given-names>JJ</given-names></name> <name><surname>Kwack</surname> <given-names>K</given-names></name></person-group>. <article-title>Epistasis between FSHR and CYP19A1 polymorphisms is associated with premature ovarian failure.</article-title> <source><italic>Fertil Steril.</italic></source> (<year>2011</year>) <volume>95</volume>:<fpage>2585</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2010.12.042</pub-id> <pub-id pub-id-type="pmid">21269619</pub-id></citation></ref>
<ref id="B145"><label>145.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aittom&#x00E4;ki</surname> <given-names>K</given-names></name> <name><surname>Lucena</surname> <given-names>JL</given-names></name> <name><surname>Pakarinen</surname> <given-names>P</given-names></name> <name><surname>Sistonen</surname> <given-names>P</given-names></name> <name><surname>Tapanainen</surname> <given-names>J</given-names></name> <name><surname>Gromoll</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure.</article-title> <source><italic>Cell.</italic></source> (<year>1995</year>) <volume>82</volume>:<fpage>959</fpage>&#x2013;<lpage>68</lpage>.</citation></ref>
<ref id="B146"><label>146.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katari</surname> <given-names>S</given-names></name> <name><surname>Wood-Trageser</surname> <given-names>MA</given-names></name> <name><surname>Jiang</surname> <given-names>H</given-names></name> <name><surname>Kalynchuk</surname> <given-names>E</given-names></name> <name><surname>Muzumdar</surname> <given-names>R</given-names></name> <name><surname>Yatsenko</surname> <given-names>SA</given-names></name><etal/></person-group> <article-title>Novel inactivating mutation of the fsh receptor in two siblings of indian origin with premature ovarian failure.</article-title> <source><italic>J Clin Endocrinol Metab.</italic></source> (<year>2015</year>) <volume>100</volume>:<fpage>2154</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2015-1401</pub-id> <pub-id pub-id-type="pmid">25875778</pub-id></citation></ref>
<ref id="B147"><label>147.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname> <given-names>AA</given-names></name> <name><surname>Achrekar</surname> <given-names>SK</given-names></name> <name><surname>Joseph</surname> <given-names>S</given-names></name> <name><surname>Pathak</surname> <given-names>BR</given-names></name> <name><surname>Mahale</surname> <given-names>SD</given-names></name></person-group>. <article-title>Functional characterization of two naturally occurring mutations V(221)G and T(449)N in the follicle stimulating hormone receptor.</article-title> <source><italic>Mol Cell Endocrinol.</italic></source> (<year>2017</year>) <volume>440</volume>:<fpage>69</fpage>&#x2013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2016.11.020</pub-id> <pub-id pub-id-type="pmid">27889471</pub-id></citation></ref>
<ref id="B148"><label>148.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bramble</surname> <given-names>MS</given-names></name> <name><surname>Goldstein</surname> <given-names>EH</given-names></name> <name><surname>Lipson</surname> <given-names>A</given-names></name> <name><surname>Ngun</surname> <given-names>T</given-names></name> <name><surname>Eskin</surname> <given-names>A</given-names></name> <name><surname>Gosschalk</surname> <given-names>JE</given-names></name><etal/></person-group> <article-title>A novel follicle-stimulating hormone receptor mutation causing primary ovarian failure: a fertility application of whole exome sequencing.</article-title> <source><italic>Hum Reprod (Oxford, England).</italic></source> (<year>2016</year>) <volume>31</volume>:<fpage>905</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/dew025</pub-id> <pub-id pub-id-type="pmid">26911863</pub-id></citation></ref>
<ref id="B149"><label>149.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghezelayagh</surname> <given-names>Z</given-names></name> <name><surname>Totonchi</surname> <given-names>M</given-names></name> <name><surname>Zarei-Moradi</surname> <given-names>S</given-names></name> <name><surname>Asadpour</surname> <given-names>O</given-names></name> <name><surname>Maroufizadeh</surname> <given-names>S</given-names></name> <name><surname>Eftekhari-Yazdi</surname> <given-names>P</given-names></name><etal/></person-group> <article-title>The impact of genetic variation and gene expression level of the follicle-stimulating hormone receptor on ovarian reserve.</article-title> <source><italic>Cell J.</italic></source> (<year>2018</year>) <volume>19</volume>:<fpage>620</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.22074/cellj.2018.4183</pub-id> <pub-id pub-id-type="pmid">29105397</pub-id></citation></ref>
<ref id="B150"><label>150.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oduwole</surname> <given-names>OO</given-names></name> <name><surname>Huhtaniemi</surname> <given-names>IT</given-names></name> <name><surname>Misrahi</surname> <given-names>M</given-names></name></person-group>. <article-title>The roles of luteinizing hormone, follicle-stimulating hormone and testosterone in spermatogenesis and folliculogenesis revisited.</article-title> <source><italic>Int J Mol Sci.</italic></source> (<year>2021</year>) <volume>22</volume>:<issue>12735</issue>. <pub-id pub-id-type="doi">10.3390/ijms222312735</pub-id> <pub-id pub-id-type="pmid">34884539</pub-id></citation></ref>
<ref id="B151"><label>151.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>H</given-names></name> <name><surname>Guo</surname> <given-names>T</given-names></name> <name><surname>Gong</surname> <given-names>Z</given-names></name> <name><surname>Yu</surname> <given-names>Y</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Zhao</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>Novel FSHR mutations in Han Chinese women with sporadic premature ovarian insufficiency.</article-title> <source><italic>Mol Cell Endocrinol.</italic></source> (<year>2019</year>) <volume>492</volume>:<issue>110446</issue>. <pub-id pub-id-type="doi">10.1016/j.mce.2019.05.005</pub-id> <pub-id pub-id-type="pmid">31077743</pub-id></citation></ref>
<ref id="B152"><label>152.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname> <given-names>ET</given-names></name> <name><surname>Kim</surname> <given-names>HG</given-names></name> <name><surname>Nishimoto</surname> <given-names>HK</given-names></name> <name><surname>Layman</surname> <given-names>LC</given-names></name></person-group>. <article-title>The molecular basis of impaired follicle-stimulating hormone action: evidence from human mutations and mouse models.</article-title> <source><italic>Reprod Sci (Thousand Oaks, Calif.).</italic></source> (<year>2013</year>) <volume>20</volume>:<fpage>211</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1177/1933719112461184</pub-id> <pub-id pub-id-type="pmid">23184658</pub-id></citation></ref>
<ref id="B153"><label>153.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Desai</surname> <given-names>SS</given-names></name> <name><surname>Roy</surname> <given-names>BS</given-names></name> <name><surname>Mahale</surname> <given-names>SD</given-names></name></person-group>. <article-title>Mutations and polymorphisms in FSH receptor: functional implications in human reproduction.</article-title> <source><italic>Reproduction (Cambridge, England).</italic></source> (<year>2013</year>) <volume>146</volume>:<fpage>R235</fpage>&#x2013;<lpage>48</lpage>.</citation></ref>
<ref id="B154"><label>154.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Desai</surname> <given-names>SS</given-names></name> <name><surname>Achrekar</surname> <given-names>SK</given-names></name> <name><surname>Sahasrabuddhe</surname> <given-names>KA</given-names></name> <name><surname>Meharji</surname> <given-names>PK</given-names></name> <name><surname>Desai</surname> <given-names>SK</given-names></name> <name><surname>Mangoli</surname> <given-names>VS</given-names></name><etal/></person-group> <article-title>Functional characterization of two naturally occurring mutations (Val514Ala and Ala575Val) in follicle-stimulating hormone receptor.</article-title> <source><italic>J Clin Endocrinol Metab.</italic></source> (<year>2015</year>) <volume>100</volume>:<fpage>E638</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2014-3662</pub-id> <pub-id pub-id-type="pmid">25581598</pub-id></citation></ref>
<ref id="B155"><label>155.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>W</given-names></name> <name><surname>Cao</surname> <given-names>Y</given-names></name> <name><surname>Shi</surname> <given-names>L</given-names></name></person-group>. <article-title>Effects of FSHR polymorphisms on premature ovarian insufficiency in human beings: a meta-analysis.</article-title> <source><italic>Reprod Biol Endocrinol.</italic></source> (<year>2019</year>) <volume>17</volume>:<issue>80</issue>. <pub-id pub-id-type="doi">10.1186/s12958-019-0528-1</pub-id> <pub-id pub-id-type="pmid">31629411</pub-id></citation></ref>
<ref id="B156"><label>156.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>H</given-names></name> <name><surname>Xu</surname> <given-names>X</given-names></name> <name><surname>Han</surname> <given-names>T</given-names></name> <name><surname>Yan</surname> <given-names>L</given-names></name> <name><surname>Cheng</surname> <given-names>L</given-names></name> <name><surname>Qin</surname> <given-names>Y</given-names></name><etal/></person-group> <article-title>A novel homozygous mutation in the FSHR gene is causative for primary ovarian insufficiency.</article-title> <source><italic>Fertil Steril.</italic></source> (<year>2017</year>) <volume>108</volume>:<fpage>1050</fpage>&#x2013;<lpage>55.e2</lpage>.</citation></ref>
<ref id="B157"><label>157.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Polyzos</surname> <given-names>NP</given-names></name> <name><surname>Neves</surname> <given-names>AR</given-names></name> <name><surname>Drakopoulos</surname> <given-names>P</given-names></name> <name><surname>Spits</surname> <given-names>C</given-names></name> <name><surname>Alvaro Mercadal</surname> <given-names>B</given-names></name> <name><surname>Garcia</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>The effect of polymorphisms in FSHR and FSHB genes on ovarian response: a prospective multicenter multinational study in Europe and Asia.</article-title> <source><italic>Hum Reprod (Oxford, England).</italic></source> (<year>2021</year>) <volume>36</volume>:<fpage>1711</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/deab068</pub-id> <pub-id pub-id-type="pmid">33889959</pub-id></citation></ref>
<ref id="B158"><label>158.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vilodre</surname> <given-names>LC</given-names></name> <name><surname>Kohek</surname> <given-names>MB</given-names></name> <name><surname>Spritzer</surname> <given-names>PM</given-names></name></person-group>. <article-title>Screening of follicle-stimulating hormone receptor gene in women with premature ovarian failure in southern Brazil and associations with phenotype.</article-title> <source><italic>J Endocrinol Invest.</italic></source> (<year>2008</year>) <volume>31</volume>:<fpage>552</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1007/BF03346407</pub-id> <pub-id pub-id-type="pmid">18591890</pub-id></citation></ref>
<ref id="B159"><label>159.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cordts</surname> <given-names>EB</given-names></name> <name><surname>Santos</surname> <given-names>MC</given-names></name> <name><surname>Bianco</surname> <given-names>B</given-names></name> <name><surname>Barbosa</surname> <given-names>CP</given-names></name> <name><surname>Christofolini</surname> <given-names>DM</given-names></name></person-group>. <article-title>Are FSHR polymorphisms risk factors to premature ovarian insufficiency?</article-title> <source><italic>Gynecol Endocrinol.</italic></source> (<year>2015</year>) <volume>31</volume>:<fpage>663</fpage>&#x2013;<lpage>6</lpage>.</citation></ref>
<ref id="B160"><label>160.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>KL</given-names></name> <name><surname>Gan</surname> <given-names>K</given-names></name> <name><surname>Ying</surname> <given-names>Y</given-names></name> <name><surname>Zheng</surname> <given-names>J</given-names></name> <name><surname>Chen</surname> <given-names>R</given-names></name> <name><surname>Xue</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Oligo/Amenorrhea is an independent risk factor associated with low ovarian response.</article-title> <source><italic>Front Endocrinol.</italic></source> (<year>2021</year>) <volume>12</volume>:<issue>612042</issue>. <pub-id pub-id-type="doi">10.3389/fendo.2021.612042</pub-id> <pub-id pub-id-type="pmid">34177795</pub-id></citation></ref>
<ref id="B161"><label>161.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>X</given-names></name> <name><surname>Xie</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>Q</given-names></name> <name><surname>Cai</surname> <given-names>H</given-names></name> <name><surname>Xie</surname> <given-names>C</given-names></name> <name><surname>Fu</surname> <given-names>X</given-names></name></person-group>. <article-title>miR-21 and Pellino-1 expression profiling in autoimmune premature ovarian insufficiency.</article-title> <source><italic>J Immunol Res.</italic></source> (<year>2020</year>) <volume>2020</volume>:<issue>3582648</issue>. <pub-id pub-id-type="doi">10.1155/2020/3582648</pub-id> <pub-id pub-id-type="pmid">32352018</pub-id></citation></ref>
<ref id="B162"><label>162.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Welt</surname> <given-names>CK</given-names></name></person-group>. <article-title>Primary ovarian insufficiency: a more accurate term for premature ovarian failure.</article-title> <source><italic>Clin. Endocrinol.</italic></source> (<year>2008</year>) <volume>68</volume>:<fpage>499</fpage>&#x2013;<lpage>509</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2265.2007.03073.x</pub-id> <pub-id pub-id-type="pmid">17970776</pub-id></citation></ref>
<ref id="B163"><label>163.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Fan</surname> <given-names>S</given-names></name> <name><surname>Han</surname> <given-names>D</given-names></name> <name><surname>Xie</surname> <given-names>J</given-names></name> <name><surname>Kuang</surname> <given-names>H</given-names></name> <name><surname>Ge</surname> <given-names>P</given-names></name></person-group>. <article-title>Microarray gene expression profiling and bioinformatics analysis of premature ovarian failure in a rat model.</article-title> <source><italic>Exp Mol Pathol.</italic></source> (<year>2014</year>) <volume>97</volume>:<fpage>535</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.yexmp.2014.10.015</pub-id> <pub-id pub-id-type="pmid">25445499</pub-id></citation></ref>
<ref id="B164"><label>164.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname> <given-names>LM</given-names></name></person-group>. <article-title>Clinical practice. Primary ovarian insufficiency.</article-title> <source><italic>N Eng J Med.</italic></source> (<year>2009</year>) <volume>360</volume>:<fpage>606</fpage>&#x2013;<lpage>14</lpage>.</citation></ref>
<ref id="B165"><label>165.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuang</surname> <given-names>H</given-names></name> <name><surname>Han</surname> <given-names>D</given-names></name> <name><surname>Xie</surname> <given-names>J</given-names></name> <name><surname>Yan</surname> <given-names>Y</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Ge</surname> <given-names>P</given-names></name></person-group>. <article-title>Profiling of differentially expressed microRNAs in premature ovarian failure in an animal model.</article-title> <source><italic>Gynecol Endocrinol.</italic></source> (<year>2014</year>) <volume>30</volume>:<fpage>57</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.3109/09513590.2013.850659</pub-id> <pub-id pub-id-type="pmid">24188450</pub-id></citation></ref>
<ref id="B166"><label>166.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Winking</surname> <given-names>H</given-names></name> <name><surname>Gerdes</surname> <given-names>J</given-names></name> <name><surname>Traut</surname> <given-names>W</given-names></name></person-group>. <article-title>Expression of the proliferation marker Ki-67 during early mouse development.</article-title> <source><italic>Cytogenet Genome Res.</italic></source> (<year>2004</year>) <volume>105</volume>:<fpage>251</fpage>&#x2013;<lpage>6</lpage>.</citation></ref>
<ref id="B167"><label>167.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname> <given-names>MR</given-names></name> <name><surname>Ichii</surname> <given-names>O</given-names></name> <name><surname>Nakamura</surname> <given-names>T</given-names></name> <name><surname>Irie</surname> <given-names>T</given-names></name> <name><surname>Masum</surname> <given-names>MA</given-names></name> <name><surname>Otani</surname> <given-names>Y</given-names></name><etal/></person-group> <article-title>Developmental changes of the ovary in neonatal cotton rat (<italic>Sigmodon hispidus</italic>).</article-title> <source><italic>Front Physiol.</italic></source> (<year>2020</year>) <volume>11</volume>:<issue>601927</issue>. <pub-id pub-id-type="doi">10.3389/fphys.2020.601927</pub-id> <pub-id pub-id-type="pmid">33519507</pub-id></citation></ref>
<ref id="B168"><label>168.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sobecki</surname> <given-names>M</given-names></name> <name><surname>Mrouj</surname> <given-names>K</given-names></name> <name><surname>Colinge</surname> <given-names>J</given-names></name> <name><surname>Gerbe</surname> <given-names>F</given-names></name> <name><surname>Jay</surname> <given-names>P</given-names></name> <name><surname>Krasinska</surname> <given-names>L</given-names></name><etal/></person-group> <article-title>Cell-cycle regulation accounts for variability in Ki-67 expression levels.</article-title> <source><italic>Cancer Res.</italic></source> (<year>2017</year>) <volume>77</volume>:<fpage>2722</fpage>&#x2013;<lpage>34</lpage>.</citation></ref>
<ref id="B169"><label>169.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scholzen</surname> <given-names>T</given-names></name> <name><surname>Gerdes</surname> <given-names>J</given-names></name></person-group>. <article-title>The Ki-67 protein: from the known and the unknown.</article-title> <source><italic>J Cell. Physiol.</italic></source> (<year>2000</year>) <volume>182</volume>:<fpage>311</fpage>&#x2013;<lpage>22</lpage>.</citation></ref>
<ref id="B170"><label>170.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gavish</surname> <given-names>Z</given-names></name> <name><surname>Spector</surname> <given-names>I</given-names></name> <name><surname>Peer</surname> <given-names>G</given-names></name> <name><surname>Schlatt</surname> <given-names>S</given-names></name> <name><surname>Wistuba</surname> <given-names>J</given-names></name> <name><surname>Roness</surname> <given-names>H</given-names></name><etal/></person-group> <article-title>Follicle activation is a significant and immediate cause of follicle loss after ovarian tissue transplantation.</article-title> <source><italic>J. Assist Reprod Genet.</italic></source> (<year>2018</year>) <volume>35</volume>:<fpage>61</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s10815-017-1079-z</pub-id> <pub-id pub-id-type="pmid">29098533</pub-id></citation></ref>
<ref id="B171"><label>171.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>XY</given-names></name> <name><surname>Gu</surname> <given-names>C</given-names></name> <name><surname>Ma</surname> <given-names>M</given-names></name> <name><surname>Cong</surname> <given-names>Q</given-names></name> <name><surname>Guo</surname> <given-names>T</given-names></name> <name><surname>Ma</surname> <given-names>D</given-names></name><etal/></person-group> <article-title>A mouse model of premature ovarian insufficiency induced by tripterygium glycoside via subcutaneous injection.</article-title> <source><italic>Int J Clin Exp Pathol.</italic></source> (<year>2014</year>) <volume>7</volume>:<fpage>144</fpage>&#x2013;<lpage>51</lpage>.</citation></ref>
<ref id="B172"><label>172.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aguiar</surname> <given-names>FLN</given-names></name> <name><surname>Gastal</surname> <given-names>GDA</given-names></name> <name><surname>Ishak</surname> <given-names>GM</given-names></name> <name><surname>Gastal</surname> <given-names>MO</given-names></name> <name><surname>Teixeira</surname> <given-names>DIA</given-names></name> <name><surname>Feugang</surname> <given-names>JM</given-names></name><etal/></person-group> <article-title>Effects of FSH addition to an enriched medium containing insulin and EGF after long-term culture on functionality of equine ovarian biopsy tissue.</article-title> <source><italic>Theriogenology.</italic></source> (<year>2017</year>) <volume>99</volume>:<fpage>124</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.theriogenology.2017.04.045</pub-id> <pub-id pub-id-type="pmid">28708493</pub-id></citation></ref>
<ref id="B173"><label>173.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>S</given-names></name> <name><surname>Liu</surname> <given-names>M</given-names></name> <name><surname>Ma</surname> <given-names>H</given-names></name> <name><surname>Jin</surname> <given-names>Q</given-names></name> <name><surname>Ma</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>C</given-names></name><etal/></person-group> <article-title>Ameliorative effect of recombinant human lactoferrin on the premature ovarian failure in rats after cyclophosphamide treatments.</article-title> <source><italic>J Ovarian Res.</italic></source> (<year>2021</year>) <volume>14</volume>:<issue>17</issue>. <pub-id pub-id-type="doi">10.1186/s13048-020-00763-z</pub-id> <pub-id pub-id-type="pmid">33478578</pub-id></citation></ref>
<ref id="B174"><label>174.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chaffin</surname> <given-names>CL</given-names></name> <name><surname>Schwinof</surname> <given-names>KM</given-names></name> <name><surname>Stouffer</surname> <given-names>RL</given-names></name></person-group>. <article-title>Gonadotropin and steroid control of granulosa cell proliferation during the periovulatory interval in rhesus monkeys.</article-title> <source><italic>Biol Reprod.</italic></source> (<year>2001</year>) <volume>65</volume>:<fpage>755</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1095/biolreprod65.3.755</pub-id> <pub-id pub-id-type="pmid">11514338</pub-id></citation></ref>
<ref id="B175"><label>175.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alonso-Pozos</surname> <given-names>I</given-names></name> <name><surname>Rosales-Torres</surname> <given-names>AM</given-names></name> <name><surname>valos-Rodr&#x00ED;guez</surname> <given-names>AA</given-names></name> <name><surname>Vergara-Onofre</surname> <given-names>M</given-names></name> <name><surname>Rosado-Garc&#x00ED;a</surname> <given-names>A</given-names></name></person-group>. <article-title>Mechanism of granulosa cell death during follicular atresia depends on follicular size.</article-title> <source><italic>Theriogenology.</italic></source> (<year>2003</year>) <volume>60</volume>:<fpage>1071</fpage>&#x2013;<lpage>81</lpage>.</citation></ref>
<ref id="B176"><label>176.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>X</given-names></name> <name><surname>Xu</surname> <given-names>J</given-names></name> <name><surname>Zhao</surname> <given-names>R</given-names></name> <name><surname>Qin</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>X</given-names></name> <name><surname>Yan</surname> <given-names>Y</given-names></name><etal/></person-group> <article-title>The role of inactivated NF-&#x03BA;B in premature ovarian failure.</article-title> <source><italic>Am J Pathol.</italic></source> (<year>2022</year>) <volume>192</volume>:<fpage>468</fpage>&#x2013;<lpage>83</lpage>.</citation></ref>
<ref id="B177"><label>177.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname> <given-names>HY</given-names></name> <name><surname>Xia</surname> <given-names>HX</given-names></name> <name><surname>Chen</surname> <given-names>XY</given-names></name> <name><surname>Wang</surname> <given-names>L</given-names></name> <name><surname>Tang</surname> <given-names>ZJ</given-names></name> <name><surname>Zhang</surname> <given-names>W</given-names></name></person-group>. <article-title>Toll-like receptor 4 inhibits estradiol secretion via NF-&#x03BA;B signaling in human granulosa cells.</article-title> <source><italic>Front Endocrinol.</italic></source> (<year>2021</year>) <volume>12</volume>:<issue>629554</issue>. <pub-id pub-id-type="doi">10.3389/fendo.2021.629554</pub-id> <pub-id pub-id-type="pmid">33776924</pub-id></citation></ref>
<ref id="B178"><label>178.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chottanapund</surname> <given-names>S</given-names></name> <name><surname>Van Duursen</surname> <given-names>MB</given-names></name> <name><surname>Navasumrit</surname> <given-names>P</given-names></name> <name><surname>Hunsonti</surname> <given-names>P</given-names></name> <name><surname>Timtavorn</surname> <given-names>S</given-names></name> <name><surname>Ruchirawat</surname> <given-names>M</given-names></name><etal/></person-group> <article-title>Anti-aromatase effect of resveratrol and melatonin on hormonal positive breast cancer cells co-cultured with breast adipose fibroblasts.</article-title> <source><italic>Toxicol In Vitro.</italic></source> (<year>2014</year>) <volume>28</volume>:<fpage>1215</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.tiv.2014.05.015</pub-id> <pub-id pub-id-type="pmid">24929094</pub-id></citation></ref>
<ref id="B179"><label>179.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>MacCallum</surname> <given-names>DE</given-names></name> <name><surname>Hall</surname> <given-names>PA</given-names></name></person-group>. <article-title>The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle.</article-title> <source><italic>J Pathol.</italic></source> (<year>2000</year>) <volume>190</volume>:<fpage>537</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="pmid">10727979</pub-id></citation></ref>
<ref id="B180"><label>180.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strzalka</surname> <given-names>W</given-names></name> <name><surname>Ziemienowicz</surname> <given-names>A</given-names></name></person-group>. <article-title>Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation.</article-title> <source><italic>Ann Bot.</italic></source> (<year>2011</year>) <volume>107</volume>:<fpage>1127</fpage>&#x2013;<lpage>40</lpage>.</citation></ref>
<ref id="B181"><label>181.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname> <given-names>H</given-names></name> <name><surname>Nasim</surname> <given-names>MM</given-names></name> <name><surname>Sarraf</surname> <given-names>CE</given-names></name> <name><surname>Alison</surname> <given-names>MR</given-names></name> <name><surname>Love</surname> <given-names>S</given-names></name> <name><surname>Lambert</surname> <given-names>HE</given-names></name><etal/></person-group> <article-title>Proliferating cell nuclear antigen (PCNA) immunostaining&#x2013;a prognostic factor in ovarian cancer?</article-title> <source><italic>Br J Cancer.</italic></source> (<year>1995</year>) <volume>71</volume>:<fpage>357</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1038/bjc.1995.72</pub-id> <pub-id pub-id-type="pmid">7841053</pub-id></citation></ref>
<ref id="B182"><label>182.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muskhelishvili</surname> <given-names>L</given-names></name> <name><surname>Wingard</surname> <given-names>SK</given-names></name> <name><surname>Latendresse</surname> <given-names>JR</given-names></name></person-group>. <article-title>Proliferating cell nuclear antigen&#x2013;a marker for ovarian follicle counts.</article-title> <source><italic>Toxicol Pathol.</italic></source> (<year>2005</year>) <volume>33</volume>:<fpage>365</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1080/01926230590930164</pub-id> <pub-id pub-id-type="pmid">15805074</pub-id></citation></ref>
<ref id="B183"><label>183.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mahran</surname> <given-names>YF</given-names></name> <name><surname>Badr</surname> <given-names>AM</given-names></name> <name><surname>Aldosari</surname> <given-names>A</given-names></name> <name><surname>Bin-Zaid</surname> <given-names>R</given-names></name> <name><surname>Alotaibi</surname> <given-names>HN</given-names></name></person-group>. <article-title>Carvacrol and thymol modulate the cross-talk between TNF-&#x03B1; and IGF-1 signaling in radiotherapy-induced ovarian failure.</article-title> <source><italic>Oxid Med Cell Longev.</italic></source> (<year>2019</year>) <volume>2019</volume>:<issue>3173745</issue>. <pub-id pub-id-type="doi">10.1155/2019/3173745</pub-id> <pub-id pub-id-type="pmid">31531182</pub-id></citation></ref>
<ref id="B184"><label>184.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tom&#x00E1;nek</surname> <given-names>M</given-names></name> <name><surname>Chronowska</surname> <given-names>E</given-names></name></person-group>. <article-title>Immunohistochemical localization of proliferating cell nuclear antigen (PCNA) in the pig ovary.</article-title> <source><italic>Folia Histochem Cytobiol.</italic></source> (<year>2006</year>) <volume>44</volume>:<fpage>269</fpage>&#x2013;<lpage>74</lpage>.</citation></ref>
<ref id="B185"><label>185.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sonmezer</surname> <given-names>M</given-names></name> <name><surname>Oktay</surname> <given-names>K</given-names></name></person-group>. <article-title>Fertility preservation in young women undergoing breast cancer therapy.</article-title> <source><italic>Oncologist.</italic></source> (<year>2006</year>) <volume>11</volume>:<fpage>422</fpage>&#x2013;<lpage>34</lpage>.</citation></ref>
<ref id="B186"><label>186.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delkhosh</surname> <given-names>A</given-names></name> <name><surname>Delashoub</surname> <given-names>M</given-names></name> <name><surname>Tehrani</surname> <given-names>AA</given-names></name> <name><surname>Bahrami</surname> <given-names>AM</given-names></name> <name><surname>Niazi</surname> <given-names>V</given-names></name> <name><surname>Shoorei</surname> <given-names>H</given-names></name><etal/></person-group> <article-title>Upregulation of FSHR and PCNA by administration of coenzyme Q10 on cyclophosphamide-induced premature ovarian failure in a mouse model.</article-title> <source><italic>J Biochem Mol Toxicol.</italic></source> (<year>2019</year>) <volume>33</volume>:<issue>e22398</issue>. <pub-id pub-id-type="doi">10.1002/jbt.22398</pub-id> <pub-id pub-id-type="pmid">31557371</pub-id></citation></ref>
<ref id="B187"><label>187.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>J</given-names></name> <name><surname>Zeng</surname> <given-names>F</given-names></name> <name><surname>Xu</surname> <given-names>Q</given-names></name> <name><surname>Ma</surname> <given-names>J</given-names></name></person-group>. <article-title>Cryptotanshinone decreases granulosa cell apoptosis and restores ovarian function in mice with premature ovarian failure.</article-title> <source><italic>Gen Physiol Biophys.</italic></source> (<year>2020</year>) <volume>39</volume>:<fpage>277</fpage>&#x2013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.4149/gpb_2019059</pub-id> <pub-id pub-id-type="pmid">32525821</pub-id></citation></ref>
<ref id="B188"><label>188.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>H</given-names></name> <name><surname>Jiang</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Xu</surname> <given-names>B</given-names></name> <name><surname>Hua</surname> <given-names>J</given-names></name> <name><surname>Ma</surname> <given-names>T</given-names></name><etal/></person-group> <article-title>microRNA 376a regulates follicle assembly by targeting Pcna in fetal and neonatal mouse ovaries.</article-title> <source><italic>Reproduction (Cambridge, England).</italic></source> (<year>2014</year>) <volume>148</volume>:<fpage>43</fpage>&#x2013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1530/REP-13-0508</pub-id> <pub-id pub-id-type="pmid">24686458</pub-id></citation></ref>
<ref id="B189"><label>189.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname> <given-names>X</given-names></name> <name><surname>He</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>X</given-names></name> <name><surname>Peng</surname> <given-names>D</given-names></name> <name><surname>Chen</surname> <given-names>X</given-names></name> <name><surname>Li</surname> <given-names>X</given-names></name><etal/></person-group> <article-title>Overexpression of miR-21 in stem cells improves ovarian structure and function in rats with chemotherapy-induced ovarian damage by targeting PDCD4 and PTEN to inhibit granulosa cell apoptosis.</article-title> <source><italic>Stem Cell Res Ther.</italic></source> (<year>2017</year>) <volume>8</volume>:<issue>187</issue>. <pub-id pub-id-type="doi">10.1186/s13287-017-0641-z</pub-id> <pub-id pub-id-type="pmid">28807003</pub-id></citation></ref>
<ref id="B190"><label>190.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haraguchi</surname> <given-names>H</given-names></name> <name><surname>Hirota</surname> <given-names>Y</given-names></name> <name><surname>Saito-Fujita</surname> <given-names>T</given-names></name> <name><surname>Tanaka</surname> <given-names>T</given-names></name> <name><surname>Shimizu-Hirota</surname> <given-names>R</given-names></name> <name><surname>Harada</surname> <given-names>M</given-names></name><etal/></person-group> <article-title>Mdm2-p53-SF1 pathway in ovarian granulosa cells directs ovulation and fertilization by conditioning oocyte quality.</article-title> <source><italic>FASEB J.</italic></source> (<year>2019</year>) <volume>33</volume>:<fpage>2610</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201801401R</pub-id> <pub-id pub-id-type="pmid">30260703</pub-id></citation></ref>
<ref id="B191"><label>191.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Del Rosario</surname> <given-names>BC</given-names></name> <name><surname>Kriz</surname> <given-names>AJ</given-names></name> <name><surname>Del Rosario</surname> <given-names>AM</given-names></name> <name><surname>Anselmo</surname> <given-names>A</given-names></name> <name><surname>Fry</surname> <given-names>CJ</given-names></name> <name><surname>White</surname> <given-names>FM</given-names></name><etal/></person-group> <article-title>Exploration of CTCF post-translation modifications uncovers Serine-224 phosphorylation by PLK1 at pericentric regions during the G2/M transition.</article-title> <source><italic>eLife.</italic></source> (<year>2019</year>) <volume>8</volume>:<issue>e42341</issue>. <pub-id pub-id-type="doi">10.7554/eLife.42341</pub-id> <pub-id pub-id-type="pmid">30676316</pub-id></citation></ref>
<ref id="B192"><label>192.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname> <given-names>KA</given-names></name> <name><surname>Cot&#x00E9;</surname> <given-names>A</given-names></name> <name><surname>Nguyen</surname> <given-names>SC</given-names></name> <name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Gholamalamdari</surname> <given-names>O</given-names></name> <name><surname>Agudelo-Garcia</surname> <given-names>P</given-names></name><etal/></person-group> <article-title>p53 mediates target gene association with nuclear speckles for amplified RNA expression.</article-title> <source><italic>Mol Cell.</italic></source> (<year>2021</year>) <volume>81</volume>:<fpage>1666</fpage>&#x2013;<lpage>81.e6</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2021.03.006</pub-id> <pub-id pub-id-type="pmid">33823140</pub-id></citation></ref>
<ref id="B193"><label>193.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kastan</surname> <given-names>MB</given-names></name> <name><surname>Zhan</surname> <given-names>Q</given-names></name> <name><surname>El-Deiry</surname> <given-names>WS</given-names></name> <name><surname>Carrier</surname> <given-names>F</given-names></name> <name><surname>Jacks</surname> <given-names>T</given-names></name> <name><surname>Walsh</surname> <given-names>WV</given-names></name><etal/></person-group> <article-title>A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.</article-title> <source><italic>Cell.</italic></source> (<year>1992</year>) <volume>71</volume>:<fpage>587</fpage>&#x2013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(92)90593-2</pub-id> <pub-id pub-id-type="pmid">1423616</pub-id></citation></ref>
<ref id="B194"><label>194.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karimian</surname> <given-names>A</given-names></name> <name><surname>Ahmadi</surname> <given-names>Y</given-names></name> <name><surname>Yousefi</surname> <given-names>B</given-names></name></person-group>. <article-title>Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage.</article-title> <source><italic>DNA Repair.</italic></source> (<year>2016</year>) <volume>42</volume>:<fpage>63</fpage>&#x2013;<lpage>71</lpage>.</citation></ref>
<ref id="B195"><label>195.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mansilla</surname> <given-names>SF</given-names></name> <name><surname>de la Vega</surname> <given-names>MB</given-names></name> <name><surname>Calzetta</surname> <given-names>NL</given-names></name> <name><surname>Siri</surname> <given-names>SO</given-names></name> <name><surname>Gottifredi</surname> <given-names>V</given-names></name></person-group>. <article-title>CDK-independent and PCNA-dependent functions of p21 in DNA replication.</article-title> <source><italic>Genes.</italic></source> (<year>2020</year>) <volume>11</volume>:<issue>593</issue>. <pub-id pub-id-type="doi">10.3390/genes11060593</pub-id> <pub-id pub-id-type="pmid">32481484</pub-id></citation></ref>
<ref id="B196"><label>196.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>TE</given-names></name> <name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Wang</surname> <given-names>S</given-names></name> <name><surname>Chen</surname> <given-names>C</given-names></name> <name><surname>Zheng</surname> <given-names>J</given-names></name></person-group>. <article-title>Tripterygium glycosides induce premature ovarian failure in rats by promoting p53 phosphorylation and activating the serine/threonine kinase 11-p53-p21 signaling pathway.</article-title> <source><italic>Exp Ther Med.</italic></source> (<year>2015</year>) <volume>10</volume>:<fpage>12</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3892/etm.2015.2498</pub-id> <pub-id pub-id-type="pmid">26170905</pub-id></citation></ref>
<ref id="B197"><label>197.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>El-Derany</surname> <given-names>MO</given-names></name> <name><surname>Said</surname> <given-names>RS</given-names></name> <name><surname>El-Demerdash</surname> <given-names>E</given-names></name></person-group>. <article-title>Bone marrow-derived mesenchymal stem cells reverse radiotherapy-induced premature ovarian failure: emphasis on signal integration of TGF-&#x03B2;, Wnt/&#x03B2;-catenin and hippo pathways.</article-title> <source><italic>Stem Cell Rev Rep.</italic></source> (<year>2021</year>) <volume>17</volume>:<fpage>1429</fpage>&#x2013;<lpage>45</lpage>.</citation></ref>
<ref id="B198"><label>198.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Habara</surname> <given-names>O</given-names></name> <name><surname>Logan</surname> <given-names>CY</given-names></name> <name><surname>Kanai-Azuma</surname> <given-names>M</given-names></name> <name><surname>Nusse</surname> <given-names>R</given-names></name> <name><surname>Takase</surname> <given-names>HM</given-names></name></person-group>. <article-title>WNT signaling in pre-granulosa cells is required for ovarian folliculogenesis and female fertility.</article-title> <source><italic>Development (Cambridge, England).</italic></source> (<year>2021</year>) <volume>148</volume>:<issue>dev198846</issue>. <pub-id pub-id-type="doi">10.1242/dev.198846</pub-id> <pub-id pub-id-type="pmid">33914868</pub-id></citation></ref>
<ref id="B199"><label>199.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>HX</given-names></name> <name><surname>Li</surname> <given-names>TY</given-names></name> <name><surname>Kidder</surname> <given-names>GM</given-names></name></person-group>. <article-title>WNT2 regulates DNA synthesis in mouse granulosa cells through beta-catenin.</article-title> <source><italic>Biol. Reprod.</italic></source> (<year>2010</year>) <volume>82</volume>:<fpage>865</fpage>&#x2013;<lpage>75</lpage>.</citation></ref>
<ref id="B200"><label>200.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>HX</given-names></name> <name><surname>Tekpetey</surname> <given-names>FR</given-names></name> <name><surname>Kidder</surname> <given-names>GM</given-names></name></person-group>. <article-title>Identification of WNT/beta-CATENIN signaling pathway components in human cumulus cells.</article-title> <source><italic>Mol Hum Reprod.</italic></source> (<year>2009</year>) <volume>15</volume>:<fpage>11</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1093/molehr/gan070</pub-id> <pub-id pub-id-type="pmid">19038973</pub-id></citation></ref>
<ref id="B201"><label>201.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hernandez Gifford</surname> <given-names>JA</given-names></name></person-group>. <article-title>The role of WNT signaling in adult ovarian folliculogenesis.</article-title> <source><italic>Reproduction (Cambridge, England).</italic></source> (<year>2015</year>) <volume>150</volume>:<fpage>R137</fpage>&#x2013;<lpage>48</lpage>.</citation></ref>
<ref id="B202"><label>202.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nagasawa</surname> <given-names>T</given-names></name></person-group>. <article-title>CXC chemokine ligand 12 (CXCL12) and its receptor CXCR4.</article-title> <source><italic>J Mol Med (Berlin, Germany).</italic></source> (<year>2014</year>) <volume>92</volume>:<fpage>433</fpage>&#x2013;<lpage>9</lpage>.</citation></ref>
<ref id="B203"><label>203.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>Q</given-names></name> <name><surname>Yin</surname> <given-names>N</given-names></name> <name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Yuan</surname> <given-names>W</given-names></name> <name><surname>Zhao</surname> <given-names>W</given-names></name> <name><surname>Luan</surname> <given-names>X</given-names></name><etal/></person-group> <article-title>Role of SDF-1/CXCR4 and cytokines in the development of ovary injury in chemotherapy drug induced premature ovarian failure mice.</article-title> <source><italic>Life Sci.</italic></source> (<year>2017</year>) <volume>179</volume>:<fpage>103</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2017.05.001</pub-id> <pub-id pub-id-type="pmid">28478265</pub-id></citation></ref>
<ref id="B204"><label>204.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>B</given-names></name> <name><surname>Suo</surname> <given-names>P</given-names></name> <name><surname>Chen</surname> <given-names>B</given-names></name> <name><surname>Wei</surname> <given-names>Z</given-names></name> <name><surname>Yang</surname> <given-names>L</given-names></name> <name><surname>Zhou</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>Haplotype analysis of chemokine CXCL12 polymorphisms and susceptibility to premature ovarian failure in Chinese women.</article-title> <source><italic>Hum Reprod (Oxford, England).</italic></source> (<year>2011</year>) <volume>26</volume>:<fpage>950</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/der001</pub-id> <pub-id pub-id-type="pmid">21296802</pub-id></citation></ref>
<ref id="B205"><label>205.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holt</surname> <given-names>JE</given-names></name> <name><surname>Jackson</surname> <given-names>A</given-names></name> <name><surname>Roman</surname> <given-names>SD</given-names></name> <name><surname>Aitken</surname> <given-names>RJ</given-names></name> <name><surname>Koopman</surname> <given-names>P</given-names></name> <name><surname>McLaughlin</surname> <given-names>EA</given-names></name></person-group>. <article-title>CXCR4/SDF1 interaction inhibits the primordial to primary follicle transition in the neonatal mouse ovary.</article-title> <source><italic>Dev Biol.</italic></source> (<year>2006</year>) <volume>293</volume>:<fpage>449</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2006.02.012</pub-id> <pub-id pub-id-type="pmid">16545793</pub-id></citation></ref>
<ref id="B206"><label>206.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>Y</given-names></name> <name><surname>Yao</surname> <given-names>R</given-names></name> <name><surname>Yang</surname> <given-names>Z</given-names></name> <name><surname>Li</surname> <given-names>S</given-names></name> <name><surname>Meng</surname> <given-names>W</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name><etal/></person-group> <article-title>Interleukin-4 activates the PI3K/AKT signaling to promote apoptosis and inhibit the proliferation of granulosa cells.</article-title> <source><italic>Exp Cell Res.</italic></source> (<year>2022</year>) <volume>412</volume>:<issue>113002</issue>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2021.113002</pub-id> <pub-id pub-id-type="pmid">34973261</pub-id></citation></ref>
<ref id="B207"><label>207.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanverdi</surname> <given-names>I</given-names></name> <name><surname>Kilicci</surname> <given-names>C</given-names></name> <name><surname>Cogendez</surname> <given-names>E</given-names></name> <name><surname>Abide Yayla</surname> <given-names>C</given-names></name> <name><surname>Ozkaya</surname> <given-names>E</given-names></name></person-group>. <article-title>Utility of complete blood count parameters to detect premature ovarian insufficiency in cases with oligomenorrhea/amenorrhea.</article-title> <source><italic>J Clin Lab Anal.</italic></source> (<year>2018</year>) <volume>32</volume>:<issue>e22372</issue>. <pub-id pub-id-type="doi">10.1002/jcla.22372</pub-id> <pub-id pub-id-type="pmid">29243847</pub-id></citation></ref>
<ref id="B208"><label>208.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Townson</surname> <given-names>DH</given-names></name> <name><surname>Liptak</surname> <given-names>AR</given-names></name></person-group>. <article-title>Chemokines in the corpus luteum: implications of leukocyte chemotaxis.</article-title> <source><italic>Reprod Biol Endocrinol.</italic></source> (<year>2003</year>) <volume>1</volume>:<issue>94</issue>. <pub-id pub-id-type="doi">10.1186/1477-7827-1-94</pub-id> <pub-id pub-id-type="pmid">14613530</pub-id></citation></ref>
<ref id="B209"><label>209.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname> <given-names>M</given-names></name> <name><surname>Rath</surname> <given-names>D</given-names></name> <name><surname>Gawaz</surname> <given-names>M</given-names></name></person-group>. <article-title>Role of chemokine receptors CXCR4 and CXCR7 for platelet function.</article-title> <source><italic>Biochem Soc Trans.</italic></source> (<year>2015</year>) <volume>43</volume>:<fpage>720</fpage>&#x2013;<lpage>6</lpage>.</citation></ref>
<ref id="B210"><label>210.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname> <given-names>L</given-names></name> <name><surname>Hou</surname> <given-names>J</given-names></name> <name><surname>Liu</surname> <given-names>D</given-names></name> <name><surname>Tang</surname> <given-names>D</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Zeng</surname> <given-names>Q</given-names></name><etal/></person-group> <article-title>Important role of the SDF-1/CXCR4 axis in the homing of systemically transplanted human amnion-derived mesenchymal stem cells (hAD-MSCs) to ovaries in rats with chemotherapy-induced premature ovarian insufficiency (POI).</article-title> <source><italic>Stem Cell Res. Ther.</italic></source> (<year>2022</year>) <volume>13</volume>:<issue>79</issue>. <pub-id pub-id-type="doi">10.1186/s13287-022-02759-6</pub-id> <pub-id pub-id-type="pmid">35197118</pub-id></citation></ref>
<ref id="B211"><label>211.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Won</surname> <given-names>YW</given-names></name> <name><surname>Patel</surname> <given-names>AN</given-names></name> <name><surname>Bull</surname> <given-names>DA</given-names></name></person-group>. <article-title>Cell surface engineering to enhance mesenchymal stem cell migration toward an SDF-1 gradient.</article-title> <source><italic>Biomaterials.</italic></source> (<year>2014</year>) <volume>35</volume>:<fpage>5627</fpage>&#x2013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2014.03.070</pub-id> <pub-id pub-id-type="pmid">24731711</pub-id></citation></ref>
<ref id="B212"><label>212.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname> <given-names>FY</given-names></name> <name><surname>Leung</surname> <given-names>KS</given-names></name> <name><surname>Li</surname> <given-names>G</given-names></name> <name><surname>Qin</surname> <given-names>J</given-names></name> <name><surname>Chow</surname> <given-names>SK</given-names></name> <name><surname>Huang</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>Low intensity pulsed ultrasound enhanced mesenchymal stem cell recruitment through stromal derived factor-1 signaling in fracture healing.</article-title> <source><italic>PLoS One.</italic></source> (<year>2014</year>) <volume>9</volume>:<issue>e106722</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0106722</pub-id> <pub-id pub-id-type="pmid">25181476</pub-id></citation></ref>
<ref id="B213"><label>213.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Croft</surname> <given-names>M</given-names></name></person-group>. <article-title>Behind the walls at stillwater prison.</article-title> <source><italic>MNA Accent.</italic></source> (<year>1991</year>) <volume>63</volume>:<issue>15</issue>. <pub-id pub-id-type="pmid">1650891</pub-id></citation></ref>
<ref id="B214"><label>214.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiu</surname> <given-names>G</given-names></name> <name><surname>Li</surname> <given-names>X</given-names></name> <name><surname>Yin</surname> <given-names>Y</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Li</surname> <given-names>B</given-names></name> <name><surname>Chen</surname> <given-names>X</given-names></name><etal/></person-group> <article-title>SDF1/CXCR4 augments the therapeutic effect of bone marrow mesenchymal stem cells in the treatment of lipopolysaccharide-induced liver injury by promoting their migration through PI3K/Akt signaling pathway.</article-title> <source><italic>Cell Trans.</italic></source> (<year>2020</year>) <volume>29</volume>:<issue>963689720929992</issue>. <pub-id pub-id-type="doi">10.1177/0963689720929992</pub-id> <pub-id pub-id-type="pmid">32452221</pub-id></citation></ref>
<ref id="B215"><label>215.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Teicher</surname> <given-names>BA</given-names></name> <name><surname>Fricker</surname> <given-names>SP</given-names></name></person-group>. <article-title>CXCL12 (SDF-1)/CXCR4 pathway in cancer.</article-title> <source><italic>Clin. Cancer Res.</italic></source> (<year>2010</year>) <volume>16</volume>:<fpage>2927</fpage>&#x2013;<lpage>31</lpage>.</citation></ref>
<ref id="B216"><label>216.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname> <given-names>D</given-names></name> <name><surname>Wang</surname> <given-names>F</given-names></name> <name><surname>Yao</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>Q</given-names></name> <name><surname>Wu</surname> <given-names>X</given-names></name> <name><surname>Xiang</surname> <given-names>C</given-names></name></person-group>. <article-title>Human endometrial mesenchymal stem cells restore ovarian function through improving the renewal of germline stem cells in a mouse model of premature ovarian failure.</article-title> <source><italic>J. Transl. Med.</italic></source> (<year>2015</year>) <volume>13</volume>:<issue>155</issue>. <pub-id pub-id-type="doi">10.1186/s12967-015-0516-y</pub-id> <pub-id pub-id-type="pmid">25964118</pub-id></citation></ref>
<ref id="B217"><label>217.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname> <given-names>L</given-names></name> <name><surname>Mao</surname> <given-names>X</given-names></name> <name><surname>Yu</surname> <given-names>Q</given-names></name> <name><surname>Yu</surname> <given-names>D</given-names></name></person-group>. <article-title>Effect of the PI3K/AKT signaling pathway on hypoxia-induced proliferation and differentiation of bone marrow-derived mesenchymal stem cells.</article-title> <source><italic>Exp Ther Med.</italic></source> (<year>2017</year>) <volume>13</volume>:<fpage>55</fpage>&#x2013;<lpage>62</lpage>.</citation></ref>
<ref id="B218"><label>218.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jozkowiak</surname> <given-names>M</given-names></name> <name><surname>Hutchings</surname> <given-names>G</given-names></name> <name><surname>Jankowski</surname> <given-names>M</given-names></name> <name><surname>Kulcenty</surname> <given-names>K</given-names></name> <name><surname>Mozdziak</surname> <given-names>P</given-names></name> <name><surname>Kempisty</surname> <given-names>B</given-names></name><etal/></person-group> <article-title>The stemness of human ovarian granulosa cells and the role of resveratrol in the differentiation of MSCs-A review based on cellular and molecular knowledge.</article-title> <source><italic>Cells.</italic></source> (<year>2020</year>) <volume>9</volume>:<issue>1418</issue>. <pub-id pub-id-type="doi">10.3390/cells9061418</pub-id> <pub-id pub-id-type="pmid">32517362</pub-id></citation></ref>
<ref id="B219"><label>219.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Basini</surname> <given-names>G</given-names></name> <name><surname>Falasconi</surname> <given-names>I</given-names></name> <name><surname>Bussolati</surname> <given-names>S</given-names></name> <name><surname>Grolli</surname> <given-names>S</given-names></name> <name><surname>Lecce</surname> <given-names>R. Di</given-names></name> <name><surname>Grasselli</surname> <given-names>F</given-names></name></person-group>. <article-title>Swine granulosa cells show typical endothelial cell characteristics.</article-title> <source><italic>Reprod Sci (Thousand Oaks, Calif.).</italic></source> (<year>2016</year>) <volume>23</volume>:<fpage>630</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1177/1933719115612130</pub-id> <pub-id pub-id-type="pmid">26494700</pub-id></citation></ref>
<ref id="B220"><label>220.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>M</given-names></name> <name><surname>Qiu</surname> <given-names>Y</given-names></name> <name><surname>Xue</surname> <given-names>Z</given-names></name> <name><surname>Wu</surname> <given-names>R</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Niu</surname> <given-names>X</given-names></name><etal/></person-group> <article-title>Small extracellular vesicles derived from embryonic stem cells restore ovarian function of premature ovarian failure through PI3K/AKT signaling pathway.</article-title> <source><italic>Stem Cell Res. Ther.</italic></source> (<year>2020</year>) <volume>11</volume>:<issue>3</issue>. <pub-id pub-id-type="doi">10.1186/s13287-019-1508-2</pub-id> <pub-id pub-id-type="pmid">31900201</pub-id></citation></ref>
<ref id="B221"><label>221.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>J</given-names></name> <name><surname>Kim</surname> <given-names>TH</given-names></name> <name><surname>Seok</surname> <given-names>J</given-names></name> <name><surname>Jun</surname> <given-names>JH</given-names></name> <name><surname>Park</surname> <given-names>H</given-names></name> <name><surname>Kweon</surname> <given-names>M</given-names></name><etal/></person-group> <article-title>Vascular remodeling by placenta-derived mesenchymal stem cells restores ovarian function in ovariectomized rat model via the VEGF pathway.</article-title> <source><italic>Lab Invest A J Techn Methods Pathol.</italic></source> (<year>2021</year>) <volume>101</volume>:<fpage>304</fpage>&#x2013;<lpage>17</lpage>.</citation></ref>
<ref id="B222"><label>222.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname> <given-names>N</given-names></name> <name><surname>Wang</surname> <given-names>Y</given-names></name> <name><surname>Lu</surname> <given-names>X</given-names></name> <name><surname>Liu</surname> <given-names>R</given-names></name> <name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Zhao</surname> <given-names>W</given-names></name><etal/></person-group> <article-title>hPMSC transplantation restoring ovarian function in premature ovarian failure mice is associated with change of Th17/Tc17 and Th17/Treg cell ratios through the PI3K/Akt signal pathway.</article-title> <source><italic>Stem Cell Res. Ther.</italic></source> (<year>2018</year>) <volume>9</volume>:<issue>37</issue>.</citation></ref>
<ref id="B223"><label>223.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname> <given-names>QX</given-names></name> <name><surname>Wang</surname> <given-names>ZB</given-names></name> <name><surname>Lin</surname> <given-names>F</given-names></name> <name><surname>Zhang</surname> <given-names>CH</given-names></name> <name><surname>Sun</surname> <given-names>HM</given-names></name> <name><surname>Zhou</surname> <given-names>L</given-names></name><etal/></person-group> <article-title>Ablation of beta subunit of protein kinase CK2 in mouse oocytes causes follicle atresia and premature ovarian failure.</article-title> <source><italic>Cell Death Dis.</italic></source> (<year>2018</year>) <volume>9</volume>:<issue>508</issue>. <pub-id pub-id-type="doi">10.1038/s41419-018-0505-1</pub-id> <pub-id pub-id-type="pmid">29725001</pub-id></citation></ref>
<ref id="B224"><label>224.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ivell</surname> <given-names>R</given-names></name> <name><surname>Anand-Ivell</surname> <given-names>R</given-names></name></person-group>. <article-title>Biology of insulin-like factor 3 in human reproduction.</article-title> <source><italic>Hum Reprod Update.</italic></source> (<year>2009</year>) <volume>15</volume>:<fpage>463</fpage>&#x2013;<lpage>76</lpage>.</citation></ref>
<ref id="B225"><label>225.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname> <given-names>Y</given-names></name> <name><surname>Ivell</surname> <given-names>R</given-names></name> <name><surname>Anand-Ivell</surname> <given-names>R</given-names></name></person-group>. <article-title>Theca cell INSL3 and steroids together orchestrate the growing bovine antral follicle.</article-title> <source><italic>Front Physiol.</italic></source> (<year>2017</year>) <volume>8</volume>:<issue>1033</issue>. <pub-id pub-id-type="doi">10.3389/fphys.2017.01033</pub-id> <pub-id pub-id-type="pmid">29311967</pub-id></citation></ref>
<ref id="B226"><label>226.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonser</surname> <given-names>J</given-names></name> <name><surname>Walker</surname> <given-names>J</given-names></name> <name><surname>Purohit</surname> <given-names>A</given-names></name> <name><surname>Reed</surname> <given-names>MJ</given-names></name> <name><surname>Potter</surname> <given-names>BV</given-names></name> <name><surname>Willis</surname> <given-names>DS</given-names></name><etal/></person-group> <article-title>Human granulosa cells are a site of sulphatase activity and are able to utilize dehydroepiandrosterone sulphate as a precursor for oestradiol production.</article-title> <source><italic>J Endocrinol.</italic></source> (<year>2000</year>) <volume>167</volume>:<fpage>465</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1677/joe.0.1670465</pub-id> <pub-id pub-id-type="pmid">11115773</pub-id></citation></ref>
<ref id="B227"><label>227.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Irving-Rodgers</surname> <given-names>HF</given-names></name> <name><surname>Bathgate</surname> <given-names>RA</given-names></name> <name><surname>Ivell</surname> <given-names>R</given-names></name> <name><surname>Domagalski</surname> <given-names>R</given-names></name> <name><surname>Rodgers</surname> <given-names>RJ</given-names></name></person-group>. <article-title>Dynamic changes in the expression of relaxin-like factor (INSL3), cholesterol side-chain cleavage cytochrome p450, and 3beta-hydroxysteroid dehydrogenase in bovine ovarian follicles during growth and atresia.</article-title> <source><italic>Biol Reprod.</italic></source> (<year>2002</year>) <volume>66</volume>:<fpage>934</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1095/biolreprod66.4.934</pub-id> <pub-id pub-id-type="pmid">11906911</pub-id></citation></ref>
<ref id="B228"><label>228.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ivell</surname> <given-names>R</given-names></name> <name><surname>Anand-Ivell</surname> <given-names>R</given-names></name></person-group>. <article-title>Insulin-like peptide 3 (INSL3) is a major regulator of female reproductive physiology.</article-title> <source><italic>Hum Reprod Update.</italic></source> (<year>2018</year>) <volume>24</volume>:<fpage>639</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1093/humupd/dmy029</pub-id> <pub-id pub-id-type="pmid">30204868</pub-id></citation></ref>
<ref id="B229"><label>229.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawamura</surname> <given-names>K</given-names></name> <name><surname>Kumagai</surname> <given-names>J</given-names></name> <name><surname>Sudo</surname> <given-names>S</given-names></name> <name><surname>Chun</surname> <given-names>SY</given-names></name> <name><surname>Pisarska</surname> <given-names>M</given-names></name> <name><surname>Morita</surname> <given-names>H</given-names></name><etal/></person-group> <article-title>Paracrine regulation of mammalian oocyte maturation and male germ cell survival.</article-title> <source><italic>Proc Natl. Acad Sci U S A.</italic></source> (<year>2004</year>) <volume>101</volume>:<fpage>7323</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0307061101</pub-id> <pub-id pub-id-type="pmid">15123806</pub-id></citation></ref>
<ref id="B230"><label>230.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname> <given-names>Y</given-names></name> <name><surname>Ivell</surname> <given-names>R</given-names></name> <name><surname>Liu</surname> <given-names>X</given-names></name> <name><surname>Janowski</surname> <given-names>D</given-names></name> <name><surname>Anand-Ivell</surname> <given-names>R</given-names></name></person-group>. <article-title>Relaxin-family peptide receptors 1 and 2 are fully functional in the bovine.</article-title> <source><italic>Front. Physiol.</italic></source> (<year>2017</year>) <volume>8</volume>:<issue>359</issue>. <pub-id pub-id-type="doi">10.3389/fphys.2017.00359</pub-id> <pub-id pub-id-type="pmid">28634453</pub-id></citation></ref>
<ref id="B231"><label>231.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anand-Ivell</surname> <given-names>R</given-names></name> <name><surname>Tremellen</surname> <given-names>K</given-names></name> <name><surname>Dai</surname> <given-names>Y</given-names></name> <name><surname>Heng</surname> <given-names>K</given-names></name> <name><surname>Yoshida</surname> <given-names>M</given-names></name> <name><surname>Knight</surname> <given-names>PG</given-names></name><etal/></person-group> <article-title>Circulating insulin-like factor 3 (INSL3) in healthy and infertile women.</article-title> <source><italic>Hum Reprod (Oxford, England).</italic></source> (<year>2013</year>) <volume>28</volume>:<fpage>3093</fpage>&#x2013;<lpage>102</lpage>.</citation></ref>
<ref id="B232"><label>232.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname> <given-names>K</given-names></name> <name><surname>Kim</surname> <given-names>JY</given-names></name> <name><surname>Liu</surname> <given-names>JY</given-names></name> <name><surname>Tsang</surname> <given-names>BK</given-names></name></person-group>. <article-title>Insulin-like 3-induced rat preantral follicular growth is mediated by growth differentiation factor 9.</article-title> <source><italic>Endocrinology.</italic></source> (<year>2014</year>) <volume>155</volume>:<fpage>156</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1210/en.2013-1491</pub-id> <pub-id pub-id-type="pmid">24169563</pub-id></citation></ref>
<ref id="B233"><label>233.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>C</given-names></name> <name><surname>Luo</surname> <given-names>W</given-names></name> <name><surname>Li</surname> <given-names>Z</given-names></name> <name><surname>Zhang</surname> <given-names>X</given-names></name> <name><surname>Hu</surname> <given-names>J</given-names></name> <name><surname>Zhao</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>New theca-cell marker insulin-like factor 3 is associated with premature ovarian insufficiency.</article-title> <source><italic>Fertil Steril.</italic></source> (<year>2021</year>) <volume>115</volume>:<fpage>455</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2020.08.005</pub-id> <pub-id pub-id-type="pmid">33041054</pub-id></citation></ref>
<ref id="B234"><label>234.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Introna</surname> <given-names>M</given-names></name> <name><surname>Alles</surname> <given-names>VV</given-names></name> <name><surname>Castellano</surname> <given-names>M</given-names></name> <name><surname>Picardi</surname> <given-names>G</given-names></name> <name><surname>De Gioia</surname> <given-names>L</given-names></name> <name><surname>Bottazzai</surname> <given-names>B</given-names></name><etal/></person-group> <article-title>Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites.</article-title> <source><italic>Blood.</italic></source> (<year>1996</year>) <volume>87</volume>:<fpage>1862</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="pmid">8634434</pub-id></citation></ref>
<ref id="B235"><label>235.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Camaioni</surname> <given-names>A</given-names></name> <name><surname>Klinger</surname> <given-names>FG</given-names></name> <name><surname>Campagnolo</surname> <given-names>L</given-names></name> <name><surname>Salustri</surname> <given-names>A</given-names></name></person-group>. <article-title>The influence of pentraxin 3 on the ovarian function and its impact on fertility.</article-title> <source><italic>Front Immunol.</italic></source> (<year>2018</year>) <volume>9</volume>:<issue>2808</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.02808</pub-id> <pub-id pub-id-type="pmid">30555480</pub-id></citation></ref>
<ref id="B236"><label>236.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Di Giacomo</surname> <given-names>M</given-names></name> <name><surname>Camaioni</surname> <given-names>A</given-names></name> <name><surname>Klinger</surname> <given-names>FG</given-names></name> <name><surname>Bonfiglio</surname> <given-names>R</given-names></name> <name><surname>Salustri</surname> <given-names>A</given-names></name></person-group>. <article-title>Cyclic AMP-elevating agents promote cumulus cell survival and hyaluronan matrix stability, thereby prolonging the time of mouse oocyte fertilizability.</article-title> <source><italic>J Biol Chem.</italic></source> (<year>2016</year>) <volume>291</volume>:<fpage>3821</fpage>&#x2013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M115.680983</pub-id> <pub-id pub-id-type="pmid">26694612</pub-id></citation></ref>
<ref id="B237"><label>237.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Varani</surname> <given-names>S</given-names></name> <name><surname>Elvin</surname> <given-names>JA</given-names></name> <name><surname>Yan</surname> <given-names>C</given-names></name> <name><surname>DeMayo</surname> <given-names>J</given-names></name> <name><surname>DeMayo</surname> <given-names>FJ</given-names></name> <name><surname>Horton</surname> <given-names>HF</given-names></name><etal/></person-group> <article-title>Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility.</article-title> <source><italic>Mol Endocrinol (Baltimore, Md.).</italic></source> (<year>2002</year>) <volume>16</volume>:<fpage>1154</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1210/mend.16.6.0859</pub-id> <pub-id pub-id-type="pmid">12040004</pub-id></citation></ref>
<ref id="B238"><label>238.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nagyova</surname> <given-names>E</given-names></name> <name><surname>Camaioni</surname> <given-names>A</given-names></name> <name><surname>Prochazka</surname> <given-names>R</given-names></name> <name><surname>Salustri</surname> <given-names>A</given-names></name></person-group>. <article-title>Covalent transfer of heavy chains of inter-alpha-trypsin inhibitor family proteins to hyaluronan in in vivo and in vitro expanded porcine oocyte-cumulus complexes.</article-title> <source><italic>Biol Reprod.</italic></source> (<year>2004</year>) <volume>71</volume>:<fpage>1838</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1095/biolreprod.104.029595</pub-id> <pub-id pub-id-type="pmid">15286040</pub-id></citation></ref>
<ref id="B239"><label>239.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scarchilli</surname> <given-names>L</given-names></name> <name><surname>Camaioni</surname> <given-names>A</given-names></name> <name><surname>Bottazzi</surname> <given-names>B</given-names></name> <name><surname>Negri</surname> <given-names>V</given-names></name> <name><surname>Doni</surname> <given-names>A</given-names></name> <name><surname>Deban</surname> <given-names>L</given-names></name><etal/></person-group> <article-title>PTX3 interacts with inter-alpha-trypsin inhibitor: implications for hyaluronan organization and cumulus oophorus expansion.</article-title> <source><italic>J Biol Chem.</italic></source> (<year>2007</year>) <volume>282</volume>:<fpage>30161</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M703738200</pub-id> <pub-id pub-id-type="pmid">17675295</pub-id></citation></ref>
<ref id="B240"><label>240.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ievoli</surname> <given-names>E</given-names></name> <name><surname>Lindstedt</surname> <given-names>R</given-names></name> <name><surname>Inforzato</surname> <given-names>A</given-names></name> <name><surname>Camaioni</surname> <given-names>A</given-names></name> <name><surname>Palone</surname> <given-names>F</given-names></name> <name><surname>Day</surname> <given-names>AJ</given-names></name><etal/></person-group> <article-title>Implication of the oligomeric state of the N-terminal PTX3 domain in cumulus matrix assembly.</article-title> <source><italic>Matrix Biol.</italic></source> (<year>2011</year>) <volume>30</volume>:<fpage>330</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2011.05.002</pub-id> <pub-id pub-id-type="pmid">21619930</pub-id></citation></ref>
<ref id="B241"><label>241.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiao</surname> <given-names>W</given-names></name> <name><surname>Mi</surname> <given-names>X</given-names></name> <name><surname>Yang</surname> <given-names>Y</given-names></name> <name><surname>Liu</surname> <given-names>R</given-names></name> <name><surname>Liu</surname> <given-names>Q</given-names></name> <name><surname>Yan</surname> <given-names>T</given-names></name><etal/></person-group> <article-title>Mesenchymal stem cells combined with autocrosslinked hyaluronic acid improve mouse ovarian function by activating the PI3K-AKT pathway in a paracrine manner.</article-title> <source><italic>Stem Cell Res Ther.</italic></source> (<year>2022</year>) <volume>13</volume>:<issue>49</issue>. <pub-id pub-id-type="doi">10.1186/s13287-022-02724-3</pub-id> <pub-id pub-id-type="pmid">35109928</pub-id></citation></ref>
<ref id="B242"><label>242.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname> <given-names>EY</given-names></name> <name><surname>Kim</surname> <given-names>DS</given-names></name> <name><surname>Lee</surname> <given-names>MJ</given-names></name> <name><surname>Lee</surname> <given-names>AR</given-names></name> <name><surname>Shim</surname> <given-names>SH</given-names></name> <name><surname>Baek</surname> <given-names>SW</given-names></name><etal/></person-group> <article-title>Prevention of chemotherapy-induced premature ovarian insufficiency in mice by scaffold-based local delivery of human embryonic stem cell-derived mesenchymal progenitor cells.</article-title> <source><italic>Stem Cell Res Ther.</italic></source> (<year>2021</year>) <volume>12</volume>:<issue>431</issue>. <pub-id pub-id-type="doi">10.1186/s13287-021-02479-3</pub-id> <pub-id pub-id-type="pmid">34332643</pub-id></citation></ref>
<ref id="B243"><label>243.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>G</given-names></name> <name><surname>Yan</surname> <given-names>G</given-names></name> <name><surname>Cheng</surname> <given-names>J</given-names></name> <name><surname>Zhou</surname> <given-names>X</given-names></name> <name><surname>Fang</surname> <given-names>T</given-names></name> <name><surname>Sun</surname> <given-names>H</given-names></name><etal/></person-group> <article-title>Hyaluronic acid prevents immunosuppressive drug-induced ovarian damage via up-regulating PGRMC1 expression.</article-title> <source><italic>Sci Rep.</italic></source> (<year>2015</year>) <volume>5</volume>:<issue>7647</issue>. <pub-id pub-id-type="doi">10.1038/srep07647</pub-id> <pub-id pub-id-type="pmid">25558795</pub-id></citation></ref>
<ref id="B244"><label>244.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>G</given-names></name> <name><surname>Zhou</surname> <given-names>X</given-names></name> <name><surname>Fang</surname> <given-names>T</given-names></name> <name><surname>Hou</surname> <given-names>Y</given-names></name> <name><surname>Hu</surname> <given-names>Y</given-names></name></person-group>. <article-title>Hyaluronic acid promotes the expression of progesterone receptor membrane component 1 via epigenetic silencing of miR-139-5p in human and rat granulosa cells.</article-title> <source><italic>Biol Reprod.</italic></source> (<year>2014</year>) <volume>91</volume>:<issue>116</issue>. <pub-id pub-id-type="doi">10.1095/biolreprod.114.120295</pub-id> <pub-id pub-id-type="pmid">25232020</pub-id></citation></ref>
<ref id="B245"><label>245.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hewlett</surname> <given-names>M</given-names></name> <name><surname>Mahalingaiah</surname> <given-names>S</given-names></name></person-group>. <article-title>Update on primary ovarian insufficiency.</article-title> <source><italic>Curr Opin Endocrinol Diabetes Obes.</italic></source> (<year>2015</year>) <volume>22</volume>:<fpage>483</fpage>&#x2013;<lpage>9</lpage>.</citation></ref>
<ref id="B246"><label>246.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kovanci</surname> <given-names>E</given-names></name> <name><surname>Schutt</surname> <given-names>AK</given-names></name></person-group>. <article-title>Premature ovarian failure: clinical presentation and treatment.</article-title> <source><italic>Obstetr Gynecol Clin North Am.</italic></source> (<year>2015</year>) <volume>42</volume>:<fpage>153</fpage>&#x2013;<lpage>61</lpage>.</citation></ref>
<ref id="B247"><label>247.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arrigo</surname> <given-names>T</given-names></name> <name><surname>Bertelloni</surname> <given-names>S</given-names></name> <name><surname>Carcione</surname> <given-names>L</given-names></name> <name><surname>De Luca</surname> <given-names>F</given-names></name> <name><surname>De Sanctis</surname> <given-names>C</given-names></name> <name><surname>Einaudi</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>Characterization of early presentation idiopathic ovarian failure in girls and adolescents.</article-title> <source><italic>J Pediatr Endocrinol Metab.</italic></source> (<year>2003</year>) <volume>16</volume>:<fpage>835</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1515/jpem.2003.16.6.835</pub-id> <pub-id pub-id-type="pmid">12948295</pub-id></citation></ref>
<ref id="B248"><label>248.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bachelot</surname> <given-names>A</given-names></name> <name><surname>Rouxel</surname> <given-names>A</given-names></name> <name><surname>Massin</surname> <given-names>N</given-names></name> <name><surname>Dulon</surname> <given-names>J</given-names></name> <name><surname>Courtillot</surname> <given-names>C</given-names></name> <name><surname>Matuchansky</surname> <given-names>C</given-names></name><etal/></person-group> <article-title>Phenotyping and genetic studies of 357 consecutive patients presenting with premature ovarian failure.</article-title> <source><italic>Eur J Endocrinol</italic></source> (<year>2009</year>) <volume>161</volume>:<fpage>179</fpage>&#x2013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1530/EJE-09-0231</pub-id> <pub-id pub-id-type="pmid">19411303</pub-id></citation></ref>
<ref id="B249"><label>249.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname> <given-names>L</given-names></name> <name><surname>Liu</surname> <given-names>JH</given-names></name></person-group>. <article-title>Primary ovarian insufficiency: an update.</article-title> <source><italic>Int J Womens Health.</italic></source> (<year>2014</year>) <volume>6</volume>:<fpage>235</fpage>&#x2013;<lpage>43</lpage>.</citation></ref>
<ref id="B250"><label>250.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ayesha, Jha</surname> <given-names>V</given-names></name> <name><surname>Goswami</surname> <given-names>D</given-names></name></person-group>. <article-title>Premature ovarian failure: an association with autoimmune diseases.</article-title> <source><italic>J Clin Diagnost Res</italic></source> (<year>2016</year>) <volume>10</volume>:<fpage>Qc10</fpage>&#x2013;<lpage>2</lpage>.</citation></ref>
<ref id="B251"><label>251.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Webber</surname> <given-names>L</given-names></name> <name><surname>Davies</surname> <given-names>M</given-names></name> <name><surname>Anderson</surname> <given-names>R</given-names></name> <name><surname>Bartlett</surname> <given-names>J</given-names></name> <name><surname>Braat</surname> <given-names>D</given-names></name> <name><surname>Cartwright</surname> <given-names>B</given-names></name><etal/></person-group> <article-title>ESHRE Guideline: management of women with premature ovarian insufficiency.</article-title> <source><italic>Hum Reprod (Oxford, England).</italic></source> (<year>2016</year>) <volume>31</volume>:<fpage>926</fpage>&#x2013;<lpage>37</lpage>.</citation></ref>
<ref id="B252"><label>252.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Michala</surname> <given-names>L</given-names></name> <name><surname>Stefanaki</surname> <given-names>K</given-names></name> <name><surname>Loutradis</surname> <given-names>D</given-names></name></person-group>. <article-title>Premature ovarian insufficiency in adolescence: a chance for early diagnosis?</article-title> <source><italic>Hormones (Athens, Greece).</italic></source> (<year>2020</year>) <volume>19</volume>:<fpage>277</fpage>&#x2013;<lpage>83</lpage>.</citation></ref>
<ref id="B253"><label>253.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname> <given-names>VL</given-names></name></person-group>. <article-title>Primary ovarian insufficiency in the adolescent.</article-title> <source><italic>Curr Opin Obstetr Gynecol.</italic></source> (<year>2013</year>) <volume>25</volume>:<fpage>375</fpage>&#x2013;<lpage>81</lpage>.</citation></ref>
<ref id="B254"><label>254.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ishizuka</surname> <given-names>B</given-names></name></person-group>. <article-title>Current understanding of the etiology, symptomatology, and treatment options in premature ovarian insufficiency (POI).</article-title> <source><italic>Front Endocrinol.</italic></source> (<year>2021</year>) <volume>12</volume>:<issue>626924</issue>. <pub-id pub-id-type="doi">10.3389/fendo.2021.626924</pub-id> <pub-id pub-id-type="pmid">33716979</pub-id></citation></ref>
<ref id="B255"><label>255.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>MY</given-names></name> <name><surname>Wang</surname> <given-names>YX</given-names></name> <name><surname>Li-Ling</surname> <given-names>J</given-names></name> <name><surname>Xie</surname> <given-names>HQ</given-names></name></person-group>. <article-title>Adult stem cell therapy for premature ovarian failure: from bench to bedside.</article-title> <source><italic>Tissue Eng Part B Rev.</italic></source> (<year>2022</year>) <volume>28</volume>:<fpage>63</fpage>&#x2013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1089/ten.TEB.2020.0205</pub-id> <pub-id pub-id-type="pmid">33427039</pub-id></citation></ref>
<ref id="B256"><label>256.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bidet</surname> <given-names>M</given-names></name> <name><surname>Bachelot</surname> <given-names>A</given-names></name> <name><surname>Bissauge</surname> <given-names>E</given-names></name> <name><surname>Golmard</surname> <given-names>JL</given-names></name> <name><surname>Gricourt</surname> <given-names>S</given-names></name> <name><surname>Dulon</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure.</article-title> <source><italic>J Clin Endocrinol Metab.</italic></source> (<year>2011</year>) <volume>96</volume>:<fpage>3864</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2011-1038</pub-id> <pub-id pub-id-type="pmid">21994953</pub-id></citation></ref>
<ref id="B257"><label>257.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname> <given-names>WH</given-names></name> <name><surname>Kelsey</surname> <given-names>TW</given-names></name></person-group>. <article-title>Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography.</article-title> <source><italic>Hum Reprod (Oxford, England).</italic></source> (<year>2004</year>) <volume>19</volume>:<fpage>1612</fpage>&#x2013;<lpage>7</lpage>.</citation></ref>
<ref id="B258"><label>258.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Broekmans</surname> <given-names>FJ</given-names></name> <name><surname>Soules</surname> <given-names>MR</given-names></name> <name><surname>Fauser</surname> <given-names>BC</given-names></name></person-group>. <article-title>Ovarian aging: mechanisms and clinical consequences.</article-title> <source><italic>Endocr Rev.</italic></source> (<year>2009</year>) <volume>30</volume>:<fpage>465</fpage>&#x2013;<lpage>93</lpage>.</citation></ref>
<ref id="B259"><label>259.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>S</given-names></name> <name><surname>Sun</surname> <given-names>M</given-names></name> <name><surname>Yu</surname> <given-names>L</given-names></name> <name><surname>Wang</surname> <given-names>Y</given-names></name> <name><surname>Yao</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>D</given-names></name></person-group>. <article-title>Niacin Inhibits Apoptosis and Rescues Premature Ovarian Failure.</article-title> <source><italic>Cell Physiol Biochem.</italic></source> (<year>2018</year>) <volume>50</volume>:<fpage>2060</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1159/000495051</pub-id> <pub-id pub-id-type="pmid">30415247</pub-id></citation></ref>
<ref id="B260"><label>260.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname> <given-names>T</given-names></name> <name><surname>Jayawardana</surname> <given-names>BC</given-names></name> <name><surname>Tetsuka</surname> <given-names>M</given-names></name> <name><surname>Miyamoto</surname> <given-names>A</given-names></name></person-group>. <article-title>Differential effect of follicle-stimulating hormone and estradiol on expressions of vascular endothelial growth factor (VEGF) 120, VEGF164 and their receptors in bovine granulosa cells.</article-title> <source><italic>J Reprod Dev.</italic></source> (<year>2007</year>) <volume>53</volume>:<fpage>105</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1262/jrd.18088</pub-id> <pub-id pub-id-type="pmid">17043385</pub-id></citation></ref>
<ref id="B261"><label>261.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ovayolu</surname> <given-names>A</given-names></name> <name><surname>Karaman</surname> <given-names>E</given-names></name> <name><surname>Turgut</surname> <given-names>A</given-names></name> <name><surname>Cekici</surname> <given-names>Y</given-names></name> <name><surname>Ortabag</surname> <given-names>T</given-names></name> <name><surname>Rapisarda</surname> <given-names>A.M</given-names></name><etal/></person-group> <article-title>Endothelial cell-specific-molecule-1 (endocan) levels in women with premature ovarian insufficiency: a prospective comparative study.</article-title> <source><italic>J Obstetr Gynaecol.</italic></source> (<year>2021</year>) <volume>41</volume>:<fpage>637</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1080/01443615.2020.1789952</pub-id> <pub-id pub-id-type="pmid">32808833</pub-id></citation></ref>
<ref id="B262"><label>262.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Donato</surname> <given-names>ML</given-names></name> <name><surname>Gershenson</surname> <given-names>D</given-names></name> <name><surname>Ippoliti</surname> <given-names>C</given-names></name> <name><surname>Wharton</surname> <given-names>JT</given-names></name> <name><surname>Bast</surname> <given-names>RC</given-names> <suffix>Jr.</suffix></name> <name><surname>Aleman</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer.</article-title> <source><italic>Bone Marrow Transpl.</italic></source> (<year>2000</year>) <volume>25</volume>:<fpage>1137</fpage>&#x2013;<lpage>40</lpage>.</citation></ref>
<ref id="B263"><label>263.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noory</surname> <given-names>P</given-names></name> <name><surname>Navid</surname> <given-names>S</given-names></name> <name><surname>Zanganeh</surname> <given-names>BM</given-names></name> <name><surname>Talebi</surname> <given-names>A</given-names></name> <name><surname>Borhani-Haghighi</surname> <given-names>M</given-names></name> <name><surname>Gholami</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>Human menstrual blood stem cell-derived granulosa cells participate in ovarian follicle formation in a rat model of premature ovarian failure in vivo.</article-title> <source><italic>Cell Reprogr.</italic></source> (<year>2019</year>) <volume>21</volume>:<fpage>249</fpage>&#x2013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1089/cell.2019.0020</pub-id> <pub-id pub-id-type="pmid">31596622</pub-id></citation></ref>
<ref id="B264"><label>264.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhartiya</surname> <given-names>D</given-names></name> <name><surname>Shaikh</surname> <given-names>A</given-names></name> <name><surname>Anand</surname> <given-names>S</given-names></name> <name><surname>Patel</surname> <given-names>H</given-names></name> <name><surname>Kapoor</surname> <given-names>S</given-names></name> <name><surname>Sriraman</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>Endogenous, very small embryonic-like stem cells: critical review, therapeutic potential and a look ahead.</article-title> <source><italic>Hum Reprod Update.</italic></source> (<year>2016</year>) <volume>23</volume>:<fpage>41</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1093/humupd/dmw030</pub-id> <pub-id pub-id-type="pmid">27614362</pub-id></citation></ref>
<ref id="B265"><label>265.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhartiya</surname> <given-names>D</given-names></name> <name><surname>Sharma</surname> <given-names>D</given-names></name></person-group>. <article-title>Ovary does harbor stem cells - size of the cells matter!</article-title> <source><italic>J Ovarian Res.</italic></source> (<year>2020</year>) <volume>13</volume>:<issue>39</issue>. <pub-id pub-id-type="doi">10.1186/s13048-020-00647-2</pub-id> <pub-id pub-id-type="pmid">32303227</pub-id></citation></ref>
<ref id="B266"><label>266.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>H&#x00F6;glund</surname> <given-names>M</given-names></name></person-group>. <article-title>Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)&#x2013;what is the difference?</article-title> <source><italic>Med Oncol (Northwood, London, England).</italic></source> (<year>1998</year>) <volume>15</volume>:<fpage>229</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1007/BF02787205</pub-id> <pub-id pub-id-type="pmid">9951685</pub-id></citation></ref>
<ref id="B267"><label>267.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skaznik-Wikiel</surname> <given-names>ME</given-names></name> <name><surname>McGuire</surname> <given-names>MM</given-names></name> <name><surname>Sukhwani</surname> <given-names>M</given-names></name> <name><surname>Donohue</surname> <given-names>J</given-names></name> <name><surname>Chu</surname> <given-names>T</given-names></name> <name><surname>Krivak</surname> <given-names>TC</given-names></name><etal/></person-group> <article-title>Granulocyte colony-stimulating factor with or without stem cell factor extends time to premature ovarian insufficiency in female mice treated with alkylating chemotherapy.</article-title> <source><italic>Fertil Steril.</italic></source> (<year>2013</year>) <volume>99</volume>:<fpage>2045</fpage>&#x2013;<lpage>54.e3</lpage>.</citation></ref>
<ref id="B268"><label>268.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mantawy</surname> <given-names>EM</given-names></name> <name><surname>Said</surname> <given-names>RS</given-names></name> <name><surname>Kassem</surname> <given-names>DH</given-names></name> <name><surname>Abdel-Aziz</surname> <given-names>AK</given-names></name> <name><surname>Badr</surname> <given-names>AM</given-names></name></person-group>. <article-title>Novel molecular mechanisms underlying the ameliorative effect of N-acetyl-L-cysteine against &#x03B3;-radiation-induced premature ovarian failure in rats.</article-title> <source><italic>Ecotoxicol Environ Saf.</italic></source> (<year>2020</year>) <volume>206</volume>:<issue>111190</issue>. <pub-id pub-id-type="doi">10.1016/j.ecoenv.2020.111190</pub-id> <pub-id pub-id-type="pmid">32871518</pub-id></citation></ref>
<ref id="B269"><label>269.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Liu</surname> <given-names>MW</given-names></name> <name><surname>He</surname> <given-names>Y</given-names></name> <name><surname>Deng</surname> <given-names>N</given-names></name> <name><surname>Chen</surname> <given-names>Y</given-names></name> <name><surname>Huang</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Protective effect of resveratrol on estrogen deficiency-induced osteoporosis though attenuating NADPH oxidase 4/nuclear factor kappa B pathway by increasing miR-92b-3p expression.</article-title> <source><italic>Int J Immunopathol Pharmacol.</italic></source> (<year>2020</year>) <volume>34</volume>:<issue>2058738420941762</issue>. <pub-id pub-id-type="doi">10.1177/2058738420941762</pub-id> <pub-id pub-id-type="pmid">32674689</pub-id></citation></ref>
<ref id="B270"><label>270.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Recchia</surname> <given-names>F</given-names></name> <name><surname>Necozione</surname> <given-names>S</given-names></name> <name><surname>Bratta</surname> <given-names>M</given-names></name> <name><surname>Rosselli</surname> <given-names>M</given-names></name> <name><surname>Guerriero</surname> <given-names>G</given-names></name> <name><surname>Rea</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>analogues in the treatment of young women with early breast cancer: long-term follow-up of a phase II study.</article-title> <source><italic>Int J Oncol.</italic></source> (<year>2015</year>) <volume>46</volume>:<fpage>1354</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.3892/ijo.2014.2811</pub-id> <pub-id pub-id-type="pmid">25572674</pub-id></citation></ref>
<ref id="B271"><label>271.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>S</given-names></name> <name><surname>Pei</surname> <given-names>L</given-names></name> <name><surname>Hu</surname> <given-names>T</given-names></name> <name><surname>Jia</surname> <given-names>M</given-names></name> <name><surname>Wang</surname> <given-names>S</given-names></name></person-group>. <article-title>Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China.</article-title> <source><italic>Hum Reprod (Oxford, England).</italic></source> (<year>2021</year>) <volume>36</volume>:<fpage>976</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/deaa349</pub-id> <pub-id pub-id-type="pmid">33411897</pub-id></citation></ref>
<ref id="B272"><label>272.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>J</given-names></name> <name><surname>Fang</surname> <given-names>L</given-names></name> <name><surname>Shi</surname> <given-names>L</given-names></name> <name><surname>Lai</surname> <given-names>Z</given-names></name> <name><surname>Lu</surname> <given-names>Z</given-names></name> <name><surname>Xiong</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Protective effects and mechanisms investigation of Kuntai capsule on the ovarian function of a novel model with accelerated aging ovaries.</article-title> <source><italic>J Ethnopharmacol.</italic></source> (<year>2017</year>) <volume>195</volume>:<fpage>173</fpage>&#x2013;<lpage>81</lpage>.</citation></ref>
<ref id="B273"><label>273.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>H</given-names></name> <name><surname>Qin</surname> <given-names>F</given-names></name> <name><surname>Liu</surname> <given-names>A</given-names></name> <name><surname>Sun</surname> <given-names>Q</given-names></name> <name><surname>Wang</surname> <given-names>Q</given-names></name> <name><surname>Li</surname> <given-names>Q</given-names></name><etal/></person-group> <article-title>Kuntai capsule attenuates premature ovarian failure through the PI3K/AKT/mTOR pathway.</article-title> <source><italic>J Ethnopharmacol.</italic></source> (<year>2019</year>) <volume>239</volume>:<issue>111885</issue>.</citation></ref>
<ref id="B274"><label>274.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>M</given-names></name> <name><surname>Xie</surname> <given-names>L</given-names></name> <name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Liu</surname> <given-names>J</given-names></name> <name><surname>Nie</surname> <given-names>G</given-names></name> <name><surname>Yang</surname> <given-names>H</given-names></name></person-group>. <article-title>Synergistic effect of Huyang Yangkun Formula and embryonic stem cells on 4-vinylcyclohexene diepoxide induced premature ovarian insufficiency in mice.</article-title> <source><italic>Chin Med.</italic></source> (<year>2020</year>) <volume>15</volume>:<issue>83</issue>. <pub-id pub-id-type="doi">10.1186/s13020-020-00362-6</pub-id> <pub-id pub-id-type="pmid">32774448</pub-id></citation></ref>
<ref id="B275"><label>275.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>L</given-names></name> <name><surname>Wu</surname> <given-names>S</given-names></name> <name><surname>Cao</surname> <given-names>D</given-names></name> <name><surname>Li</surname> <given-names>M</given-names></name> <name><surname>Liu</surname> <given-names>J</given-names></name> <name><surname>Nie</surname> <given-names>G</given-names></name><etal/></person-group> <article-title>Huyang yangkun formula protects against 4-Vinylcyclohexene diepoxide-induced premature ovarian insufficiency in rats via the Hippo-JAK2/STAT3 signaling pathway.</article-title> <source><italic>Biomed Pharmacother Biomed Pharmacother.</italic></source> (<year>2019</year>) <volume>116</volume>:<issue>109008</issue>. <pub-id pub-id-type="doi">10.1016/j.biopha.2019.109008</pub-id> <pub-id pub-id-type="pmid">31152926</pub-id></citation></ref>
<ref id="B276"><label>276.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>P&#x00E9;rez-Palma</surname> <given-names>EP</given-names></name> <name><surname>May</surname> <given-names>P</given-names></name> <name><surname>Iqbal</surname> <given-names>S</given-names></name> <name><surname>Niestroj</surname> <given-names>LM</given-names></name> <name><surname>Du</surname> <given-names>J</given-names></name> <name><surname>Heyne</surname> <given-names>HO</given-names></name><etal/></person-group> <article-title>Identification of pathogenic variant enriched regions across genes and gene families.</article-title> <source><italic>Genome Res.</italic></source> (<year>2020</year>) <volume>30</volume>:<fpage>62</fpage>&#x2013;<lpage>71</lpage>.</citation></ref>
</ref-list>
</back>
</article>
